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Abstract 
Proteins are the molecular machines that control and regulate most of the vital cellular functions 
in living organisms, and account for about half of the total dry mass of the cell. For a protein to 
function properly, it must attain its correct conformation and location within the crowded milieu 
of the cell. A complex set of molecular chaperone proteins assist polypeptides to acquire their 
native functional fold within the relevant biological timescale. However, the intricacy and 
diverse nature of the protein folding process and various environmental factors present 
numerous opportunities for error, which may lead to its misfolding and aggregation. Misfolded, 
aggregated, non-functional proteins and peptides within the cell are implicated with more than 
55 pathological conditions including various neurodegenerative diseases such as Alzheimer’s, 
Parkinson’s and haemodialysis-related amyloidosis, which together affect more than 24 million 
people worldwide. Collectively, these disorders are classified as protein conformational or 
protein aggregation diseases. Over the past few years, significant progress has been made to 
understand the various types and processes of protein aggregation, identify the toxic species, 
structurally characterise various species generated during their assembly and comprehend the 
underlying mechanisms which regulate protein conformational diseases. This thesis has 
attempted to address some of the issues discussed above, to assist in advancing the 
understanding of the complexities of protein misfolding, aggregation and their mitigation.  
In this thesis, I have found that various fragments of mouse Acyl co-enzyme thioesterase 7 
(mAcot7) and human full-length ACOT7 form amyloid fibrils under physiological conditions. 
Acot7 is a brain cytosolic protein, involved in fatty acid metabolism, and has a putative role 
during inflammation. Using various mouse Acot7 constructs, I demonstrated that mAcot7 
undergoes nucleation-independent, multi-stranded polymerisation, leading to the formation of 
globular oligomeric species and subsequently amyloid fibrils. Arachidonoyl-CoA, the substrate 
of mAcot7 did not prevent the fibrillation of mAoct7, and the protein remained enzymatically 
active throughout the assembly process. Understanding the biological significance of fibrillar 
and other forms of Acot7 is one of the avenues to be explored in the future.  
After putting forth a unique molecular model of mouse Acot7 fibrillation, the next objective 
was to identify and characterise the heterogeneous population of protein aggregates formed 
during polymerisation. Bis(Triphenylphosphonium) tetraphenylethene (TPE-TPP), a novel 
aggregation-induced emission luminogen aided in detecting early-stage protein aggregates; the 
species that are considered to be the most toxic entities during the development and progression 
of protein conformational diseases. Compared to traditional amyloid binding fluorescent dyes 
such as Thioflavin T (ThT), TPE-TPP showed a broader applicability in monitoring the process 
of fibrillation in various conditions such as acidic pH, elevated temperature, presence of 
potential amyloid inhibitors, and its ability to detect variations in amyloid fibril morphologies. 
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Once I could differentiate between the different species generated during protein aggregation, 
I attempted to explore ways to modify these entities. Utilising the intra- and extra-cellular 
molecular chaperones αB-crystallin (αB-C), clusterin, α2-macroglobulin and haptoglobin, I 
observed that αB-C and clusterin stabilise various forms of D76N β2-microglobulin (a potent 
amyloidogenic variant of β2-microglobulin) generated during the fibrillation process. It is 
likely that these chaperones prevent primary and secondary nucleation of D76N β2-
microglobulin (D76N β2m) fibrillation in vivo and decelerate the proliferation of amyloid fibril 
plaques. 
Experiments performed in vitro are usually less confined compared to the crowded cellular 
environment, and such crowding conditions further confound the process of protein aggregation. 
Moreover, oligomers of various amyloid proteins such as α-synuclein (αS) are believed to be 
the primary cause of cellular damage, for example in Parkinson’s disease. Utilising the highly 
identical presynaptic α- and β-synuclein and crowding agents such as Ficoll 400, I analysed the 
impact of crowding on the association of the synuclein proteins. Under physiologically relevant 
conditions, I found that β-synuclein (βS) exists as positively charged oligomers, which 
gradually polymerise to form self-assembled, non-amyloid fibril-like structures. Furthermore, 
βS destabilises αS and induces its aggregation, which is significantly moderated under the 
crowded cell-like environment.  
The results documented in this dissertation have assisted in advancing our knowledge and 
understanding of the molecular, biophysical and biochemical mechanisms of amyloid fibril 
formation. In addition, this thesis determined the broader applicability of TPE-TPP compared 
to the standard amyloid dye (i.e. ThT) as a fluorescent probe to monitor amyloid fibril formation, 
detect early-stage aggregates, variations in fibril morphologies, and can be deemed useful in 
screening amyloid inhibitors. Part of the aim to identify and characterise various protein 
aggregate species was to develop a method for regulating potentially toxic entities. I showed 
that intra- and extra-cellular molecular chaperones were capable of acting on different stages 
of D76N β2m aggregation, thereby reducing the effects of undesirable, misfolded toxic protein 
forms. Furthermore, I demonstrated that there could be other potentially hazardous forms of 
unwanted protein aggregates (i.e. βS self-assembled structures) that are not necessarily amyloid 
fibrils. Greater comprehension of protein aggregation will not only shed light on protein 
conformational disorders and aid in the development of therapeutics against their toxic effects, 
but may also offer insights into opportunities for exploiting stable, non-toxic protein 
conformations to our advantage.  
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CHAPTER 1  
Introduction 
Proteins are long polypeptide chains of amino acids that regulate most of the vital cellular 
functions in living organisms and account for about half of the total dry mass of the cell (1). Short 
polypeptides containing ~20-40 amino acid residues are often termed peptides or oligopeptides. 
For the majority of proteins to become functional, a nascent polypeptide must fold into a correct 
three-dimensional conformation, which is highly dependent on the intrinsic properties of their 
amino acid sequences and the crowded cellular milieu (2). Furthermore, proteins must maintain 
their structural integrity to perform their required function and thus have a limited range of 
thermodynamically stable conformers under physiological conditions. Approximately half of the 
mammalian proteins have long regions of disordered structures, and a quarter of these are 
predicted to be intrinsically disordered in nature (3). Although many aspects of proteins acquiring 
their native functional form via folding are intrinsic to the biophysical and biochemical properties 
of the protein itself, the micro-/milli-second timescale of the protein folding process provides a 
window of opportunity for errors (4). Protein misfolding and aggregation have generated much 
excitement worldwide among protein chemists and neurobiologists since the introduction of the 
concept in 1974 by Goldberg and his colleagues. They suggested that the aggregation of 
tryptophanase was facilitated through the intermolecular contact of two separate polypeptide 
chains, which was driven by the same stereospecific interactions involved during the folding 
process of the polypeptide chain to its native functional form (5). They also advocated for the 
specificity of these intermolecular interactions and the generation of intermediate species during 
aggregation. 
 
 
Figure 1. The protein’s on- and off-folding pathways that lead to protein aggregation. An unfolded protein folds 
to its native state via the formation of partially folded intermediates. This process is fast and reversible. However, under 
conditions in which the partially folded intermediates persist (e.g. during times of cellular stress or due to mutation), 
they can mutually associate via exposed hydrophobic regions that are normally buried in the core of the protein in its 
native state. When this occurs, the intermediates aggregate via either a disordered or ordered mechanism, leading to 
the formation of amorphous (disordered) precipitates or ordered amyloid fibrils, respectively. Figure and figure legend 
is taken from Ecroyd and Carver (6). The figure legend text has been modified. 
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As shown in Figure 1, a nascent or unfolded polypeptide can attain various folds including those 
of a native conformation and an amyloid fibril via the on- and off-folding pathways, respectively. 
However, which specific features of a polypeptide that warrant folding to the correct native 
functional form are unanswered. Studies into how off-pathway entities are avoided will help in 
advancing our knowledge of de novo protein folding and refolding and may assist in alleviating 
protein aggregation associated problems. 
1.1 Different forms of protein aggregates  
The off-folding pathway comprises two common routes by which aggregation of the protein via 
the generation of intermediates (molten globule and transient oligomeric) conformations may 
occur (i.e. the process of amyloid fibril or amorphous aggregate formation). Protein aggregates 
vary in size from nanometres to millimetres in length, dimeric to large molecular entities, 
containing more than 106 subunits. Traditionally, protein aggregates have been broadly classified 
into three groups: amorphous, oligomers and amyloid fibrils (7). As the name implies, amorphous 
aggregates are disordered protein clumps, which have a short-range order containing the partially 
folded intermediates in relatively extended conformations. An oligomer is usually defined as the 
macromolecular complex formed by non-covalent interactions of natively folded proteins and 
sometimes via disulfide linkages of ~2-50 protein molecules. An amyloid fibril is a 
thermodynamically stable, insoluble filamentous protein aggregate comprising of repetitive units 
of β-sheets, having both short- and long-range order (8, 9). Moreover, recent studies have shown 
that proteins can also self-assemble to form spherulites – a spherical ordered conformer that 
exhibits a “Maltese-cross” extinction pattern when viewed under cross-polarised light (10-12). 
Capsids are another class of protein aggregates that resemble empty virus core shells. Several 
food proteins such as bovine serum albumin (BSA), ovalbumin and β-lactoglobulin also form 
fractal clusters that undergo gelation under appropriate conditions (10).  
1.2 Pathological and functional amyloid fibrils 
Among the types of protein aggregates, amyloid fibrils have attracted a lot of interest due to their 
direct involvement in many pathological conditions including Alzheimer’s disease, 
synucleinopathies such as Parkinson’s disease, Dementia with Lewy bodies, multiple system 
atrophy, haemodialysis–related amyloidosis, cataract, type 2 diabetes and systemic amyloidosis. 
In addition to amyloid-related conditions, α1–antitrypsin, antithrombin, plasminogen activator 
inhibitor 1 and other non-fibrillar aggregates result in liver disease, cataract and early-onset 
emphysema (8, 13, 14). This broad range of human diseases generally initiates from the failure 
of a particular protein, or in some cases a peptide, to adopt or maintain its native functional form 
leading to the proteinaceous deposition in the affected tissues and organs. Hence, these 
pathologies are commonly referred to as protein aggregation diseases (15-18). To date, more than 
55 human diseases associated with both extracellular and intracellular protein and peptide 
aggregates affecting various organs have been reported (see Table 1) (19, 20). 
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Table 1. A summary of the human protein aggregation diseases, the proteins or peptides involved, and 
the tissues/cells affected by them 
Clinical Condition Fibril component Tissue/Cell 
Alzheimer’s disease Aβ peptides; Tau 
Cerebral cortex and certain subcortical 
regions 
Parkinson’s disease α-synuclein Basal ganglia 
Multiple system atrophy α-synuclein 
Striatonigral, olivopontocerebellar parts 
of brain, and spinal cord 
Fronto-temporal dementia Tau Frontal lobe 
Familial Danish dementia Adan peptide Brain, spinal cord and retina 
Familial British dementia ABri peptide Brain and spinal cord 
Hereditary cerebral 
haemorrhage 
Cystatin C, Aβ peptides Cerebral blood vessels 
Amyotrophic lateral sclerosis Superoxide dismutase Nerve cells of the brain and spinal cord 
Dentatorubro-pallidoluysian 
atrophy 
Atrophin 1 
Globus pallidus, sub-thalamic nucleus and 
dentate nucleus 
Huntington disease Huntingtin Basal ganglia and the frontal lobe 
Cerebellar ataxia Ataxins Cerebellum 
Kennedy disease Androgen receptor 
Motor neurons of the brain stem and 
spinal cord 
Spinocerebellar ataxia 17 
TATA box-binding 
protein 
Cerebellum 
Haemodialysis-related 
amyloidosis 
β2-microglobulin Kidney 
Primary systemic amyloidosis Ig light chain 
Mesenchymal tissue, tongue, heart, 
gastrointestinal tract, and skin 
Secondary systemic 
amyloidosis 
Serum amyloid A Adrenal gland, liver, spleen, and kidney 
Familial Mediterranean fever Serum amyloid A Abdomen, lungs and joints 
Senile systemic amyloidosis Transthyretin Heart 
Familial amyloid 
polyneuropathy I 
Transthyretin Peripheral nervous system 
Familial amyloid 
polyneuropathy III 
Apolipoprotein A-1 Peripheral nerve tissue 
Finnish hereditary systemic 
amyloidosis 
Gelsolin Corneal stroma 
Type II diabetes Amylin Kidney, blood and heart 
Medullary carcinoma of the 
thyroid 
Calcitonin Thyroid tissues 
Atrial amyloidosis Atrial natriuretic factor Heart 
Lysozyme systemic 
amyloidosis 
Lysozyme 
Gastrointestinal tract, liver, spleen, 
adrenal glands, muscles, vessels, lymph 
nodes, bone marrow and gallbladder 
Injection-localised 
amyloidosis 
Insulin 
Repeated insulin injection site in diabetic 
patients 
Fibrinogen α-chain 
amyloidosis 
Fibrinogen Kidney 
Chronic lung diseases Surfactant protein C Lung 
Retinal dystrophies Rhodopsin Retina 
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Cataract (sporadic/congenital) γ-crystallins Lens 
Familial corneal amyloidosis Lactoferrin Cornea 
Inherited corneal dystrophies βig-h3 Cornea 
Lattice corneal dystrophies Keratoepithelin Cornea 
Pseudoexfoliation syndrome Unknown Aqueous humour 
Aortic medial amyloidosis Medin Aortic wall 
Oculopharyngeal muscular 
dystrophy 
PAPB2 Skeletal muscle 
Sporadic inclusion body 
myositis 
Amyloid β peptide Muscles of the arm and legs 
Hypotrichosis simplex of the 
scalp 
Corneodesmosin Hair follicle 
Atherosclerosis LDL/ApoB100 Vessel walls 
DFNA9 Cochlin Inner ear 
Hirschsprung disease RET Colon 
Cutaneous lichen amyloidosis Keratins Papillary dermis 
Charcot–Marie–Tooth-like 
diseases 
Myelin protein 22/0 Peripheral nerve tissue 
Short-chain acyl-CoA DH 
deficiency 
SCAD Skeletal muscle 
Pituitary prolactinoma Prolactin Pituitary gland 
Cancers p53 Tumoural tissues 
Wilson disease ATP7B Eyes, kidney, heart and brain 
Fabry’s disease α-galactosidase 
Blood vessels, skin, kidney, heart and 
brain 
Gaucher’s disease β-glucocerebrosidase Bone marrow, lungs, spleen and liver 
Marfan syndrome Fibrillin Connective tissue 
Alexander disease 
Glial fibrillary acidic 
protein (GFAP) 
Myelin 
Myotonic dystrophy 
Myotonic dystrophy 
protein kinase 
Smooth and skeletal muscle 
Cancers 
Von Hippel Lindau 
protein 
Tumoural cells 
Atrial amyloidosis of heart 
α-atrial natriuretic 
peptide 
Atria of the heart 
Serpinopathies and 
Conformational Disorders 
Serpin superfamily Liver, lungs and blood vessels 
Familial encephalopathy with 
neuroserpin inclusion bodies 
Neuroserpin Cerebral cortex 
Spongiform encephalopathies 
Prion proteins (full-
length or fragments) 
Cerebral and cerebellar cortex 
 
The assembly of amyloid fibrils into tangled amyloid plaques and their deposition in cell(s), 
tissue(s) or organ(s) are the hallmarks of most neurodegenerative diseases. However, the exact 
mechanisms by which protein aggregation causes cell damage is not yet understood. These protein 
conformational diseases are studied avidly to help develop therapeutics which halt or mitigate 
neuronal loss, as currently available treatments only alleviate symptoms. Interestingly, not all 
amyloid fibrils are pathological to the cell. The presence of naturally occurring amyloid fibril-like 
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structures have been reported to possess biologically beneficial functions. The cell produces these 
amyloid fibrils in a highly-mechanised fashion and are commonly referred to as functional 
amyloids (see Table 2) (19-34).  
Table 2. Physiological functions of proteins forming non-pathological amyloid-like fibrils 
Protein Source Function 
Curli Escherichia coli (bacterium) 
Biofilm formation, substrate adhesion 
and mediation to host cell binding, 
immune system activation 
Tafi Salmonella enterica (bacterium) 
Promote bacterial cell to cell interactions 
and aid in host invasion 
Bacterial toxins Bacterium Mediate targeted cell killing 
Microcin E492 Klebsiella pneumoniae (bacterium) 
Membrane pore formation and 
bactericidal 
Hairpins Plant pathogenic bacteria Causes plant cell death 
Chaplins Streptomyces coelicolor (bacterium) 
Decreases water surface tension and 
promotes aerial hyphae formation 
Hydrophobins Fungi 
Reduces water surface tension, 
modulates adhesion and fungal coat 
formation 
HET-s (prion) Podospora anserine (fungi) 
Modulation of heterokaryon formation 
for self/non-self- recognition during 
complex programmed cell death 
phenomenon 
URE2p (prion) Saccharomyces cerevisiae (yeast) Aid in the nitrogen regulation system 
Swi1p (prion) Saccharomyces cerevisiae (yeast) 
Global gene regulation and chromatin 
remodelling 
Sup35p (prion) Saccharomyces cerevisiae (yeast) Facilitate stop codons on mRNA 
Rnq1p (prion) Saccharomyces cerevisiae (yeast) 
Ease the appearance of other prion 
strains 
Mot3p (prion) Saccharomyces cerevisiae (yeast) Increases phenotypic heterogeneity 
Chorion Bombyx mori (silkmoth) 
Structural and protective function in egg 
and embryo 
Spidroin Nephila edulis (spider) 
Maintain structural properties such as 
spider silk fibre formation 
Neuronal CPEB 
(prion) 
Aplysia californica (marine snail) 
Facilitation and long-term maintenance 
of synaptic signals 
Crystallins Mammals 
Maintain the refractive index of the eye 
lens 
Pore proteins Mammals Regulate cell death/apoptosis 
Serum amyloid 
A 
Mammals 
Activation of the inflammasome 
cascade, epigenetic regulation 
Aβ peptides Homo sapiens 
Small cerebral vessel sealing and 
antimicrobial activity 
Peptide 
hormones 
Homo sapiens 
Natural storage, categorisation and 
release of diverse hormones 
Pmel17 Homo sapiens 
Involved in premelanosomes formation, 
scaffolding and protection from toxic 
intermediates 
 
Table 1 summarises the extensive list of human diseases associated with amyloid fibrils implying 
that the process of amyloid formation is innately toxic to cells. However, the ever-increasing list 
of peptides and proteins that form functional amyloid fibrils present a contrasting view. 
Furthermore, structural polymorphisms of amyloid fibrils have been seen with numerous 
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polypeptide systems, for example, amylin, glucagon, calcitonin, insulin, lysozyme and various 
Aβ constructs (35-40). It seems quite likely that the variations in molecular structures may 
generate many different amyloid states with distinct activities. Thus, toxicity like other protein 
functions may be associated with particular conformations of polypeptides (41, 42). 
1.3 Molecular structure of amyloid fibrils  
Typically, a mature amyloid fibril is comprised of 2-6 protofilaments, which twist around each 
other to form a helical rope-like structure of 10-30 nm in diameter (43, 44). The repeating β-sheet 
motifs constitute the core of the amyloid protofilament (45). Each protofilament possesses parallel 
or antiparallel β-strands which run perpendicular to the fibrillar axis and is stabilised by the cross-
β sheet interaction, giving rise to the characteristic X-ray fibre diffraction pattern with an intra-β 
strand meridional reflection at ~4.7 Å and an inter-β sheet equatorial reflection at ~9-11 Å (see 
Figure 2) (46, 47). 
 
 
Figure 2. Underlying structure of amyloid fibrils. (A) Amyloid fibrils are composed of long filaments that are visible 
in negatively stained transmission electron micrographs. (B) The schematic diagram of the cross-β sheets in a fibril, 
with the backbone hydrogen bonds represented by dashed lines, indicates the repetitive spacing that gives rise to the 
X-ray fibre diffraction pattern. (C) The typical fiber diffraction pattern with a meridional reflection at ∼4.7 Å (black 
dashed box) and an equatorial reflection at ∼6–11 Å (white dashed box). Figure and figure legend is taken from 
Greenwald and Riek (41).  
 
Due to the amyloid fibril’s ability to adopt more than one quaternary conformation, significant 
morphological differences exist (39, 40, 48, 49). Morphological variations formed from the same 
peptides, proteins or different polypeptides depend on its growth conditions (e.g. pH, salt(s), 
temperature, agitation, polypeptide concentration) as well as heterogeneity in the positioning of 
the polypeptide chain within the fibrils (19, 50, 51). Atomic resolution of the amyloid fibril’s 
typical “cross-β motif” revealed a conformer named the “steric zipper” which is comprised of a 
pair of tightly bound β-sheets. Steric zippers are formed from short self-complementary sequences 
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that repeat along the fibril’s length. The basic arrangement of steric zippers in amyloid fibrils 
depend on the β-strand alignment as parallel or antiparallel and “face-to-face” or ‘face-to-back” 
packing, and “up-up” or “up-down” orientation (see Figure 3). These arrangements form the basis 
of fibril polymorphism (52). 
 
 
Figure 3. Two identical sheets can be classified by: the orientation of their faces (either ‘face-to-face’ or ‘face-to-
back’), the orientation of their strands (with both sheets having the same edge of the strand ‘up’, or one ‘up’ and the 
other ‘down’), and whether the strands within the sheets are parallel or antiparallel. Both side views (left) and top views 
(right) show which of the six residues of the segment point into the zipper and which point outward. Green arrows 
show two-fold screw axes, and yellow arrows show translational symmetry. Below each class are listed protein 
segments that belong to their respective class. Figure and figure legend is taken from Sawaya et al (52). 
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1.4 Molecular mechanisms of amyloid fibril formation 
Apart from different fibril forms or polymorphs, amyloid-forming proteins can exhibit many 
intermediate species including transient, low molecular weight oligomers and prefibrillar entities, 
during fibrillogenesis (37, 53-60). Full elucidation of the aggregation process is required to 
understand these variations and transitions. The reaction scheme involved in protein aggregation 
is a complicated, mutually inter-dependent process, with multiple assembly pathways and is prone 
to mutations and changes in its environment (61-64). To simplify, the pathways have been 
categorised into three broad groups (see Table 3 and Figure 4a): (a) nucleation-dependent 
assembly, (b) two-state polymerisation and (c) biological assembly via domain-swapping. 
Nucleation-dependent or the “nucleated-growth” mechanism is a widely accepted polymerisation 
method where the assembly of proteins is mediated via the intermediate, unfavourable nuclei.  
Table 3. Various models of protein aggregation with example(s) and their characteristic features 
Model of aggregation Example(s) Characteristic Features 
Active polymerisation (AP 
model) (65-67) 
Actin and Tubulin 
Involves nucleoside triphosphate hydrolysis, 
equilibrium nucleation in actin, downhill 
polymerisation (forward nucleation) in 
tubulin, fibril elongation via subsequent 
monomer addition, secondary nucleation via 
fibril fragmentation in both. 
Heterogeneous-nucleation 
polymerisation (DNP 
model) (68, 69) 
Sickle cell 
haemoglobin, Insulin 
Homogeneous nucleation of a single fibre, 
secondary growth through heterogeneous 
nucleation leading to branching in sickle cell 
haemoglobin. Secondary nucleation pathway 
controls fibril formation in insulin. 
Templated assembly (TA 
model) (70-73) 
Fibronectin, Laminin, 
Collagen, Prion 
Nucleation-dependent, receptor-mediated 
polymerisation facilitated by a preformed 
matrix. 
Monomer-directed 
conversion (MDC model) 
(74-77) 
Prion, Stefin B at pH 
7, Transthyretin, 
Carboxypeptidase D 
Nucleation-dependent, linear/co-operative 
autocatalysis in the case of prion proteins. 
formation of an amyloidogenic monomer 
leading to oligomers formation and further 
assembly due to the lateral association of the 
monomer to pre-existing fibrils in the event of 
transthyretin and carboxypeptidase D. 
Nucleated polymerisation 
(NP model) (78)  
Amyloid-β peptide 
Nucleation-dependent, micelle formation 
above a critical protein concentration and 
irreversible binding of monomers to the fibril 
ends. 
Nucleated conformational 
conversions (79-81) 
Sup35 (prion), Aβ-
42, Barstar 
Nucleation-dependent, the smooth oligomeric 
complex formation is critical for nuclei 
formation. An association of the nuclei and the 
smooth oligomeric complex brings 
conformational changes in the latter, leading 
to fibril formation. Protofibril formation in 
Barstar is nucleation independent. 
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Polar zipper model (82-84) Huntingtin, Ataxin-3 
Nucleation-dependent, similar to the 
templated assembly model, characterised by 
the stabilisation of β-sheets via hydrogen 
bonds between polar side chains. 
Critical oligomers (CO 
model) (85) 
Phosphoglycerate 
kinase 
Irreversible process, formation of the critical 
oligomer is the necessary first step leading to 
the formation of protofibrils and fibrils 
through a generalised diffusion-collision 
process. 
Dipole assembly (DA) 
model (86, 87) 
Sup35, hTau40 
Generation of granular or spherical oligomers 
are critical, followed by linear polymerisation 
based on intrinsic dipole moment, charge-
dipole and dipole-dipole interactions are 
crucial factors for amyloid formation. 
Amyloidogenic precursor 
(AP) model (60)  
RCM κ-casein 
Dissociation of an amyloidogenic monomer 
from an oligomer is an important step in fibril 
formation. 
Double-concerted 
fibrillation (DCF) model 
(64, 88, 89)  
Amyloid-β, α-
synuclein, Poly-
glutamine sequences 
Association of the monomers into globular 
oligomers followed by protofibril generation 
in the absence of a template, subsequent 
structural rearrangement leading to fibril 
formation. 
Run-away (RA) model (90, 
91) 
T7 endonucleases, 
trpR 
Each molecule swaps a domain of subsequent 
neighbouring protein molecules in an open-
ended or runaway manner to produce higher-
order oligomers. 
Propagated domain-
swapping (PDS) model (92-
94) 
Cystatin C, RNAse 
A, PrPC, 
Continuous domain-swapping leads to the 
formation of disulfide stabilised oligomers and 
fibrils. 
Strand insertion and 
complementation (SIC) 
model (95-99)  
Serpins, α1-
antitrypsin, Rad51-
BRCA2, Pilus 
assembly 
In this form, the fibril is completed or 
expanded through the joining of two β-strands 
from another domain of the same molecule or 
different proteins through a process called 
donor strand complementation. 
Proline cis/trans 
isomerisation (PI) model 
(57, 100-105) 
Stefin-B, RNAse A, 
Stefin-A, β2-
microglobulin 
Proline cis/trans isomerisation acts as a gate-
keeper for the formation of domain-swapped 
oligomers, which acts as direct precursor for 
further polymerisation. 
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Figure 4a.  Schematic representations of three mechanisms of amyloid fibril formation. (A) The templated 
assembly (TA) model. In the TA model, in a rapid pre‐equilibrium step, the soluble state (S) molecules that are initially 
in a random coil conformation bind to a pre‐assembled (A) state nucleus. This binding induces the rate‐determining 
structural change from the random coil to the β‐pleated sheet structure as the molecule is added to the growing end of 
the fibril. (B) The monomer-directed conversion (MDC) model. In the MDC model, a pre‐existing monomer in the A‐
state conformation, analogous to the conformation adopted in the fibrils, binds to the soluble S‐state monomer and 
converts it to an A‐state dimer in a rate‐determining step. The dimer then dissociates, and the constituent A‐state 
monomers add to the growing end of the fibril. (C) The nucleation-dependent polymerisation (NDP) model. This model 
describes that when partially unfolded intermediates are present at a critical concentration, they slowly assemble into a 
nucleus. These oligomeric nuclei rapidly grow into globular oligomers and after reaching a critical size, form chain-
like protofibrils. We consider that the final structure labelled as ‘amyloid’ represents protofibrils rather than fibrils. The 
NDP model also predicts a lag phase that arises from the fact that the dissociation rate is initially greater than the 
association rate. Figure and figure legend is taken from Zerovnik et al (108). The figure legend text has been modified. 
 
The initiation of amyloid fibril formation is difficult, and the system is viewed as ascending an 
activation energy barrier for the fibrillation to proceed. This unusual, high energy species, 
commonly known as the nucleus, is the rate limiting step in amyloid fibril formation (106, 107).  
The development of the core may depend on various factors and hence are sub-categorised as 
active polymerisation (AP), double-nucleation polymerisation (DNP), templated assembly (TA), 
monomer-directed conversion (MDC), nucleated polymerisation (NP), the nucleated 
conformational conversion (NCC), nucleation-dependent polymerisation (NDP) and polar zipper 
models. All these models are strictly characterised by the presence of a lag phase, are heavily 
dependent on the critical nucleus concentration for the initiation of polymerisation, as the 
introduction of preformed fibrils as seeds abolishes the lag phase (108). Two-state polymerisation 
can also be termed as a linear association where protein assembly can commence from any of the 
monomeric/oligomeric subunits. Polymerisation is mediated by one kind of identical association, 
and the rate is fastest at the start of the reaction, which is heavily dependent on the concentration 
of the amyloidogenic precursor. It is characterised by the absence of a separate nucleation and 
elongation phase with no critical concentration barrier (65, 109). Models such as critical 
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oligomers (CO), dipole assembly (DA), amyloidogenic precursor (AP) and double-concerted 
fibrillation (DCF) fall under this category (108) (See Figure 4b). Domain swapping is a three-
dimensional phenomenon by which two identical protein subunits exchange a part of their chain 
or structure to form oligomers which usually act as the starting point for fibril formation. 
Oligomer formation due to domain-swapping is the rate limiting step for the initiation of 
fibrillation and often requires a very high activation energy. Different models such as run-away 
(RA), propagated domain-swapping (PDS), strand insertion and complementation (SIC), and 
proline cis-trans isomerisation (PI) have been suggested for amyloid fibril formation based on 
domain-swapping (108, 110).  
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Figure 4b.  Schematic representations of four mechanisms of amyloid fibril formation, continued: (D) The dipole 
assembly (DA) model. In the first step, nucleation units (globular oligomers) form in a process driven by the surface 
chemical potential. In the second step, the nucleation units aggregate linearly as a result of their intrinsic dipole moment. 
(E) The double concerted fibrillation (DCF) model. The final structure labelled as ‘amyloid’ represents protofibrils 
rather than fibrils. In this step, the interactive surfaces of the monomers shift from intra‐ oligomeric to inter-oligomeric. 
With the application of shear stress or organic solvents, oligomeric granules become distorted and fibril growth takes 
place almost instantaneously. (F) The general off-pathway folding (OFF) model. In this model, denatured monomers 
M
u
 are refolded into either stable the monomer M or dimer D (the latter could be domain‐ swapped) or a less stable 
dimeric intermediate I (which again could be a partially‐ unfolded domain‐ swapped dimer). The initial steps are 
practically irreversible, and are followed by cooperative assembly of the fibril-prone dimeric intermediates, I, into a 
nucleus, N, from which thin filaments, f, originate. Filaments grow linearly by repeated addition of I, and fibrils, F, 
form by lateral association of the filaments. F also elongate by end‐ to‐ end association. (G) Off‐ pathway oligomers 
model, branching at the domain‐ swapped dimer, as derived for stefin B. The growth phase shows an anomalous 
dependence on protein concentration, which is explained by off‐ pathway oligomer formation with a rate‐ limiting 
escape rate. Figure and figure text is taken from Zerovnick et al (108). The figure text has been modified.  
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1.5 Detection and monitoring of amyloid fibril formation  
In almost all of these cases, the formation of a mature fibril is preceded by the development of a 
soluble spherical/chain-like, high molecular weight entity known as the prefibrillar species. Most 
of the time, prefibrillar aggregates are formed from the association of many low molecular weight 
oligomers/amyloidogenic precursors. In the past few decades, several attempts have been directed 
towards the identification, isolation and characterisation of prefibrillar aggregates or protofibrils 
to fully elucidate the mechanism of amyloid fibril formation, fibril polymorphism and to discern 
between pathological and functional amyloid (19). Studies have revealed different protofibril 
assemblies such as spherical beads, linear/curly chains and annular structures of 2-5 nm in 
diameter (111-113). Interestingly, these species are made up of ~20 molecules (114), display 
antibody-specificity (115), contain extensive β-sheet conformers and can bind to Thioflavin T 
(ThT) and Congo red (CR) (112). These characteristics have been observed in many protein 
aggregating systems including α-synuclein (116) and β2-microglobulin (117). There is growing 
evidence that the soluble oligomeric intermediates in the aggregation pathways are primarily the 
pathogenic species in many protein deposition diseases (118-120). The structural element of these 
intermediates that causes cellular dysfunction has been a long standing question due to their 
dynamic and heterogeneous nature. Furthermore, Campioni et al (121) observed that HypF-N 
produces two types of oligomers which are morphologically and tinctorially similar, although 
they have different functions. One form of the 91 residues N-terminal domain of Escherichia coli 
(HypF-N) causes damage to cells while the other is benign. Such diverse oligomeric species have 
also been demonstrated in other proteins including α-synuclein, emphasising the conformational 
complexities of the oligomerisation process (122, 123). 
As discussed above, one of the main issues affecting our understanding of protein conformational 
diseases is to precisely define the conformation, dynamics and biochemical properties of the 
heterogeneous population preceding amyloid fibril formation. ‘‘Know your product(s)” is the first 
step to identify ways to inhibit disease-related protein aggregation and prevent its effect (124, 
125) .  Fluorescent dye-binding assays have traditionally been used to recognise in vitro amyloid 
fibril formation. Table 4 summarises a list of external molecular probes with their characteristics 
and shortcomings, which have been utilised for the comprehension of protein complexities 
associated with protein aggregation as discussed above. Thioflavin T is one of the most commonly 
used extrinsic probes for monitoring in vitro protein fibril formation (126, 127). Some 
fluorophores themselves can interestingly enhance amyloid fibrillation (128). Apart from other 
ThT shortcomings listed in Table 4, its inability to bind and detect low/high molecular weight 
oligomers and protofibril (129), presents an additional difficulty to completely understand the 
protein aggregation process. For this reason, there is still a need for accurate and improved probes 
to monitor oligomer formation, fibril growth and their respective dynamics. 
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Table 4. List of small molecule fluorescent probes to monitor protein aggregation 
Extrinsic 
Fluorophores 
Population of Species 
Detected 
Advantages/Disadvantages 
Congo red (CR) 
(130) 
Amyloid fibril 
Gold standard for amyloid fibril detection in vitro 
and cell cultures, histopathological staining of 
amyloid plaques, promotes β-sheet formation and 
proliferates amyloid β (1-40) aggregation (131), 
inhibits amyloid fibril formation (132). 
CR derivatives such 
as Chrysamine G 
(133), Methoxy-X04, 
X-34 (134) 
Amyloid fibril 
Does not inhibit/or induce β-sheet formation, 
limited ability to cross the blood-brain-barrier 
(BBB). 
Thioflavin T (ThT) 
(135, 136)  
Amyloid fibril  
(amyloid plaques) 
In vitro characterisation of amyloid fibril 
formation, histopathological staining of amyloid 
plaques, not suitable for in vivo imaging, spectral 
properties are influenced by various external 
factors such as (a) the presence of small molecule 
inhibitors or exogenous compounds (137, 138), (b) 
composition/properties of buffers, such as, pH, 
viscosity (127) and (c) protein-to dye ratios (139). 
Also interacts and emits characteristic 
fluorescence at 485 nm upon binding to DNA 
(140). 
ThT derivatives such 
as Thioflavin S 
(ThS), Pittsburgh 
compound-B (PIB), 
TZDM, IMSB, 
IMPY (141-144) 
Amyloid fibril 
(amyloid plaques) 
Used mainly for in vivo positron emission 
tomography (PET) and single photon emission 
computed tomography (SPECT) imaging. 
Stilbene derivatives 
such as (m-l-
stilbene) (145) 
Amyloid fibril 
(amyloid plaques) 
Used in PET and SPECT imaging. 
Vinyl benzoxazole 
derivatives such as 
(BF-227) (146) 
Amyloid fibril 
(amyloid plaques) 
High amyloid fibril binding affinities, ability to 
penetrate the BBB, rapid clearance from brain. 
FDDNP and its 
analogue (147) 
Amyloid fibril 
(amyloid plaques) 
High aggregate binding affinities, used as a 
radioligand for PET and magnetic resonance 
imaging (MRI). 
NIAD-4 and its 
derivatives (148, 
149) 
Amyloid fibril 
(amyloid plaques) 
High specificity to amyloid fibrils, long shelf life, 
rapid clearance from brain, suitable for tissue 
staining. 
9-(dicyano vinyl)-
julolidine (DCVJ) 
(150) 
Intermediate oligomers 
Used to demonstrate the tubulin assembly process, 
detection of hydrophobic microdomain formed 
during protein aggregation. 
Nile red (151) Melittin oligomers 
Does not bind to all proteins, specific to the 
detection of melittin oligomerisation and 
hydrophobic domains. 
ANS, Bis-ANS (152, 
153)  
Molten globule, early 
misfolded oligomers, 
misfolded spherical 
aggregates, protofibrils, 
amyloid fibrils 
Only been used for specific proteins such as 
transthyretin, amyloid-β peptides, islet amyloid 
polypeptide, and low specificity. 
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Thiazole orange 
(TO) (154) 
Amyloid fibril 
In situ monitoring of hen egg-white lysozyme 
(HEWL) fibrillation with higher sensitivity and 
reliability than ThT. 
BoDipy-oligomer 
(BD-Oligo) (155)   
Intermediate oligomer 
Identification of amyloid β oligomers in vitro and 
in vivo. 
N-aryl amino 
naphthalene 
sulfonate (NAS), 
Bis-NAS (156) 
Fibril, oligomers 
NAS emits a higher fluorescence intensity upon 
binding to α-synuclein fibrils compared to ThT; 
bis-NAS can detect both oligomers and fibrils of 
α-synuclein. 
BSPOTPE (157) Amyloid fibril Binds to insulin fibrils, has an inhibitory effect. 
TPE-peptide (158) Amyloid fibril Higher sensitivity and reliability than ThT. 
Conjugated 
polyelectrolyte 
(PTTA) (159) 
Amyloid fibril 
Monitors an in vitro conformational change during 
the process of amyloid formation. 
Luminescent 
conjugated 
polythiophenes 
(LCPs) such as 
POMT (160), tPTT 
(161) 
Amyloid fibril 
Differentiates between amyloid fibrils formed 
from diverse proteins. 
p-FTAA (162) 
Prefibrillar species, 
amyloid fibril 
High sensitivity, distinguishes prefibrillar 
aggregates from amyloid fibrils. 
Tryptophanol 
(TROL) (129) 
Prefibrillar species Does not bind to amyloid fibrils. 
p-TTCNAc (163) Prefibrillar oligomers 
Monitors HEWL amyloid formation and 
prefibrillar oligomers. 
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1.6 Molecular crowding and proteostasis - the role of molecular chaperone proteins during 
protein aggregation 
Organisms and cells respond to the complexities associated with protein aggregation with 
constitutive expression, secretion, and upregulation of a group of proteins, collectively known as 
molecular chaperones. Most members of these classes of proteins are upregulated during stress 
conditions such as oxidative stress, fluctuation in temperature and pH. They are hence referred to 
as stress proteins or heat-shock proteins (HSPs). A wide variety of structurally different 
chaperones and other regulatory factors are synthesised and secreted by cells, forming cooperative 
pathways and networks. They provide machinery for the quality control of the protein and 
maintenance of the proteome homoeostasis (proteostasis) (164-166). Molecular chaperones are 
involved with proteins from their synthesis to clearance from the body by assisting them during 
de novo folding, oligomerisation, protein transport, stabilisation and refolding of stress-damaged 
proteins and in proteolytic degradation. In humans, they are usually classified based on their 
molecular weight (HSP40, HSP60, HSP70, HSP90, HSP100 and small HSPs (sHsps) such as αB-
crystallin and related proteins). Chaperones can be broadly classified into two groups as ATP-
dependent and ATP-independent (167-169). Chaperones such as the HSP70s, HSP90s and the 
chaperonins (HSP60s) require energy in the form of ATP to perform de novo protein folding and 
refolding whereas small Hsps such as αB-crystallin are involved in protein stabilisation, carry out 
their functions without the assistance of energy. αB-crystallin, HSP27 and related sHsps are 
intracellular molecular chaperones that are characterised by the presence of a highly conserved 
central stretch of amino acids (~80 residues) known as the “α-crystallin domain” in a β–sheet 
conformation. Moreover, they possess N- and C-terminal regions of variable length and structure 
and have the ability to form large oligomers (170, 171).  Despite having no structural similarity 
with sHsps, there are a group of proteins including clusterin, haptoglobin and α2-macroglobulin, 
which act as molecular chaperones and maintain proteostasis in the extracellular space (172). As 
shown in Figure 5, this group of molecular chaperones selectively interact with the non-native 
form of aggregating proteins and protects the cell from amyloid fibril formation and diseases 
involving the intra- and extra-cellular unwanted aggregation and deposition of proteins (173).  
1. Introduction and Dissertation Layout 
17 
 
 
 
Figure 5. Proposed roles for extracellular chaperones in the maintenance of the extracellular proteostasis. Under 
normal physiological conditions, (a) scavenger receptors may directly bind misfolded proteins locally. (b) Circulating 
extracellular chaperones target and bind to misfolded proteins, maintaining their solubility and facilitating their 
transport to scavenger receptors located on the extracellular side of the cell membrane. (c) When extracellular 
proteostasis is disrupted, insoluble protein aggregates can form, giving rise to activated proteases (e.g., plasmin). 
Extracellular chaperones interact with the proteolytic fragments and facilitate their transport to scavenger receptors. In 
all cases, delivery to scavenger receptors results in the intracellular transport of misfolded proteins to lysosomes for 
degradation. Figure and figure legend is taken from Wyatt et al.,(173)  
A comprehensive list of ATP-independent chaperones synthesised and secreted by human cells 
is presented in Table 5. In a cellular context, proteostasis is achieved in a very crowded 
environment where proteins undergo high-energy collisions with neighbouring molecules, which 
potentially further enhances the protein aggregation process (174, 175). The resultant excluded 
volume effect, increased viscosity, perturbed diffusion, direct physical, and weak interactions and 
more importantly the variations in solvent properties in the presence of the crowding agent 
significantly affect proteostasis (176). 
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 Table 5. Human ATP-independent molecular chaperones, their localisation, normal function and diseases associated with their loss-of-function 
Molecular 
chaperone 
Distribution Standard functions Disease(s) associated with loss of function 
INTRACELLULAR MOLECULAR CHAPERONES (sHsps) 
Hsp27 (also known 
as HspB1)  (177-180) 
Ubiquitous 
Antioxidant, anti-apoptotic, chaperone activity, thermotolerance, 
cell development and differentiation and signal transduction. 
Unphosphorylated form prevents actin 
reorganisation affecting cell adhesion and motility. 
Assists in premature degradation of 
glucocerebrosidase. 
HspB2 (MKBP) 
(181-185) 
Heart, smooth and skeletal 
muscle 
Activates myotonic dystrophy protein kinase, anti-apoptotic 
functions, cardiac muscle maintenance and metabolism, chaperone 
activity towards both amorphous and amyloid aggregates. 
Involved in the genesis of insulin resistance. 
HspB3 (186-189) 
Brain, heart, smooth muscle 
and other foetal tissues 
Maintains myofibrillar integrity and prevents heat and chemical-
induced protein amorphous aggregation. 
A point mutation, R7S, leads to development of 
axonal motor neuropathy. 
HspB7 (CVHSP) 
(190-192) 
Heart, skeletal muscle, 
brown and white adipose 
tissue 
Chaperone activity but requires active autophagy machinery. 
Single nucleotide polymorphisms can lead to 
idiopathic dilated cardiomyopathy. 
HspB9 (CT51) (193, 
194)  
Spermatogenic cells of testis Maintains sperm flagellar integrity. - 
HspB10 (ODF1) 
(195) 
Outer dense fibre of sperm 
tail 
Proper arrangement of the mitochondrial sheath and sperm motility. - 
Hsp20 (HspB6) (196-
199) 
Ubiquitous 
Prevents heat-induced amorphous aggregation of proteins, 
cardioprotective and anti-apoptotic. 
The P20L missense mutation leads to dilated 
cardiomyopathy. 
αA-crystallin 
(HspB4) (9, 200-204) 
Lens and cornea of the eye 
Major lens protein, prevents extensive protein aggregation and 
precipitation and maintains the eye lens refractive index. 
A single missense mutation, R116C, and a 
nonsense mutation, W9X, cause cataract. 
αB-crystallin 
(HspB5) (169, 182, 
205-208) (209-211) 
Ubiquitous, the eye lens 
Chaperone activity, anti-apoptotic, maintenance of the eye lens 
refractive index, regulation of muscle differentiation, cell-cycle, 
cytoskeletal and nucleoskeletal matrix. 
A missense mutation, R120G, is linked to desmin-
related myopathy; D140N has been associated with 
autosomal dominant congenital lamellar cataract. 
Hsp22 (HspB8, α-
crystallin C) (212-
216) 
Ubiquitous 
Chaperone-like activity, prevents heat-induced amorphous 
aggregation and stimulates oxidative phosphorylation. 
Three missense mutations, K141E, K141N, K141T, 
are associated with motor neuropathies and 
Charcot-Marie-Tooth disease. 
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EXTRACELLULAR MOLECULAR CHAPERONES 
Clusterin 
(apolipoprotein J) 
(165, 208, 217-226) 
Ubiquitous, extracellular 
fluids including human 
plasma, cerebral spinal fluid 
(CSF) 
Chaperone activity, protective role against oxidative, shear, 
proteotoxic, heat, heavy-metal stress and ionising radiation. 
The Q433P mutation is linked to chronic 
haemolytic uremic syndrome. Biomarker for 
Alzheimer’s disease. 
Haptoglobin (227-
233) 
Extracellular fluids including 
human plasma, CSF, kidney, 
lung, skin, hepatocytes, 
adipose tissue  
Chaperone activity, binds free plasma haemoglobin, anti-oxidant 
and aids in prostaglandin synthesis. 
A missense mutation, C282Y, is linked to chronic 
hepatitis C. 
α2-macroglobulin 
(234-242) 
Extracellular fluids including 
human plasma, CSF, liver, 
macrophages, fibroblasts and 
adrenocortical cells 
Prevents amorphous and fibrillar protein aggregation, acts as 
protease inhibitors, potential role in immunomodulation, cancer 
progression, inhibits fibrinolysis and is a cytokine transporter.  
A point mutation, C972Y, is linked to chronic lung 
disease. 
Serum amyloid P 
component, SAP 
(9.5S α1-
glycoprotein) and C-
reactive protein (173, 
243-246) 
Hepatocytes, blood 
Chaperone activity including limited ATP-independent refolding 
ability, regulation of the innate immune response, anti-apoptotic 
and necrosis activity.   
The G141S mutation is associated with breast 
cancer. 
Apolipoprotein E 
(Apo-E) (247-249) 
Liver, brain, kidney, spleen, 
macrophages, central 
nervous system 
Regulates amyloid-β peptide aggregation and clearance in the brain, 
helps in brain lipid transport, glucose metabolism, neuronal 
signalling and neuroinflammation. 
The R145C mutation causes autosomal dominant 
type lll hyperlipoproteinemia. 
Apolipoprotein A-I 
(Apo-AI)  (245, 250-
252) 
Liver, intestine 
Regulates amyloid-β peptide aggregation associated toxicity and 
clearance in the brain, lipid metabolism, anticlotting factor 
The R173C mutation impairs its function and 
increases the risk of cardiovascular diseases.                 
Fibrinogen-420 (253-
255) 
Blood plasma 
Prevents thermal denaturation of citrate synthase, transport proteins 
and provides scaffold for clots. 
Aggregation of fibrinogen Aα-chains has been 
associated with hereditary renal amyloidosis. 
Albumin (256-258) Serum Transport proteins and chaperone-like activity. 
The R218H point mutation results in familial 
dysalbuminaemic hyperthyroxinaemia. 
 
As listed in Table 1, more than 55 human diseases associated with both intra- and extra-cellular 
protein deposition have been demonstrated so far. While substantial advances have been made to 
decipher the nature of protein aggregates, its mechanism of aggregation, identification and 
characterisation of toxic species, and their regulation by molecular chaperones, much remains to 
be uncovered for a complete comprehension of the protein aggregation process.  My thesis’ work 
has assisted in advancing our understanding of the molecular mechanisms of amyloid fibril 
formation, particularly of the Acyl-CoA thioesterases (Acots) involved in lipid metabolism and 
inflammation. I have also used a novel fluorescent dye (TPE-TPP) with aggregation-induced 
emission characteristics to precisely monitor amyloid progression via in situ dye binding and 
fluorescence polarisation based-assays, involving the detection of soluble early-stage aggregates 
in various conditions such as at acidic pH, or in the presence of exogenous compounds. I have 
also attempted to shed light on the effect of the intra- and extra-cellular molecular chaperones αB-
crystallin, clusterin, α2-macroglobulin and haptoglobin on the primary and secondary nucleation 
of D76N β2m fibrillation associated with haemodialysis-related amyloidosis. Finally, I have 
examined the biophysical and biochemical properties of α- and β-synuclein oligomers, 
particularly the propensity of β-synuclein to form non-amyloid aggregates, and their interaction 
in the crowded cell-like environment.  
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1.7 Dissertation Layout 
Chapter 2 is a draft manuscript discussing the propensity of Acyl-CoA thioesterases (Acots) to 
form amyloid fibrils, particularly mouse Acyl-coenzyme thioesterase 7 (mAcot7) and its probable 
mechanism of aggregation. This project was done in collaboration with Prof. Jade Forwood, who 
had structurally characterised different fragments of mAcot7 along with the full-length protein. 
The specific objective of our study was to decipher the mechanism of Acyl-CoA thioesterase 7 
fibrillation and understand its role during inflammation. This manuscript demonstrates a unique 
way by which mAcot7 undergoes polymerisation. Apart from cloning, expression, purification of 
various constructs of mAcot7 including the human form (carried out by Prof. Forwood’s 
laboratory) and the X-ray fibre diffraction studies of the full length mAcot7 fibre (performed by 
Prof. Margaret Sunde), I have conducted the rest of the experiments.   
Chapter 3 is a draft manuscript of my work on Bis-(Triphenylphosphonium) tetraphenylethene 
(TPE-TPP) in collaboration with Dr Yuning Hong. This study aimed to understand the working 
mechanism of oligomer detection by TPE-TPP, a novel aggregation-induced emission luminogen, 
which was earlier reported to bind α-synuclein oligomers and fibrils (Yuning Hong et al.,). I 
demonstrated that TPE-TPP specifically binds to amyloid fibrils formed from a wide range of 
proteins in different experimental conditions such as acidic pH, elevated temperature, or in the 
presence of small molecular amyloid fibril inhibitors. TPE-TPP exhibited a spectral shift upon 
binding to prefibrillar species, indicating that it can recognise their structural specificity. I also 
established the way TPE-TPP detects early-stage aggregates. TPE-TPP showed two types of 
spectral shifts upon binding to fibrils formed from different proteins, substantiating 
morphological variations in amyloid fibrils. Dr Hong and I also developed a rapid TPE-TPP based 
fluorescence polarisation assay to decipher the characteristic biophysical model of protein 
aggregation.  
Chapter 4 is a draft manuscript describing the probable role played by intra- and extra-cellular 
molecular chaperones such as αB-crystallin and clusterin in regulating D76N β2-microglobulin 
fibrillation, a potently amyloidogenic variant of β2-microglobulin. This work was undertaken in 
collaboration with Prof Rïno Esposito and Prof. Vittorio Bellotti, who provided the D76N β2m 
clone and Prof. Mark Wilson (who supplied the purified clusterin, α2M and haptoglobin). I 
investigated the effect of molecular chaperones on the amyloid fibril formation of D76N β2m and 
found that αB-crystallin and clusterin delayed the lag phase of D76N β2m fibrillation, whereas 
α2M and haptoglobin had no inhibitory effect. I also observed that hydrophobic and ionic 
interactions played a significant part in D76N β2m amyloid fibril formation and probably αB-
crystallin and clusterin modulated its primary nucleation via the stabilisation of ionic and 
hydrophobic interactions. To my surprise, I observed that αB-crystallin and α2M were 
independently forming amyloid fibrils under the same physiologically relevant aggregation 
conditions used for D76N β2m fibrillation. One purpose of this study was to assess the role of 
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both intra- and extra-cellular molecular chaperones during fibril deposition as amyloid plaques 
by D76N β2m. Hence, I also studied the effect of αB-crystallin and clusterin on the fibril’s 
chemical stability and secondary nucleation of D76N β2m fibrillation pathway and found that 
both chaperones chemically stabilise D76N β2m fibril and prevents its secondary nucleation.  
Chapter 5 highlights the importance of α- and β-synuclein (αS and βS) oligomers. The purpose of 
this investigation was to explore the relationship between the two proteins and determine whether 
βS is the saviour or perpetrator of αS-induced synucleinopathies in a crowded cell-like 
environment. Bi-directional native agarose gel electrophoresis, a technique I developed, indicated 
that the βS dimer exists as a positively charged compound, while the monomer is negatively 
charged. I showed that the process of βS oligomerisation was enhanced in the presence of αS and 
in the crowded cell-like environment. I performed Atomic Force and Transmission Electron 
Microscopy with the help of Prof Vincent Craig and Ms. Jiwon Lee, respectively and confirmed 
βS self-assembly to the non-amyloid fibril-like structure. Far-UV circular dichroism spectra 
suggested a deleterious interaction between αS and βS. Small angle scattering (SAS) studies with 
the assistance of Dr. Agata Rekas and Dr. Jitendra Mata confirmed a destabilising αS and βS 
interaction. The deuteration of the synucleins and the set-up of the small-angle X-ray scattering 
(SAXS) instrument were done by Dr. Rekas, while Dr. Mata helped me with the small-angle 
neutron scattering (SANS) instrument set up.  SANS studies were crucial to reveal that the 
negative interaction between the two proteins was mainly due to the oligomerisation and 
aggregation of βS. I also found out that the extent of the destructive αS and βS association was 
minimised in the crowded cellular milieu. 
A schematic diagram depicting the significant findings of this thesis and how they are implicated 
with the protein folding process is demonstrated below in Figure 6.  
 
 
 Figure 6. Schematic representation of the significant findings of this thesis. Four major projects have been investigated: in Chapter 2 (represented by A, B and C), I showed that mouse 
Acyl-CoA thioesterase 7 (Acot7) undergoes continuous nucleation-independent, multi-stranded polymerisation via the generation of an intermediate oligomeric species to form amyloid 
fibrils. In Chapter 3, I used a novel aggregation-induced luminogen, Bis(Triphenylphosphonium) tetraphenylethene (TPE-TPP) to monitor and characterise early-stage aggregates during 
protein fibrillation. In order to gain insight into the development of protein aggregation disease, (Chapter 4: represented by A, B, C and D), I demonstrated the regulatory role of intra- (αB-
crystallin) and extra-cellular (clusterin) molecular chaperones on paradigmatic amyloidogenic motif such as the immunoglobulin-like domain of β2-microglobulin (namely D76N β2m). In 
Chapter 5 (represented by A,E,F, and G), I observed that β-synuclein oligomerised to form positively charged oligomers, leading to the formation of a non-amyloid fibril-like conformation 
which underwent a destructive interaction with α-synuclein. 
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Abstract 
Acyl-coenzyme A thioesterases (Acots) are involved in a broad range of essential cellular roles 
including cell signalling, lipid metabolism, inflammation and the opening of ion channels. 
Additionally, dysregulation in lipid metabolism has been linked to neuroinflammatory and 
neurological disorders such as Alzheimer’s and Parkinson’s disease. Herein, we have investigated 
the structural instability of the thioesterase family to form amyloid fibrils and propose a 
mechanism underlying the fibrillation of mouse Acot7. We observed that the N-terminally 
truncated, N-terminal domain, C-terminal domain, full-length mouse Acot7 (mAcot7 FL), and 
full-length human ACOT7 (hACOT7 FL) species spontaneously form amyloid fibrils at 
physiological pH and temperature. mAcot7 FL undergoes nucleation-independent, multi-stranded, 
passive polymerisation to form a superhelical fibril structure. The fibrilliation of mAcot7 FL is 
preceded by the formation of non-covalent, non-disulphide linked, SDS and heat-resistant, high 
and low molecular weight oligomers. The α-helical to β-sheet phase transition in mAcot7 FL 
induces dissociation of the non-covalently linked, natively functionally active, hexameric 
arrangement of the protein. Furthermore, the generation of lower molecular weight species beside 
the rearrangement of monomeric N-terminal and C-terminal domains of mAcot7 FL is a critical 
step in the emergence of globular oligomeric species and amyloid fibril formation. mAcot7 
fibrillation is highly dependent on the charge of the molecules. The positively charged lysine 
completely suppressed fibril formation, while negatively charged moieties such as aspartic acid, 
glutamic acid and N-acetyl aspartic acid, and mAcot7 activity inhibitors (i.e. glutarate, 
tricarballylate and malonate) promoted fibril formation. Furthermore, mAcot7 FL underwent 
fibrillation in the presence of its substrate (Arachidonoyl-CoA) and maintained its enzymatic 
activity throughout the fibril assembly and disassembly process. Our model of mAcot7 FL 
amyloid fibril formation highlights the structural instability of the soluble protein, which favours 
enzymatically inactive oligomeric intermediates. We hypothesise that the prevention of the 
conformational phase transition in full-length Acot7 increases the proportion of functionally 
active hexameric arrangements, thereby boosting thioesterase activity and improving lipid 
regulation.   
Keywords: N-terminal hotdog domain, C-terminal hotdog domain and full-length acyl-coenzyme 
A thioesterases 7, polydispersity, α-helical to β-sheet transition, globular oligomers, nucleation-
independent, multi-stranded passive polymerisation, superhelical amyloid fibril structure, 
thioesterase activity 
Abbreviations: A-CoA: arachidonoyl-CoA,  ANS: 8-Anilinonaphthalene-1-sulfonic acid, αB-c: 
Alpha B-crystallin, CoA: Coenzyme A, CD: Circular dichroism, C-terminal domain: C-terminal 
hotdog domain of mAcot7, GdmCl: Guanidinium hydrochloride, hACOT7: Human acyl-CoA 
thioesterase 7, mAcot7 FL: mouse full-length acyl-CoA thioesterase 7, mAcot12: Mouse acyl-
CoA thioesterase 12, N-terminal domain: N-terminal hotdog domain of mAcot7, N-terminally 
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truncated: N-terminally truncated form of mAcot7, SDS-PAGE: Sodium dodecyl sulfate-
polyacrylamide gel electrophoresis, TEM: Transmission electron microscopy, ThT: Thioflavin T, 
TPE-TPP: Bis(Triphenylphosphonium) tetraphenylethene 
2.1 Introduction 
The term ‘amyloid’ was first used by Rudolf Virchow to describe a cellulose-containing 
structured mass in human tissues (1), but now refers to the ordered, fibrous cross β-sheet 
quaternary structure of proteins or peptides with common biophysical properties (2). The protein 
assembly and disassembly process leading to aggregation and deposition of amyloid fibrils forms 
the basis of more than 55 systemic and localised conformational disorders, and has been 
extensively studied in the context of pathological states (3, 4). Moreover, the concept of non-
pathological amyloids that are beneficial to organisms is now well recognised, with more than 20 
examples of functional amyloids reported so far (5-8). Structural and oligomeric heterogeneity is 
the hallmark of almost all protein assembly and disassembly processes, as also seen in prion 
proteins (9-13). A prion can acquire various conformations including that of amyloid and 
amyloid-like structures, based on the conformational changes in the assembling subunits (14, 15). 
Moreover, a protein can form amyloid fibrils of multiple, distinct conformations depending on 
the amyloid-forming conditions and its primary amino acid sequence (10, 16-18). Additionally, 
each protein follows their own route, akin to the protein folding process and hence many models 
have been proposed to describe the fibrillation process (19-21). To elucidate the mechanism 
underlying protein aggregation diseases or functional amyloids, it is necessary to understand the 
origin of conformational polymorphisms associated with the formation of amyloid fibril 
structures. As the general process involved in the formation of both pathological and non-
pathological amyloid states is almost similar, studies to determine the mechanism of fibrillation 
of as many pathological, non-pathological and beneficial proteins and peptides are desirable.  
Acyl-CoA thioesterases (Acots) are involved in a variety of important cellular roles including cell 
signalling, regulation of metabolic and enzymatic signals, and inflammation. They function by 
metabolising fatty acids and regulating cellular concentrations of activated fatty acyl-CoAs and 
CoA (22-24). Acots are ubiquitously expressed in both prokaryotes and eukaryotes. Mammalian 
Acot family members are broadly categorised into two classes (type I and type II) based on the 
molecular weight of the enzymes (22, 25). Among the mammalian type II class, Acot7 and Acot12 
have been extensively studied, and have been found in the brain and liver, respectively. Acot7 
plays a role in neuronal fatty acid metabolism (26). Recently, it has been attributed to a novel 
inflammatory role, through its production of arachidonic acid (AA), from its highly specific 
substrate arachidonoyl-CoA (AA-CoA), suggesting a link with eicosanoid metabolism. The 
structure of mouse (Mus musculus) Acot7 (mAcot7), as determined using a combination of 
chemical cross-linking, mass spectrometry, X-ray diffraction and molecular modelling techniques, 
revealed a quaternary hexameric arrangement of Acot7 that features a trimer of hotdog fold 
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dimers (Fig. 1A). Each monomeric hotdog domain comprises a central sausage-like α-helix 
surrounded by β-sheet, resembling that of a bun (27).  As indicated in figure 1A, each subunit in 
the full-length protein comprises of two hotdog domains i.e. monomeric N-terminal domain in 
association with another monomeric C-terminal hotdog domain forming a double-hotdog 
structure, referred to as a N-C heteroprotomer. The N-terminal hotdog domain comprises of five 
antiparallel β-sheets encircling an α-helix, which associates with another N-terminal domain to 
form another double-hotdog structure, termed as a N-N homoprotomer (Fig. 1B). The additional 
α-helix aligns to the opposite side of the β-sheet. The C-terminal domain also forms a double-
hotdog conformation similar to that of the N-terminal domain, termed as a C-C homoprotomer 
(Fig. 1C). In the hexameric arrangement of the full-length mAcot7, one double-hotdog (i.e. N-C 
heteroprotomer) subunit forms a complex with two more double-hotdogs (i.e. N-C 
heteroprotomers) subunits. This involves non-covalent inter-domain contacts (25% of the Acot7 
residues), with the β-sheets of each subunit forming a semicontinuous antiparallel barrel. 
Additionally, both the individual N- and C-terminal domains of mAcot7, as shown in figure 1B 
and C, have a similar hexameric arrangement to the full-length protein (24, 28), with each subunit 
forming homodimeric hotdog domains (i.e. N-N homoprotomer and C-C homoprotomer), 
respectively. Acot12, commonly known as cytoplasmic acetyl-CoA hydrolase, also forms a trimer 
of hotdog dimers in an arrangement analogous to mAcot7 (28).  
 
Figure 1. Crystal structure of various mAcot7 constructs. The structures of (A) mAcot7 FL (4ZV3) is shown in the 
above cartoon, and the coloured balls represent the substrate (AA-CoA) bound to the protein. mAcot7 FL in its 
crystalline form exists as a hexamer comprising of three double-hotdogs (N-C heteroprotomer), represented in green, 
cyan and magenta, (B) N-term domain of mAcot7 (PDB 2V1O) comprising of three double-hotdogs (N-N 
homoprotomer) and (C) C-term domain (PDB 2Q2B) also comprising of three double-hotdogs (C-C homoprotomer). 
The monomers in each hotdog dimer (protomer) are coloured in either dark or light shades of the same colour.   
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In this study, recombinant human and mouse acyl-CoA thioesterase 7 underwent in vitro 
oligomerisation and fibril formation under physiological conditions (i.e. pH 7.4 and at 37 °C). 
Furthermore, Acot7 readily formed amyloid fibrils in the presence of its substrate (AA-CoA) or 
enzyme inhibitors (i.e. glutarate, tricarballylate and malonate), and was enzymatically active 
throughout the process of fibril formation. Mechanistically, mAcot7 amyloid fibril formation is 
nucleation-independent, in which the α-helical to β-sheet structural phase transition and the 
generation of low molecular weight oligomers were critical for the formation of amyloid fibrils.  
2.2 Experimental Procedures 
2.2.1 Materials 
Recombinant mAcot12, hACOT7, mAcot7 isoform 1 (1-384 residues), N-terminally truncated 
(50-370 residues), N-term domain (13-163 residues), C-term domain (169-370 residues) of full-
length mAcot7, and αB-crystallin (αB-c) were expressed and purified as described previously (24, 
28, 29). Thioflavin T (ThT), lysine, aspartic acid, glutamic acid, N-acetyl aspartic acid, 
arachidonoyl-CoA, glutarate, malonate, tricarballylate, 1,4-Dithiothreitol (DTT), 8-
anilinonaphthalene-1-sulfonic acid (ANS), and guanidinium hydrochloride (GdmCl) were 
purchased from Sigma-Aldrich. All other chemicals were of analytical grade. 
2.2.2 Amyloid fibril formation 
Acot proteins prepared at 50-250 µM in 20 mM or 100 mM sodium phosphate buffer, pH 7.4, 
37 °C were incubated in the absence or presence of lysine, aspartic acid, glutamic acid, N-acetyl 
aspartic acid, iodoacetic acid, glutarate, malonate, tricarballylate and varying concentrations of 
αB-c, arachidonoyl-CoA in a 96 well or 384 well microplate or in 1.5 mL microcentrifuge tubes, 
with  shaking at 37 °C. The fibrillar aggregation kinetics of proteins were measured using specific 
filters of the Biotek Synergy 2 microplate reader. The transparent sealing film was used to prevent 
solvent evaporation. ThT fluorescence emission was measured using a 440/40 nm filter for 
excitation and a 485/20 nm filter for emission, while for TPE-TPP fluorescence, 380/20 and 
460/40 nm filters were used as excitation and emission filters, respectively. 1:0.33 (protein: ThT) 
molar ratio and 1:0.66 (protein: TPE-TPP) molar ratio were used for all the amyloid fibril kinetic 
assays. mAcot7 FL fibrillation experiments (Fig. 9A and Fig. 10) were conducted in a Heidolph 
Titramax 1000 (Germany) microplate shaker. 
2.2.3 Optical density measurement 
The change in light scattering at 350 nm over time was used to monitor the assembly of varying 
concentrations of mAcot7 FL in 20 mM phosphate buffer at pH 7.4, 37 °C. The assay was 
conducted in Greiner bio-one, half area, clear bottom, medium binding, 96 well plates, sealed 
with transparency film, and the light scattering was monitored using a monochromator of a Biotek 
Synergy 2 microplate reader. 
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2.2.4 Transmission electron microscopy 
Fresh mAcot7 FL and other proteins samples following incubation under the above-mentioned 
aggregation conditions were transferred to formvar- and carbon-coated copper 400 mesh or 
ultrathin holey carbon support film, copper 400 mesh, grids and negatively stained with uranyl 
acetate (2% (w/v); Ajax Chemicals) in water. Samples were examined using a Hitachi 7100 or 
JEOL JEM-2100F transmission electron microscope at a 125 kV and 200 kV accelerating voltage 
under a magnification of 100-300k. Particle sizing was performed using ImageJ software. 
2.2.5 X-ray fibre diffraction 
Fibrillar mAcot7 FL was formed by incubating 200 µM protein in the above-mentioned amyloid 
fibril forming conditions for 160 h. The fibrils were purified by centrifugation at 14,100 x g for 1 
h and then resuspended in distilled water immediately before the formation of the fibril stalk. A 
mAcot7 FL fibril stalk was prepared via the stretch frame method according to Serpell et al. (30). 
Diffraction images were collected from the fibril samples using a Cu Ka Rigaku rotating anode 
source (wavelength 1.5418 Å) and mar345 image plate detector (MarResearch GmbH, Germany). 
Images were examined and reflections measured using marView (MarResearch). 
2.2.6 Far-UV circular dichroism 
The far-UV CD spectra of 10-20 µM protein samples were collected over a wavelength range of 
180-260 nm, with a 0.5 nm step-increment, a bandwidth of 1.5 nm and scan rate of 4 s/increment 
at 37 °C. Each spectrum was obtained in the Chirascan (Applied Photophysics) using 0.01 cm as 
the path length, QS High Precision Cell (Hellma Analytics). All the samples were prepared in 10 
mM phosphate buffer, pH 7.4 and the average of 5 accumulations (blank subtracted) was 
considered as the final spectrum. All high voltage tension records above 600 V were discarded.  
2.2.7 Real-time far-UV circular dichroism 
The far-UV CD spectrum of 10 µM mAcot7 FL in 10 mM phosphate buffer, pH 7.4, 37 °C was 
collected over a period of ~65 h in a 0.01 cm path length cuvette sealed with sealing tape. The 
approximate scan-time of each spectrum was 11 min, which was collected over a wavelength 
range of (180-260) nm, with a 0.5 nm step-increment, a bandwidth of 1.5 nm and scan rate of 4 
s/ increment.  
2.2.8 Amyloid seeding experiment 
150 µM of fresh mAcot7 FL in 20 mM phosphate buffer, pH 7.4, was incubated at 37 °C with  
agitation either without (unseeded) or with (seeded) percentage (1% v/v, 5% v/v and 10% v/v) of 
purified mAcot7 FL amyloid fibrils. mAcot7 FL amyloid fibril was formed by incubating the 
protein in the above-mentioned amyloid fibril-forming conditions for 160 h. The in-situ 
aggregation kinetics were monitored via ThT fluorescence assay as described above. 
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2.2.9 Guanidinium hydrochloride unfolding experiments 
10 µM mAcot7 FL was mixed with an increasing concentration of GdmCl (0 – 7 M) in 1M 
increments in 20 mM phosphate buffer, pH 7.4, and incubated overnight at 37 °C. The unfolding 
of the protein was monitored via extrinsic and intrinsic fluorescence measurements described 
below. 
2.2.10 8-Anilinonaphthalene-1-sulfonic acid (ANS) binding assay 
The degree of exposed hydrophobicity of mAcot7 FL in denaturant-induced unfolding assays was 
monitored by measuring ANS fluorescence emission from 400 – 600 nm following excitation at 
380 nm, in a Cary Eclipse fluorescence spectrophotometer. All samples were prepared in a final 
volume of 500 µL in a high precision quartz fluorescence cuvette (Hellma Analytics) having a 
path length of 0.1 cm and equilibrated at room temperature for 15 min before the measurements. 
1:10 molar ratio of protein: ANS dye was used in all the samples. The slit width was set to 5 nm 
and the scan speed set to medium for all readings. ANS fluorescence emission spectra were 
normalised using Cary Eclipse software.  
2.2.11 mAcot7 intrinsic fluorescence measurements 
mAcot7 FL denaturant-induced unfolding assay were performed by measuring the protein 
intrinsic tryptophan(s) fluorescence emission from 305 – 400 nm following excitation at 295 nm, 
respectively in a Cary Eclipse fluorescence spectrophotometer. All samples were prepared in a 
final volume of 500 µL in a high precision quartz fluorescence cuvette (Hellma Analytics) having 
a path length of 0.1 cm and equilibrated at room temperature for 15 min before the measurements. 
The slit width was set to 5 nm and the scan speed set to medium for all readings. Fluorescence 
emission spectra were normalised using Cary Eclipse software.  
2.2.12 Real-time extrinsic fluorescence measurements 
The quaternary or tertiary structural change of 15 µM mAcot7 FL in 20 mM phosphate buffer, 
pH 7.4, 37 °C was monitored over 131 h in a 0.1 cm path length cuvette sealed with sealing tape, 
by assessing the change in ANS fluorescence emission upon binding to exposed mAcot7 
hydrophobic residues. ANS fluorescence emission was acquired from 400 – 600 nm following 
excitation at 380 nm, with a 0.5 nm step-increment, a bandwidth of 1.0 nm and scan rate of 4 s/ 
increment in a Chirascan (Applied Photophysics) coupled to a fluorescence photomultiplier. The 
approximate scan-time of each spectrum was 22 min and 1:10 molar ratio of protein: ANS dye 
was used. 
2.2.13 Real-time intrinsic fluorescence measurements 
The structural rearrangement in 15 µM mAcot7 FL in 20 mM phosphate buffer, pH 7.4, 37 °C 
was monitored over 123 h in a 0.1 cm path length cuvette sealed with sealing tape, by assessing 
the change in tryptophan fluorescence. Selective tryptophan fluorescence emission of 15 µM 
mAcot7 was collected from 305 – 400 nm following excitation at 295 nm, with 0.5 nm step-
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increment, a bandwidth of 1.0 nm and scan rate of 4 s/increment in a Chirascan (Applied 
Photophysics) coupled to a fluorescence photomultiplier. The approximate scan-time of each 
spectrum was 10 min. 
2.2.14 SDS-PAGE 
mAcot7 FL in 20 mM phosphate buffer, pH 7.4 was subjected to SDS-PAGE using NuPAGE® 
Novex® 4-12% Bis-Tris protein gels and 2-(N-morpholino)ethane sulfonic acid (MES) as a 
running buffer. Precision plus ProteinTM KaleidoscopeTM standards (Bio-rad) were used as a 
molecular weight marker. 
2.2.15 Thioesterase activity assay 
The standard reaction mixture contained 6.6 µL arachidonoyl-CoA, 190.4 µL 100 mM phosphate 
buffer, pH 7.4 and 1 µL of mAcot7 sample in a final volume of 200 µL. The enzyme activity of 
fresh and incubated mAcot7 samples under amyloid fibril-forming conditions was monitored by 
measuring the absorbance at 412 nm over 30 min, immediately after the addition of 0.1 mM 5,5′-
Dithiobis(2-nitrobenzoic acid) (DTNB). The molar absorption coefficient, ε412 (13,600 M-1 cm-1), 
was used to calculate the cleavage of the thioester bond. Units of mAcot7 FL enzyme activity (U) 
are expressed as moles of arachidonoyl-CoA hydrolysed/min at 37°C (22, 31). 
2.3 Results and Discussion 
2.3.1 Type II acyl-CoA thioesterase forms amyloid fibrils under physiologically relevant 
conditions 
We investigated the ability of human and mouse Acot7, along with its N-terminally truncated and 
individual N-terminal and C-terminal domains, and mouse Acot12, to form amyloid fibrils at pH 
7.4 and 37 °C (i.e. physiologically mimicking conditions). An in situ Thioflavin T (ThT) dye-
binding amyloid assay revealed that all forms of Acot7 readily form amyloid fibrils. As assessed 
by the intensity of ThT fluorescence after ~60 hours of incubation and the rate of initial increase 
in ThT fluorescence, the C-terminal domain of mAcot7 showed the greatest propensity to undergo 
fibrillation followed by human ACOT7, N-terminally truncated, N-term domain and full-length 
mAcot7 (Fig. 2A). By contrast, under the same conditions, no significant increase in ThT 
fluorescence was observed for Acot12, suggesting that the protein did not form ordered 
aggregates (Fig. 2A). Formation of fibrillar structures of varied size and morphology was 
confirmed by transmission electron microscopy (TEM) (Figs 2B - F). mAcot7 FL, N-term domain, 
and hACOT7 formed fibrils of more than a micrometre in length, whereas the N-terminally 
truncated and C-term domain fibrils were much shorter. Additionally, the width of the fibrils, i.e. 
mAcot7 FL (11 - 13 nm), N-terminally truncated (3 - 4 nm), N-term domain (3 - 5 nm), C-term 
domain (1 - 2 nm) and hACOT7 (8 - 10 nm), also varied with the form of Acot7 investigated. The 
TEM images also confirmed the stability of Acot12, where no visible protein aggregates were 
observed (Fig. 2G). The rapid and large ThT fluorescence intensity upon binding to the C-term 
domain of mAcot7 and hACOT7 during fibrillation implied that both formed a large number of 
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Figure 2. Amyloid fibril-forming propensity of the Acot family. mAcot7 FL, N-terminally truncated mAcot7, the N-term domain of mAcot7, the C-term domain of mAcot7, hACOT7 
and mAcot12 were incubated in 20 mM phosphate buffer, pH 7.4, at 37 °C with shaking. A: ThT fluorescence assays showing amyloid fibril formation of 100 µM mAcot7 FL (black circle, 
left Y-axis marked in black), 100 µM N-terminally truncated (cyan circle, left Y-axis marked in black), 100 µM N-terminal domain (blue circle, left Y-axis marked in black), 100 µM C-
terminal domain (red circle, right Y-axis marked in red), 50 µM hACOT7 (magenta  square, left Y-axis marked in black) and 50 µM mAcot12 (orange triangle, left Y-axis marked in black). 
TEM images of amyloid fibrils formed by (B) mAcot7 FL, (C) N-terminally truncated mAcot7, (D) N-terminal domain of mAcot7, (E) C-terminal domain of mAcot7, (F) hACOT7 and 
(G) mAcot12. The width (W) of the fibrils are listed on images. 
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amyloid fibrils, however, TEM images showed the presence of very few fibrillar structures (Fig. 
2E-F). This apparent discrepency may be due to the large scale oligomerisation accompanying 
the C-term domain and hACOT7 fibrillation, as also revealed by the presence of globular species 
in the TEM images (Fig. 2E-F). In solution, the C-term domain of mAcot7 and hACOT7 may 
readily acquire a large proportion of cross β-sheet rich structures (Fig. 5C), which binds to ThT 
and emits an unusually high fluorescence intensity, as also seen in the mouse prion protein (12) 
and Aβ42 fibrillar oligomers (32). 
2.3.2 Characterisation of the mAcot7 FL fibril structure 
Structural characterisation of mAcot7 FL fibrils was performed using X-ray fibre diffraction and 
far-UV circular dichroism (CD) studies. X-ray fibre diffraction of purified mAcot7 FL fibrils 
yielded an indistinct diffraction pattern with a meridional reflection at 4.7 Å and an equatorial 
reflection at around 8.8 - 11. 6 Å (Fig. 3A), revealing the underlying organisation of the fibril 
core to that of a cross β-sheet (33-35). From the crystal structure (Fig. 1A) (24), the mAcot7 FL 
secondary structure features both α-helix and β-sheet content. Far-UV CD spectra of mAcot7 FL 
at zero hours was consistent with such secondary structural elements (Fig. 3B). α-Helices are 
indicated by an ellipticity minimum at ~208 nm for the mAcot7 FL, and β-sheets by an ellipticity 
minimum at ~218 nm. By contrast, the far-UV CD spectra of purified mAcot7 FL fibrils indicated 
a significant ellipticity minimum from ~ 222 – 224 nm (Fig. 3B), implying the presence of a 
superhelical arrangement (36). Superhelical fibril structures have been observed in many 
amyloid-forming proteins including fimbriae (37), insulin (38), toxic amyloid-β1–42 fibrillar 
oligomers (TABFOs) (32) and several tandem heptad repeat peptides (36). TEM images of 
mAcot7 FL (Fig. 2B), also indicated the presence of twisted helical rod-like fibrillar structures. 
 
 
Figure 3. Substructure of mAcot7 fibrils. Fresh mAcot7 FL was incubated in 10 mM phosphate buffer, pH 7.4 at 
37 °C with shaking for 160 h. mAcot7 FL fibrils were purified by centrifugation at 14,100 x g for 1 h. A: X-ray fibre 
diffraction pattern of mAcot7 FL fibrils. The major reflections are indicated at 4.7 and 8.8-11.6 Å. B: Far-UV circular 
dichroism of freshly prepared (0 h; solid curve) and fibrillar (dashed curve)  mAcot7 FL. 
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2.3.3 Amyloid fibril formation by mAcot7 FL does not proceed by a standard nucleation-
dependent mechanism 
To understand the molecular mechanism of mAcot7 FL polymerisation, we first examined the 
dependence of the initial rate of aggregation on the initial concentration of mAcot7 FL, based on 
the in-situ ThT fluorescence profiles (Fig. 4A, inset). The initial rate of mAcot7 FL fibril assembly, 
using ThT as a probe, was linearly dependent on the protein concentration and followed first-
order kinetics (Fig. 4A) (39). However, aggregation profiles using the oligomeric-sensitive probe 
Bis(Triphenylphosphonium) tetraphenylethene (TPE-TPP) revealed a deviation from non-
linearity which most likely followed higher-order rate kinetics (Fig. 4B). Additionally, there was 
no significant lag or nucleation phase during mAcot7 FL oligomerisation and fibril formation, as 
an immediate increase (i.e. from 0 h of incubation) in both TPE-TPP and ThT fluorescence 
intensity was observed. Furthermore, work presented in chapter 3 showed that TPE-TPP binds 
and emits enhanced fluorescence upon the generation of early-stage aggregates during amyloid 
fibril formation, thereby providing a probable way to measure the rate of 
oligomerisation/nucleation. The absence of a noticeable lag-phase, as revealed by the abrupt 
increase in ThT fluorescence emission, suggests that mAcot7 FL undergoes spontaneous fibril 
formation. However, the absence of any observable lag-phase can also imply that the formation 
of mAcot7 prefibrillar species is relatively faster than the fibril growth. The measured rate of 
mAcot7 oligomerisation as shown in figure 4B, was faster than its fibrillation (Fig. 4A). Therefore, 
the nucleation process may not be the rate-limiting step in the transition of a soluble protein to 
insoluble amyloid fibrils.   
Previously, we and others have reported that small heat-shock proteins (sHsps) such as alpha B-
crystallin (αB-c) interact with intermediately folded monomeric and  unfavourable prefibrillar 
species and suppress their further polymerisation in a concentration-dependent manner (40-46). 
Prefibrillar species or rather stable nuclei (principally a higher molecular weight protein 
assembled form) are mostly generated during nucleation-dependent amyloid fibril formation (5, 
47). To gain further insight into the fibril growth mechanism of mAcot7 FL, we co-incubated αB-
c and mAcot7 FL in 1:2 and 1:1 molar ratios in mAcot7 fibril-forming conditions. As revealed by 
the normalised ThT fluorescence aggregation profile, αB-c did not suppress or modulate the 
assembly or disassembly process of mAcot7 FL (Fig. 4C). The inability of αB-c to prevent 
mAcot7 FL amyloid formation also suggested that the protein nucleation process is expeditious 
in nature, as αB-c and other molecular chaperones work more efficiently with slowly aggregating 
proteins compared to those aggregating quickly (48). Additionally, it has also been shown that 
sHsps like αB-c do not prevent nucleation-independent aggregation of proteins (49), as is also 
observed in our case. 
The nucleated growth mechanism is a widely established polymerisation method whereby the 
assembly of proteins is mediated via a set of necessary but thermodynamically unfavourable 
nuclei the mechanism has been well studied both theoretically and experimentally in many other 
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Figure 4. Determination of the rate order and 
type of mAcot7 polymerisation. (A) Natural 
log-log plot of initial rate of amyloid fibril 
formation of 100 µM (black circle), 150 µM (blue 
triangle), 200 µM (yellow square) and 250 µM 
(red star) of mAcot7 FL determined based on ThT 
aggregation profiles. (Inset) Actual ThT 
fluorescence of the samples mentioned above, 
respectively. Natural log-log plot of (B) TPE-TPP 
aggregation kinetics of 100 µM (black circle), 
150 µM (blue triangle), 200 µM (yellow square) 
and 250 µM (red star) of mAcot7 FL. (Inset) 
Actual TPE-TPP fluorescence of the samples 
mentioned above, respectively. The order of the 
reactions were determined from the slope of a 
linear regression to rates of the reactions, as 
shown in cyan line. (C) Normalised ThT 
fluorescence profiles of 150 µM mAcot7 FL 
(black circle) alone, and in the presence of 75 µM 
αB-c (empty diamond) or 150 µM αB-c (star). 
(Inset) Actual ThT fluorescence of 75 µM αB-c 
(dotted line) or 150 µM αB-c (solid line) 
incubated in 20 mM phosphate buffer, pH 7.4, at 
37 °C with shaking. (D) Relative initial rate of 
150 µM mAcot7 alone (black circle) or in the 
presence of 1% v/v (blue circle), 5% v/v (magenta 
circle) and 10% v/v (red circle) preformed 
mAcot7 FL fibril. (Inset) Actual ThT 
fluorescence showing the effect of seeding on the 
kinetics of 150 µM mAcot7 FL in 20 mM 
phosphate buffer, pH 7.4, at 37 °C with  shaking 
incubated in the absence (black circle) or 
presence of 1% v/v (blue circle), 5% v/v (magenta 
circle) and 10% v/v (red circle) preformed 
mAcot7 FL fibril as seed. ThT binding to 1% v/v 
(blue line), 5% v/v (magenta line) and 10% v/v 
(red line) preformed mAcot7 FL fibril are also 
included in the inset. Initial rates of mAcot7 
aggregation were estimated from the slopes of a 
linear regression to the standard curves. 
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processes, most notably in crystallisation (50).As found in other nucleation-dependent processes, 
including crystallisation, upon the introduction of preformed fibrils as seeds to the native protein, 
there is an exponential increase in the rate of initial aggregation (51-54).  We therefore determined 
the initial rate of mAcot7 FL assembly and measured the change in the rate of aggregation upon 
the addition of 1%, 5%, 10% v/v preformed mAcot7 FL fibrils as a seed to fresh mAcot7 FL, 
based on ThT fluorescence profiles (Fig. 4D, inset). Around 1.6, 2.0 and 2.3 fold increase 
respectively (i.e. non-exponential) in the initial rate of aggregation was observed upon the 
addition of an increasing concentration of preformed mAcot7 FL fibril seeds (Fig. 4D). Thus, 
from the above experiments, it is concluded that mAcot7 FL amyloid formation does not occur 
via a standard nucleated growth mechanism. 
2.3.4 Conformational changes during Acot7 amyloid fibril formation 
To monitor the conformational phase transition in mAcot7 FL during its fibrillogenesis, we 
performed far-UV CD spectroscopy and measured the change in mAcot7 FL secondary structure 
for over 56 hours continuously under amyloid fibril forming conditions (Fig. 5A). A marked 
change in mAcot7 FL ellipticity at ~208 nm and ~218 nm was observed (i.e. at minima 
corresponding to α-helix and β-sheet conformations respectively). The decrease in mAcot7 FL α-
helical ellipticity at 208 nm was observed only after ~20 hours of incubation, while ellipticity at 
218 nm of β-sheet steadily increased during the same time period (Fig. 5B). Additionally, as 
shown in figure 5B, the rate of loss of the protein’s α-helicity was 35 times slower compared to 
the gain of β-sheet. In most proteins, assembly processes occur via oligomeric intermediates 
following a nucleated growth mechanism, with the acquisition of β-sheet conformation occurring 
only after the assembly of associating units to the growing aggregate (12, 13, 52, 55-57). 
Conformational conversion with a ~35 fold higher rate of increase in β-sheet acquisition 
compared to the destabilisation of mAcot7 FL native structure, and simultaneous growth of the 
aggregates, also support nucleation-independent polymerisation in mAcot7 FL. 
Additionally, we measured the far-UV CD spectra of fresh (0 h), and 24 h N-terminally truncated, 
N-term and C-term domains of mAcot7 along with mAcot7 FL, hACOT7 and mAcot12, under 
amyloid-forming conditions (not shown). To gain more insight into the change in secondary 
structure, we normalised and deconvoluted the 0 h and 24 h spectra and compared the secondary 
structure components of the amyloid-forming forms of Acot7 to non-aggregating Acot12 (Fig. 
5C). A consistent decrease of the regular and distorted α-helical conformation and the increase in 
antiparallel β-sheet was observed for all proteins undergoing fibrillation. On the one hand, 
approximately, 5.7%, 5.6%, 7.5%, 3.7%, 2.7% decrease in regular α-helix and 2.0%, 0.3%, 4.7%, 
2.6%, and 1.0% reduction in distorted α-helix were determined for mAcot7 FL, N-terminal 
truncated, N-term domain, C-term domain and hACOT7, respectively. On the other hand, the 
antiparallel β-sheet content increased from 29.7% to 34.1%, 31.6% to 32.4%, 24.1% to 34.7%, 
36.1% to 37.1% and 34.7% to 35.0% in mAcot7 FL, N-terminal truncated, N-term domain, C-
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term domain and hACOT7, respectively. Understandably, Acot12 regular as well as distorted α-
helical content did not decrease upon incubation for 24 h under amyloid-forming conditions. In 
fact, a ~2.0% increase in the regular α-helix content was observed. Additionally, a decrease of ~ 
2.9% in antiparallel β-sheet and the appearance of parallel β-sheets were also noticed. The slight 
β-sheet rearrangement in Acot12 possibly provides stability to the protein and prevents its 
aggregation. Follow-up studies may help in determining the precise role of parallel β-sheet, and 
mechanism involved in Acot12 conformational transition. Comparing the conformational 
transition in Acot undergoing fibrillation to that in the non-aggregating mAcot12, may signify 
that the α-helical to β-sheet conversion is a critical step in the amyloid fibril formation of the 
Acot7 proteins.  
 
 
 
Figure 5. Secondary structural transition in Acot proteins upon amyloid fibril formation. (A) Continuous far-UV 
CD spectra of 10 µM mAcot7 FL in 10 mM phosphate buffer, pH 7.4 at 37 °C. Scan time for each spectrum was ~11 
min and data were collected for ~56 h. Each colour-coded spectrum, i.e. black curves (0 h – 14 h), yellow curves (14 h 
– 23 h), green and cyan curves (23 h – 38 h), magenta curves (38 h – 46 h) and blue curves (46 h – 56 h), represents a 
different interval of mAcot7 incubation in a sequential way, as indicated in the figure by the blue arrow. (B) Change in 
ellipticity at 218 nm (empty circles) and 208 nm (solid circles) of mAcot7 FL over the incubation period of ~56 h. The 
initial rate of gain was determined from the slope of a linear regression (cyan line). The initial loss of ellipticity was 
determined based on a quadratic fitting, as represented by the cyan line. (C) Secondary structure content estimation for 
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freshly prepared (0 h) and fibrillar (24 h) protein samples. 24 h proteins samples are highlighted in bold. 15 µM of the 
protein in 10 mM phosphate buffer, pH 7.4, at 37 °C was used to collect the spectra for both incubated and non-
incubated samples. Deconvolution of the spectra to determine the percentage of each secondary structural component 
was performed using BeStSel software http://bestsel.elte.hu/. 
2.3.5 Additional forces influencing the propensity of mAcot7 FL to form amyloid fibrils 
From the above, α-helical to β-sheet transition in mAcot7 FL, N-terminally truncated, N-term 
domain, C-term domain and hACOT7 appears to be one of the important factors in their 
aggregation process. Additionally, disulphide linkages, hydrophobic contacts, electrostatic 
interactions and hydrogen bonding (H-bonding) often plays a crucial role in protein 
oligomerisation and fibrillation (58-61). To measure hydrophobicity changes with the conversion 
to a fibrillar form, we co-incubated fresh mAcot7 FL and 8-anilinonaphthalene-1-sulfonic acid 
(ANS) at pH 7.4, 37 °C and monitored the ANS fluorescence emission over the period of ~131 h 
(Fig. 6A). Apart from a small increase in ANS fluorescence intensity, with time, there was no 
significant spectral changes indicating that there was little alteration in exposed hydrophobicity 
associated with mAcot7 FL amyloid fibril formation.  
To understand the effect of electrostatic interactions and hydrogen bonding, the capacity of 
mAcot7 FL to form fibrils was measured in the presence of positively and negatively charged 
amino acids at pH 7.4 (Fig. 6B). Lysine, a positively charged amino acid, completely suppressed 
mAcot7 FL’s ability to form amyloid fibrils, whereas the negatively charged amino acids, aspartic 
acid and glutamic acid, promoted fibrillation. The propensity of mAcot7 FL to form amyloid 
fibrils was significantly enhanced in the presence of N-acetyl aspartic acid compared to aspartic 
and glutamic acids. It appears that electrostatic interactions play a role in influencing the capacity 
of mAcot7 FL to form amyloid fibrils. 
mAcot7 FL has seven free cysteines, which may be involved in oligomerisation and amyloid fibril 
formation, as seen in many amyloid-forming proteins including Stefin A, Stefin B, Cystatin C, 
RNase A, PrPc and others (21, 62-64). To determine whether disulphide bond (cystine) formation 
leads to mAcot7 FL oligomerisation and further assembly to an amyloid fibril, we blocked the 
free cysteine residues of mAcot7 FL upon treatment with excess iodoacetic acid. Upon such 
treatment, an immediate increase in the rate of mAcot7 FL fibrillation occurred, thereby ruling 
out the possibility of oligomerisation via disulphide linkages (Fig. 6C). The substantial increase 
in the propensity of mAcot7 FL to form amyloid fibrils in the presence of iodoacetic acid can be 
attributed to the proliferating effect of the addition of negatively charged moieties to the cysteine 
residues. Hence, apart from a conformational phase transition, electrostatic interactions affects 
the propensity of mAcot7 FL to form amyloid fibrils.  
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Figure 6. Chemical forces involved during the process of mAcot7 amyloid fibril formation. (A) ANS binding 
fluorescence emission of 15 µM mAcot7 FL in 10 mM phosphate buffer, pH 7.4 at 37 °C with time over 131 h. Scan 
time for each spectrum was ~22 min. Each colour-coded spectrum, i.e. black spline curves (0 h – 37 h), cyan and red 
spline curves (37 h – 73 h), green spline curves (73 h – 110 h) and yellow spline curve (110 h – 131 h) represents 
different intervals of mAcot7 incubation, as labelled in the figure. (B) Relative ThT fluorescence of 150 µM mAcot7 
FL (black circle) alone, and in the presence of 10 mM lysine (magenta dot), 10 mM aspartic acid (cyan triangle), 10 
mM glutamic acid (blue diamond) or 10 mM N-acetyl aspartic acid (red circle, right Y-axis marked in red). (C) Relative 
ThT fluorescence of 150 µM mAcot7 FL (black circle) alone, and in the presence of 450 µM iodoacetic acid (red 
diamond). mAcot7 FL was incubated in 100 mM phosphate buffer, pH 7.4 at 37 °C with shaking. 
  
A. 
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2.3.6 Aggregation of mAcot7 may not involve complete unfolding of its native structure 
It is believed that globular proteins like acyl-CoA thioesterase, need to unfold, at least partially, 
as it increases the accessibility of their non-polar segments to trigger the conformational transition 
leading to amyloid fibril formation (59, 65, 66). The presence of aromatic amino acids, 
particularly tryptophan are intrinsically fluorescent and their fluorescence has been commonly 
used as a non-invasive technique to monitor protein conformational changes. In general, 
fluorescent signals from tryptophan is highly sensitive to the immediate environment of the probe, 
which drastically change upon the denaturation, unfolding, misfolding and structural 
rearrangement of the protein (67). In addition, the extrinsic fluorescence intensity of ANS 
increases dramatically upon binding to the hydrophobic regions of the polypeptide. It has also 
been used to monitor and characterise protein folding intermediates including partially folded, 
partially unfolded and molten globule states of the protein (68, 69).  
We performed GdmCl-induced equilibrium unfolding studies of mAcot7 and determined the 
protein stability by measuring mAcot7 FL intrinsic tryptophan fluorescence and extrinsic ANS 
fluorescence (Fig. 7A & B). The selective tryptophan fluorescence emission maximum (λEM = ~ 
344 – 346 nm) revealed that the tryptophan residues’ quaternary arrangements in mAcot7 FL 
were partially exposed to solvents (Fig. 7A), as demonstrated in the crystal structure (24). 
Moreover, treatment of mAcot7 FL comprising of a double-hotdog conformer with increasing 
concentration of GdmCl resulted in a spectral red-shift (λEM = ~ 354 – 356 nm) for the tryptophan 
fluorescence emission maxima (Fig. 7A). A spectral red shift of ~10 nm in mAcot7 FL in the 
presence of ≥ 2 M GdmCl, revealed an environmental change in the protein domain(s) containing 
tryptophan, due to the disruption of the native protein structure. Furthermore, ANS fluorescence 
intensity of mAcot7 FL decreased progressively, along with the red shift of emission maxima i.e. 
from λEM = ~475 nm to λEM = ~530 nm, upon increasing the concentration of GdmCl from 0 M to 
3 M (Fig. 7B). A gradual decline of ANS quantum yield and a major spectral red-shift in mAcot7 
FL native structure upon treatment with 3 M GdmCl indicated complete denaturation of the 
surface’s hydrophobic regions in the protein. It is interesting to note that the complete debasing 
of mAcot7 FL surface hydrophobicity at ≥ 3 M GdmCl was preceded by an intermediate state as 
suggested by the spectral red-shift of the ANS emission maximum (λEM = ~ 487 – 489 nm) and 
reduced intensity, at 2 M GdmCl. 
To examine whether mAcot7 FL followed a similar unfolding mechanism via an intermediate 
state during amyloid fibril formation, we continuously measured the ANS fluorescence for ~131 
h under mAcot7 FL amyloid-forming conditions (Fig. 6A). We did not observe any spectral shift 
in the ANS fluorescence maxima, indicating no significant debasing occurring in the native 
structure of mAcot7 FL during fibrillation. However, it is possible that the unfolding of mAcot7 
FL, at least partially, may have taken place at a much faster timescale compared to the detection 
limit of the fluorescence photomultiplier. 
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Figure 7. Comparison of mAcot7 FL conformational changes in the presence of a denaturant and under amyloid 
fibril-forming conditions. Guanidinium hydrochloride (GdmCl) induced equilibrium unfolding of 10 µM mAcot7 FL 
in 20 mM phosphate buffer, pH 7.4 at 37 °C, monitored based on normalised (A) mAcot7 Tryptophan fluorescence 
emission and (B) ANS fluorescence emission (Extrinsic Fluorescence). Each spectrum represents different 
concentrations of GdmCl and is colour coded: 0 M (black spline curve), 1 M (cyan spline curve), 2 M (red spline curve), 
3 M (blue spline curve), 4 M (yellow spline curve), 5 M (green spline curve), 6 M (magenta spline curve) and 0 M 
(grey spline curve) as indicated in the figures. (C) Real time tryptophan fluorescence emission of 15 µM mAcot7 FL 
in 10 mM phosphate buffer, pH 7.4, at 37 °C. Scan time for each spectrum was ~10 min and was collected for ~123 h. 
Each colour-coded spectrum i.e. black spline curves (0 h – 28 h), yellow spline curves (28 h – 45 h), cyan spline curves 
(45 h – 52 h), green spline curves (52 h – 71 h), red spline curves (71 h – 78 h), grey spline curves (78 h – 96 h), blue 
spline curves (96 h – 117 h) and magenta spline curve (117 h – 123 h) represents different intervals of mAcot7 
incubation, as indicated in the figure. 
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Similarly, we followed the unfolding, misfolding and structural rearrangement of mAcot7 FL 
using intrinsic tryptophan (Trp) fluorescence measurement for over ~123 h during amyloid fibril 
formation (Fig. 7C). Trp fluorescence intensity, and emission maximum (λEM) are mostly 
influenced by the polarity of its local environment, hydrogen bonding and other non-covalent 
interactions. Though it can be difficult to predict the effect of the solvent on the total intensity, 
the customarily red-shift of the emission energy of even a partially buried Trp residue in a folded 
protein upon unfolding, due to the increase in the microenvironment polarity, can be invaluable 
(68, 70). Selective Trp emission energy showed a slight red-shift in emission maxima i.e. from 
λEM = ~ (344 – 346) nm to λEM = ~350 nm, alongside a gradual decrease in fluorescence intensity 
upon increasing the protein’s incubation time (Fig. 7C). mAcot7 FL primary sequence contains 
two Trp residues: Trp165 forming a part of an anti-parallel β-sheet involving the N-term hotdog 
domain which is buried, and Trp210 which is unassigned in the mAcot7 crystal structure, and is 
present between the N-term and C-term hotdog domains. A slight red-shift in Trp residues 
suggested structural perturbation involving the N-term hotdog domain or the subunit breakage of 
the N-term and C-term hotdog dimers of mAcot7 FL. Therefore, a disturbance in the native 
arrangement of the N-term hotdog domain may result in the above-discussed α-helical to a β-
sheet phase transition. Concomitantly, it can also disrupt the non-covalently linked trimeric 
arrangement of mAcot7 FL, thereby generating various small molecular mass oligomers or 
subunits. Furthermore, a decrease in Trp quantum yield over time may be due to the quenching 
effect of one Trp over the other Trp residue. Another possible explanation for this fall in the 
quantum yield is that the regions involving Trp residues may form the core of the insoluble 
mAcot7 FL amyloid fibril. Therefore, this may have led to its progressive precipitation and 
thereby reducing the effective soluble protein concentration, decreasing the fluorescence intensity.  
2.3.7 The generation of lower molecular weight species of mAcot7 FL is critical to 
oligomerisation and amyloid fibril formation 
A SDS-PAGE of heat, SDS and dithiothreitol (DTT) treated and non-treated mAcot7 FL samples 
exhibited low and high molecular weight species together with monomeric mAcot7 FL (~37 kDa) 
(Fig. 8A). mAcot7 FL has seven cysteine residues, that do not form disulphide bonds in the crystal 
structure. Similarly in solution, mAcot7 does not form disulphide bonds, as revealed by the 
presence of several oligomeric bands in our DTT-treated samples. Heat-treatment of mAcot7 FL 
enhances oligomerisation, developing temperature-resistant, high molecular weight, aggregated 
species. Interestingly, the concentrated mAcot7 FL lane in figure 8A, indicated the presence of 
various weak bands of lower molecular weight species (< 37 kDa), probably arising from the 
rearrangement of the C-term and the N-term hotdog structures of the full-length protein. The 
lowest species observed in the gel by Coomassie staining was that of ~ 12 – 15 kDa, likely that 
of the monomeric N-term and C-term hotdog domains. 
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Furthermore, the turbidity measurement of mAcot7 FL at 350 nm did not reveal any rise in the 
overall size for at least 16-18 h during amyloid fibril formation (Fig. 8B). However, earlier we 
observed a dramatic and steady increase in TPE-TPP and ThT fluorescence intensities, 
respectively, commencing from 0 h of the protein incubation, which implied successive 
generation or formation of ordered β-sheet rich mAcot7 oligomers, which were not large enough 
to scatter light at 350 nm. Thus, no change in the optical density for the first ~18 h of the mAcot7 
FL incubation under aggregation conditions suggest that the larger species may not initiate protein 
fibrillation. Additionally, no increase in light scattering for the initial ~18 h may also indicate that 
mAcot7 FL fibril assembly perhaps requires specific, β-sheet rich, low-molecular weight 
oligomeric conformations. 
 
Figure 8. Generation of mAcot7 FL lower molecular weight species. (A) SDS-PAGE of freshly prepared highly 
concentrated and 20 x diluted mAcoT7 FL, boiled mAcot7 FL, DTT-treated mAcot7 FL with and without boiling, as 
labelled in the figure. (B) Light scattering profile of 150 µM mAcot7 FL (empty circle) in 20 mM phosphate buffer, 
pH 7.4, at 37 °C, with shaking.  
 
 
2.3.8 mAcot7 FL enzyme activity is not significantly affected by amyloid fibril formation 
and the binding of its substrate, enzyme inhibitors do not prevent mAcot7 fibrillation 
No significant change in the thioesterase activity of mAcot7 FL protein occurred during amyloid 
fibril formation (Fig. 9A). Furthermore, around 1.2, 1.4 and 2.4 fold increase in the rate of mAcot7 
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FL fibrillation, as monitored by ThT fluorescence, in the presence of increasing concentrations 
(100, 150 and 300 µM) of the substrate (AA-CoA), respectively was observed (Fig. 9B). In 
addition, inhibitors of mAcot7 enzyme activity such as glutarate, tricarballylate and malonate also 
increased the rate of the protein’s amyloid fibril formation by around 4.8, 4.5 and 5.9 times, 
respectively (Fig. 9C). A similar proliferation of mAcot7 FL aggregation was observed in the 
presence of negatively charged amino acids such as aspartic, glutamic and N-acetyl aspartic acid 
(Fig. 6B). It appears that the negatively charged moieties affect mAcot7 FL stability and promote 
the process of fibrillation. Perhaps the negatively charged species disrupt the hexameric 
arrangement, resulting in dissociation and generation of oligomeric and amyloidogenic species 
which therefore promotes fibril formation. 
Binding of AA-CoA to the CoA-binding site in mAcot7, neighbouring the large, conserved 
thioesterase hydrophobic interdomain tunnel (24) did not alter the rate of mAcot7 FL amyloid 
fibril formation. The thioesterase activity of mAcot7, which requires both the N-term and the C-
term hotdog domains in the hexameric arrangement to be fully functional (Fig. 1A), mostly 
remained constant during the assembly and disassembly process of fibril formation. Moreover, 
the α-helical to β-sheet conformational phase transition (Fig. 5) occurred, however no change in 
ANS fluorescence emission was observed, apart from the small change in intensity during 
mAcot7 FL fibrillation (Fig. 6A). Hence, it is possible that the native functionally active ‘trimer 
of hotdog protomers’ conformation of mAcot7 FL is not directly involved in amyloid fibril 
formation.  
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Figure 9.  Determination of mAcot7 FL enzyme activity, the effect of substrate and inhibitors during the process 
of mAcot7 FL amyloid fibril formation. (A) The activity of mAcot7 FL during the process of its aggregation. (B) 
Relative ThT fluorescence of 150 µM mAcot7 FL alone (black circle) or in the presence of 100 µM Arachidonoyl-CoA 
(blue triangle), 150 µM Arachidonoyl-CoA (yellow diamond) and 300 µM Arachidonoyl-CoA (red star) incubated in 
100 mM phosphate buffer, pH 7.4, at 37 °C with shaking. Initial rates of mAcot7 FL were determined from the slopes 
of a linear regression to the standard curves, as shown by cyan lines. The relative rate was found to be 1, 1.2, 1.4 and 
2.4, respectively. (C) Relative ThT fluorescence showing fibrillation kinetics of 150 µM mAcot7 FL alone (black circle) 
or in the presence of 2 mM, glutarate (blue triangle), malonate (red star) tricarballylate (yellow square). Initial rates of 
mAcot7 FL were determined from the slopes of a linear regression to the standard curves, as shown by cyan lines. The 
relative rate was found to be 1, 4.8, 4.5 and 5.9, respectively. 
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2.3.9 Evidence for globular oligomeric intermediates in mAcot7 FL fibril assembly and 
disassembly 
To look for the presence of intermediates during mAcot7 fibril assembly and disassembly, the 
morphological changes of mAcot7 FL were examined by TEM at various times during fibril 
formation (Fig. 10). mAcot7 FL was incubated for ~7 days under amyloid-forming conditions, 
aliquoted at 0, 8, 18, 28, 47, 74, 90, 128 and 160 h, flash-frozen and imaged via TEM. The images 
of fresh soluble 0 h mAcot7 FL protein revealed the presence of both small and long fibrillar 
structures along with some globular species. Furthermore, TEM images after 8 h of mAcot7 FL 
protein incubation were dominated by the globular protein aggregates and with disaggregated 
mAcot7 FL fibrils, indicating fibril disassembly. mAcot7 FL fibril disassembly was more 
prominent at 18 h with more disaggregated fibrils. More importantly, the 28 h mAcot7 FL 
aggregated protein samples did not exhibit any long fibrillar structures. However, small fibrils 
and globular protein aggregates were quite common. Images of 47 h samples also did not contain 
any mature fibrillar structures, though small fibrillar forms appeared to acquire a more organised 
morphology, including circular and globular among others. mAcot7 FL protein samples imaged 
at 74, 90, 128, and 160 h displayed sequential assembly of small structured fibrils to more ordered, 
mature, insoluble mAcot7 fibrils. The sequential TEM images in figure 10, displaying mAcot7 
FL fibril assembly and disassembly, represent only the major events occurring in soluble mAcot7 
FL over the period of 160 h under amyloid-forming conditions.  
The presence of low molecular weight oligomers (Fig. 8) besides the emergence of globular 
intermediates, before the formation of mAcot7 FL amyloid fibril suggests conformational and 
oligomeric rearrangement of the soluble full-length protein. 
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Figure 10. Morphological changes in mAcot7 FL, demonstrating its assembly and disassembly process. 200 µM 
mAcot7 FL was incubated in 20 mM phosphate buffer, pH 7.4, at 37 °C, with constant fast shaking and protein samples 
were aliquoted at different time points from 0 – 160 h. Representative TEM images of mAcot7 FL at different time 
points illustrates the mAcot7 assembly and disassembly processes. Scale bar = 50, 100 and 200 nm as indicated in the 
figure. 
 
 
2.3.10 The propensity of mAcot7 to form amyloid fibrils is highly dependent on the hotdog 
domain arrangement 
To gain further insight into the structural aspects of the tendency of mAcot7 FL to form amyloid 
fibrils, we compared various forms of the protein, i.e. N-terminally truncated, N-term and C-term 
domains of mAcot7 and evaluated their relative rates of fibrillation. As demonstrated in figure 
11A, the N-term and the C-term domains of mAcot7 FL underwent fibrillation at a significantly 
faster rate, i.e. 8.5 and 5.0 times, respectively compared to the full-length protein. The N-
terminally truncated (with the first 50 residues trimmed from the N-terminal region) form of 
mAcot7 formed amyloid fibrils with only a slightly faster rate (1.3 times) than the full-length 
protein.    
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Figure 11. Aggregation kinetics of mAcot7 constructs. (A) Normalised ThT fluorescence demonstrating fibrillation 
kinetics of 100 µM, mAcot7 FL (black circle), N-terminally truncated mAcot7 (cyan circle), the N-term domain of 
mAcot7 (blue circle) and C-term domain of mAcot7 (red circle). (Inset) Relative initial rates of various mAcot7 
constructs, as indicated in the figure. Initial rates were determined from the slopes of straight line fits, to the normalised 
data as indicated by solid blue lines.  
 
As determined by X-ray crystallography and discussed in the introduction, the N-term domain 
(PDB 2V1O), the C-term domain (PDB 2Q2B) and the full-length mAcot7 (PDB 4ZV3) adopt a 
similar hexameric (trimer of double-hotdog domains) arrangement (Fig. 1) (24, 28). In the 
hexameric arrangement, the N-term domain of mAcot7 (residues 13 – 163) features a double-
hotdog (residues 23 – 118) structure (i.e. N-N homoprotomer), with each monomer comprising 
five antiparallel β-sheets surrounding an α-helix. Three N-N homoprotomers non-covalently 
associate to form a trimer of double-hotdog structures, as indicated in figure 1B. On the other 
hand, the C-term domain (residues 169 – 370) similarly forms a non-covalently linked ‘trimer of 
C-C double-hotdog’ (residues 171 – 299) structure, which involves less intra- and inter-protomer 
contact area at the domain interfaces compared to the N-term domain (Fig. 1C). In the case of 
full-length Acot7, a monomeric N-term hotdog domain associates with a monomeric C-term 
hotdog domain to form a N-C double-hotdog conformation. Each heteroprotomer non-covalently 
associates with another two more heteroprotomers to give the hexameric arrangement as shown 
in figure 1A (24, 28).  
Comparing the amyloid fibril formation rate kinetics of mAcot7 FL, N-term and C-term domains 
of mAcot7 indicate that the double-hotdog conformations formed by the association of the same 
monomeric hotdog domain (i.e. N- or C- term hotdog associating with another N- or C- term 
hotdog, respectively) is highly amyloidogenic (fibril-prone). A double-hotdog structure in the 
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full-length protein formed by the association of the N-term and the C-term hotdog domains (i.e. 
N-C heteroprotomer) is less susceptible to form amyloid fibrils compared to the N-N and C-C 
homoprotomers, and are probably involved in oligomerisation.                                                                                                                                                                                                                                                                                            
2.3.11 Postulated mouse acyl-CoA thioesterase 7 molecular model of oligomerisation and 
fibrillation 
Based on the above-discussed results, we propose a model for mAcot7 FL oligomerisation and 
amyloid fibril formation. A schematic representation of the postulated molecular mechanism of 
mAcot7 oligomerisation and amyloid fibril formation is given in figure 12. Table 1 summaries 
the terminologies used to describe various hotdog conformations the full-length protein may 
acquire during the assembly and disassembly process. The hexameric arrangement of mAcot7 FL, 
i.e. the trimer of N-C double-hotdog structure is the functionally active form (Fig. 1) (24). 
Structural perturbation of mAcot7 FL, possibly in the region involving Trp210 (Fig. 7) present 
between the N-term and C-term hotdog domains, may lead to an α-helical to β-sheet 
conformational transition and dissociation of the non-covalently linked N-C heteroprotomer from 
the hexameric arrangement (Fig. 5 and Fig. 7). A similar mechanism involving the production of 
amyloidogenic precursors including the conformational conversion has been observed with a 
model amyloid-forming protein (Barstar), (13),  prion (Sup35) (52) and the Alzheimer’s related 
peptide (Aβ-42) (55). The separation of the mAcot7 FL hexameric arrangement into low 
molecular weight subunits including monomeric N-C heteroprotomers, presents an additional 
opportunity for the entropically favourable structural rearrangement. The association between the 
two monomers is stronger than between a monomer and higher molecular weight oligomers due 
to the entropic effect (71). We have also previously shown that amyloid fibril formation by RCM 
κ-casein involves the dissociation of its spherical, oligomeric form into a monomeric 
amyloidogenic precursor, which then undergoes rapid polymerisation to form fibrillar structures 
(39, 72).  
 
Table 1. Terminology used to describe the structural rearrangement of mAcot7. 
 
Heteroprotomer (N-C) 
Monomeric N-C double-
hotdog structure 
 Homoprotomer (C-C) 
Monomeric C-C double-
hotdog structure 
 
Dimer of homoprotomers 
(fibril-prone) 
(Two) monomeric N-N, C-C  
double-hotdog structures 
 
Homoprotomer (N-N) 
Monomeric N-N double-
hotdog structure 
 
Dimer of 
heteroprotomers 
(oligomeric-prone) 
(Two) monomeric N-C 
double-hotdog structures 
 Hexameric arrangement 
(functionally active) 
Trimer of N-C double- 
hotdog structures 
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Figure 12. Postulated model of mAcot7 FL oligomerisation and amyloid fibril formation. Predominantly, mAcot7 FL exists in a hexameric arrangement, the functionally active ‘trimer of 
heteroprotomers’ in solution. Probable structural destabilisation in the region involving Trp210 along with the rapid α-helical to β-sheet phase transition, leads to the dissociation of N-C heteroprotomers 
of mAcot7 FL from the hexameric arrangements. This provide an opportunity for an entropically favoured mAcot7 structural rearrangement, leading to the formation of the dimer of heteroprotomers 
(oligomeric prone) and dimer of homoprotomers (fibril-prone) for further large scale oligomerisation and amyloid fibril formation. The dimer of homoprotomers can steadily self-assemble in a nucleation-
independent manner, resulting in the formation of a multi-stranded superhelical amyloid fibril structure. 
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Furthermore, the monomeric N-term and C-term hotdog conformers can act as two different 
nuclei for the association and possible formation of the homo- and hetero-hotdog protomers in 
the soluble mAcot7 protein. Polymerisation into larger structures including fibril formation 
involving two different classes of bonds results in multi-stranded filament formation (71, 73, 74). 
While reassembling, the monomeric N-term and C-term double-hotdog structures (i.e. N-C 
heteroprotomer) can associate with another N-C heteroprotomers to form a ‘dimer of 
heteroprotomers’ or ‘dimer of homoprotomers,’ as depicted in figure 12. Such arrangements are 
highly oligomeric and amyloidogenic in nature (Figs 2, 8, 11). Additional evidence for the 
presence of different forms of oligomeric intermediates has been presented in figure 10.  
To conclude, the dimer of heteroprotomers may act as nuclei for further oligomerisation and result 
in the formation of a trimer of heteroprotomers (arrangement similar to a hexameric, functionally 
active form of mAcot7 FL) and other higher oligomeric species as presented in figure 12. Constant 
formation of the mAcot7 FL’s hexameric arrangement explains why the thioesterase activity of 
the mAcot7 FL protein almost remained constant during the process of amyloid fibril formation 
(Fig. 9A). The formation of the C-C, N-N dimer of homoprotomers most likely act as nuclei for 
fibrillation, which steadily self-assemble in a nucleation-independent manner (Fig. 4), leading to 
the formation of a multi-stranded superhelical amyloid fibril structure (Fig. 3), as depicted in 
figure 12. Co-operative multi-stranded polymerisation has commonly been observed in actin, 
tubulin, prion proteins and others (75-78). However, mAcot7 FL amyloid fibril formation will be 
one of the first instance of non-cooperative multi-stranded passive polymerisation. The presence 
of fibrillar structures in the fresh soluble mAcot7 FL protein, their subsequent breakdown to 
globular aggregates and their re-assembly to a superhelical fibril structure, indicated fibril 
dynamic instability or treadmilling (Fig. 10). The mAcot7 FL fibril instability was also observed 
in the X-ray fibre diffraction pattern, with no distinct equatorial and meridional reflections (Fig. 
3A). Treadmilling or fibril dynamic instability is a common phenomenon involving multi-
stranded filaments and has frequently been observed in microtubules and other similar proteins 
(78, 79). 
2.4 Significance 
Acot7 catalyses the hydrolysis of cytoplasmic long-chain acyl-CoA in neurons to regulate lipid 
retention and metabolism and plays a crucial role in eicosanoid activity and neuroinflammation 
(24, 26, 31). Acot7 shows high specificity for AA-CoA and hence could act as a primary regulator 
of arachidonic acid (AA). In addition, the overexpression of Acot7 in a mouse macrophage cell 
line controls the incorporation of AA into membrane phospholipids (24). AA, on the other hand, 
modulates voltage-gated ion channels and is also involved in the synthesis of prostaglandins, 
leukotrienes and thromboxanes, which are critical for the physiological manifestations of 
inflammation (80, 81). Furthermore, fatty acids act as precursors for the biosynthesis of 
membranes and signalling lipids, energy production and storage, and many post-translational 
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modifications including palmitoylation (26). Dysregulation of lipid metabolism can result in 
neurological disorders, as the unique composition of lipids in neurons is vital for the development 
and function of the nervous system. Metabolic dysfunction involving dysregulated lipid 
metabolism has been associated with many neurodegenerative disorders such as Alzheimer’s and 
Parkinson’s diseases, multiple system atrophy and amyotrophic lateral sclerosis (82-88). The 
presence of proteinaceous deposits also containing amyloid fibrils in the affected tissues and 
organs are considered to be the common hallmark of such degenerative diseases (4, 59, 89). 
Alzheimer’s disease pathology is also characterised by neuroinflammation primarily driven by 
microglia cells, which intensifies as the disease progresses (90). Thus, dysregulated 
neurometabolism may contribute to the progression of neurodegenerative disorders. Additionally, 
a range of conformational states are available to proteins, and their relative stabilities are largely 
dependent on their polypeptide chains, environmental and other biological conditions.  Moreover, 
it is increasingly becoming clear that all peptides or proteins under appropriate conditions can 
form amyloid fibrils. Thus, slight perturbations in the stability of the native state of a protein 
having normal functional behaviour, may thereby contribute to the susceptibility of the protein to 
convert to amyloid fibrils leading to the loss of normal function (5, 91), as also shown in this 
study. Therefore, the insight into the structural instability of the enzymes such as acyl-CoA 
thioesterases regulating lipid metabolism, their ability and pathway they follow to form amyloid 
fibrils or other protein aggregates, may broaden our overall understanding of the pathogenesis of 
the neurodegenerative diseases. This, in turn, may ultimately lead to novel therapeutic targets for 
preventing or controlling the disease process. 
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ABSTRACT: Highly ordered protein aggregates, termed amyloid
ﬁbrils, are associated with a broad range of diseases, many of which
are neurodegenerative, for example, Alzheimer’s and Parkinson’s. The
transition from soluble, functional protein into insoluble amyloid ﬁbril
occurs via a complex process involving the initial generation of highly
dynamic early stage aggregates or preﬁbrillar species. Amyloid probes,
for example, thioﬂavin T and Congo red, have been used for decades as
the gold standard for detecting amyloid ﬁbrils in solution and tissue
sections. However, these well-established dyes do not detect the
presence of preﬁbrillar species formed during the early stages of protein
aggregation. Preﬁbillar species have been proposed to play a key role in
the cytotoxicity of amyloid ﬁbrils and the pathogenesis of neuro-
degenerative diseases. Herein, we report a novel ﬂuorescent dye
(bis(triphenylphosphonium) tetraphenylethene (TPE-TPP)) with aggregation-induced emission characteristics for monitoring
the aggregation process of amyloid ﬁbrils. An increase in TPE-TPP ﬂuorescence intensity is observed only with ordered protein
aggregation, such as amyloid ﬁbril formation, and not with stable molten globules states or amorphously aggregating species.
Importantly, TPE-TPP can detect the presence of preﬁbrillar species formed early during ﬁbril formation. TPE-TPP exhibits a
distinctive spectral shift in the presence of preﬁbrillar species, indicating a unique structural feature of these intermediates. Using
ﬂuorescence polarization, which reﬂects the mobility of the emitting entity, the speciﬁc oligomeric pathways undertaken by
various proteins during ﬁbrillation could be discerned. Furthermore, we demonstrate the broad applicability of TPE-TPP to
monitor amyloid ﬁbril aggregation, including under diverse conditions such as at acidic pH and elevated temperature, or in the
presence of amyloid inhibitors.
Fluorescence-based techniques have been widely used tostudy protein structure due to their ease of application,
ﬂexibility, and noninvasive nature.1 In particular, dye-based
assays have signiﬁcantly enhanced our understanding of the
complex conformational transition of soluble ordered/disor-
dered proteins and peptides into insoluble β-sheet rich species,
commonly known as amyloid ﬁbrils. The aggregation of
proteins or peptides into amyloid ﬁbrils is a pathological
hallmark of more than 50 human disorders, including
Alzheimer’s, Parkinson’s and dialysis-related amyloidosis.2,3 In
contrast, amyloid ﬁbrils with essential biological activities, often
termed functional amyloid, have been reported.4 In general,
protein and peptide aggregation is not the direct conversion of
soluble monomers to insoluble ﬁbrils. Instead, multiple
processes may be involved including the generation of
transient, intermediately folded, or unfolded states and
oligomers (commonly known as preﬁbrillar species) that act
as primary nuclei for further ﬁbril growth.5 These small
oligomeric species are considered to be the dominant cytotoxic
forms of misfolded proteins.6,7 However, in situ and ex situ
identiﬁcation and characterization of early stage aggregates are
diﬃcult because they are generally heterogeneous, are present
in minute quantities for a limited time, and are highly dynamic
in nature.8 Congo red and thioﬂavin T (ThT) are the most
commonly used dyes in the study of protein aggregation
associated with diseases. The green birefringence from Congo
red under polarized light and the enhanced ﬂuorescence of
ThT are indicative of the presence of amyloid ﬁbrils. Assays
based on Congo red and ThT, however, are not able to detect
the presence of early stage aggregates.9−13 More recently,
penta-formylthiophene acetic acid, 9-(dicyanovinyl)-julolidine,
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Nile red, BODIPY-oligomer, N-aryl amino naphthalenesulfo-
nate and its analogue, and tryptophanol have been used for the
identiﬁcation of preﬁbrillar species of various ﬁbril-forming
peptides and proteins,14−19 but most of these are speciﬁc to
particular amyloid proteins. Therefore, novel probes that have
broad applicability to report on the presence of preﬁbrillar
species are desirable.
Full insight into the self-assembly of peptides and proteins
and their role in disease requires both the identiﬁcation and
characterization of early stage aggregates and other conforma-
tional states adopted by the polypeptide chain along the
pathway to the formation of amyloid ﬁbrils. Although some
progress has been made in this area, a better understanding of
the nanoscale assembly of amyloid ﬁbrils from normally soluble
proteins is crucial for combating protein aggregation diseases as
well as to exploit their potential beneﬁts.20 Previously, one of us
(Y.H.) reported that ﬂuorogens with aggregation-induced
emission (AIE) characteristics, such as BSPOTPE and TPE-
TPP (Figure 1A, top panel) are nonﬂuorescent in solution but
become highly ﬂuorescent when they bind to amyloid ﬁbrils of
insulin and α-synuclein, respectively.21−23 Furthermore, a
competition experiment between ThT (Figure 1A, bottom
panel) and TPE-TPP binding to α-synuclein ﬁbrils indicated
that TPE-TPP binds more eﬃciently (with a Kd of 4.36 μM) to
the same site(s) as that of ThT (whose Kd is 8.48 μM).
21 As
derivatives of tetraphenylethene (TPE), a typical AIE
luminogen, the emission of these dyes is triggered by the
restriction of intramolecular motions (RIM) of the phenyl
rotors in their aggregated form.24 Additionally, in their
aggregated state, the highly twisted nature of the molecular
structure impedes π−π interactions, thereby displaying strong
ﬂuorescence.23,25 Similarly, RIM of AIE can also be achieved
upon binding to larger macromolecules such as proteins.
Increasing viscosity, decreasing temperature and elevated
pressure are further expected to inﬂuence RIM by slowing
the intramolecular rotation and hence leading to stronger TPE-
TPP ﬂuorescence emission.23,26
In the present study, we applied the aforementioned
properties of TPE-TPP to investigate protein assembly and
disassembly. We ﬁnd that, upon interacting with protein
molecules, emission from TPE-TPP can speciﬁcally monitor
the process of ordered protein aggregation, such as amyloid
ﬁbril formation, even under solution conditions of acidic pH
and elevated temperature. Compared to ThT, TPE-TPP is
markedly more sensitive with regards to recognition of aged
amyloid ﬁbrils, and no self-quenching of ﬁbril-associated
ﬂuorescence is observed in the presence of excess dye. In
contrast, complete loss of ThT ﬂuorescence was observed
during extended incubation of hen egg white lysozyme
(HEWL) and κ-casein ﬁbrils. TPE-TPP ﬂuorescence increases
upon generation of oligomeric assemblies formed during the
early stage of protein aggregation, and displays a signiﬁcant
spectral shift upon binding to preﬁbrillar species. In addition,
using a microplate-based in situ TPE-TPP ﬂuorescence assay,
we screened three diﬀerent types of potential inhibitors of
amyloid ﬁbril formation acting at various stages of aggregation.
In comparison to the routinely used amyloid probe ThT, TPE-
TPP shows broader in vitro applicability to investigate ordered
protein aggregation processes.
■ EXPERIMENTAL SECTION
Materials. TPE-TPP was synthesized as described in the
literature.21 All other reagents (proteins, amino acids,
chemicals, solvents, etc.) were purchased from Sigma Life
Sciences and Sigma-Aldrich unless otherwise speciﬁed.
The recombinant D76N variant of β2-microglobulin (D76N
β2m), αB-Crystallin, and α-synuclein were expressed and
puriﬁed as described previously.27,28 The determination of
protein concentration is described in SI.
Amorphous Aggregation. The change in light scattering
at 350 nm was used to monitor amorphous aggregation of α-LA
and hen egg white lysozyme (HEWL). Assay conditions are
described in detail in Table S1 and Table S2. Assays were
conducted in Nunc 96 well polypropylene microplates, sealed
with transparency ﬁlm, incubated at 37 °C, and light scattering
was monitored using a Biotek Synergy 2 microplate reader.
Amyloid Fibril Formation. The ﬁbrillar aggregation of
proteins was monitored in Greiner Bio-One 384-well micro-
plates (item no.: 784900, small volume, black, ﬂat bottom and
nonbinding) using a Biotek Synergy 2 microplate reader. The
conditions for ﬁbril formation are described in detail in Tables
S1−3. Transparent sealing ﬁlm was used to prevent solvent
evaporation. ThT ﬂuorescence emission was measured using a
440/40 nm ﬁlter for excitation and a 485/20 nm ﬁlter for
emission, while for TPE-TPP ﬂuorescence, the 380/20 and
460/40 nm ﬁlters were used for excitation and emission,
respectively, under the ﬁbrillation conditions appropriate for
each protein. Dye concentrations were 20 and 5 μM for in situ
and ex situ assays, respectively. The TPE-TPP ﬂuorescence
assay potentially may be aﬀected by a high-binding microplate;
Figure 1. Fluorescence response of bis(triphenylphosphonium) tetraphenylethene (TPE-TPP) to diﬀerent forms of α-LA. (A) Structure of TPE-
TPP (top panel) and ThT (bottom panel). (B) Time-course turbidity at 350 nm of molten globule (black open circle), apo (red triangle) and holo
(blue circle) forms of α-LA (O.D. = optical density). (C) In situ TPE-TPP assay of molten globule (black open circle), apo (blue circle), holo (red
triangle), and amyloid ﬁbril-forming reduced and carboxymethylated (RCM) α-LA (black circle). (D) TEM images of the holo form of α-LA and
RCM α-LA ﬁbrils formed in the presence of TPE-TPP. 20 μM of dye was used for all ﬂuorescence assays. For TPE-TPP, the excitation and emission
ﬁlters were 380/20 and 460/40 nm, respectively. The conditions for formation of the diﬀerent α-LA aggregates are summarized in Table S1.
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therefore, all TPE-TPP and ThT ﬂuorescence assays were
performed using the aforementioned nonbinding microplate.
Fluorescence Polarization. For ﬂuorescence polarization
(FP) experiments, amyloid ﬁbrils were prepared according to
the conditions outlined in Tables S1−3 using Greiner Bio-One
384-well microplates (small volume, black, ﬂat bottom, and
nonbinding) with transparent sealing ﬁlm. TPE-TPP was added
to 20 μM prior to incubation of the protein. FP was recorded in
situ with a CLARIOstar microplate reader (BMG Labtech)
using the FP mode and a FP ﬁlter set of 380/20 nm for
excitation and 485/20 nm for emission. The background
ﬂuorescence of TPE-TPP in the corresponding buﬀer solution
under the respective protein ﬁbrillation conditions was
subtracted, and the change in FP values was expressed in
milli-polarization units (ΔmP).
■ RESULTS AND DISCUSSION
TPE-TPP Speciﬁcally Monitors Ordered Protein Ag-
gregation. To determine whether TPE-TPP can distinguish
between various types of protein aggregates, we measured the
response of TPE-TPP against diﬀerent aggregation pathways
undertaken by the same protein under various experimental
conditions. We ﬁrst chose α-lactalbumin (α-LA) as the model
protein because it is a well-characterized protein that can form a
molten globule, amorphous aggregates, and amyloid ﬁbrils
under the appropriate solution conditions (as described in
Table S1).29 α-LA forms a characteristic molten globule state at
pH 2.0, and Ca2+-free (apo) and Ca2+-bound (holo) α-LA form
amorphous aggregates under reducing conditions. The rapid
formation of amorphous aggregates upon reduction of α-LA
was apparent from the change of the turbidity of the protein
solution with time, as monitored via light scattering at 350 nm
(Figure 1B). RCM α-LA, on the other hand, forms ordered
amyloid ﬁbrils under physiological conditions in the presence of
Mg2+ and with agitation.30 Figure 1C shows that TPE-TPP was
weakly ﬂuorescent in the presence of monomeric α-LA prior to
incubation. Moreover, no enhancement of TPE-TPP emission
was observed during the process of molten globule or
amorphous aggregate formation. Interestingly, a signiﬁcant
rise in TPE-TPP ﬂuorescence (in a sigmoidal manner)
occurred during the ﬁbrillar aggregation of RCM α-LA,
implying that TPE-TPP is sensitive and selective to amyloid
ﬁbril formation. The formation of amorphous aggregates by
holo α-LA, and ﬁbrils by RCM α-LA in the presence of ThT
and TPE-TPP was conﬁrmed by transmission electron
microscopy (TEM) with negative staining (Figure 1D).
Similar to α-LA, HEWL can form aggregates of diﬀerent
morphology as described in Table S2; for example, amyloid
ﬁbrils at pH 2.0 and amorphous aggregates at pH 12.2.31,32
Consistent with the response to the various forms of α-LA,
TPE-TPP remained weakly ﬂuorescent during the entire
process of amorphous aggregation of HEWL, as monitored
by light scattering at 350 nm. By contrast, TPE-TPP exhibited
signiﬁcant ﬂuorescence enhancement, displaying a typical
sigmoidal proﬁle during the formation of lysozyme amyloid
ﬁbrils at pH 2.0 and 55 °C (Figure S1). Under such extreme
pH and temperature conditions, ThT is unstable.33,34
Moreover, we observed that ThT ﬂuorescence intensity
underwent major ﬂuctuation even after mature ﬁbrils had
formed (see below). In addition to chemical reduction and the
exposure to extreme pH conditions, heat can also denature
proteins and induce aggregate formation. Both ThT and TPE-
TPP ﬂuorescence remained almost unchanged in the presence
of bovine serum albumin (BSA) before and after heating to 95
°C, pH 7.4, i.e. conditions that induce the formation of
disordered amorphous aggregates of this protein (Figure S2).
Observing Preﬁbrillar/Oligomeric Species during
Protein Aggregation. As TPE-TPP shows speciﬁc binding
to amyloid ﬁbrils over amorphous aggregates, we next
investigated its application to follow the kinetics of protein
aggregation, speciﬁcally amyloid ﬁbril formation by RCM α-LA
(Figure 2). RCM α-LA was incubated with TPE-TPP and ThT
independently, and the change in TPE-TPP and ThT
ﬂuorescence was monitored over time. TPE-TPP ﬂuorescence
Figure 2. Comparison of the time-course aggregation proﬁles of six diﬀerent amyloid ﬁbril-forming proteins as monitored by ThT and TPE-TPP
ﬂuorescence. (A−C) In situ and (D−F) ex situ dye-binding ﬂuorescence (normalized) proﬁle of (A) 100 μM RCM α-LA, (B) 50 μM RCM κ-casein,
(C) 35 μM HEWL at pH 2.0, (D) 10 μM αB-Crystallin, (E) 40 μM D76N β2m, and (F) 40 μM α-synuclein. TPE-TPP ﬂuorescence intensity data
are represented as solid circles and ThT ﬂuorescence as open circles. 20 μM of dye was used for the in situ and 5 μM for the ex situ assays. For ThT,
the excitation and emission ﬁlters were 440/40 and 485/20 nm, respectively. For TPE-TPP, the excitation and emission ﬁlters were 380/20 and
460/40 nm, respectively. Tables S2 and S3 summarize the amyloid ﬁbril-forming conditions for each protein.
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intensity decreased signiﬁcantly during the ﬁrst 30 min of
incubation and remained constant for the ﬁrst 5.5 h (Figure
2A). The ﬂuorescence emission of TPE-TPP then increased
dramatically reaching a plateau after 8 h of incubation. The
commensurate experiment with ThT showed constant weak
ﬂuorescence for the ﬁrst 7 h of incubation and then a slow
increase such that it had not reached a plateau even after 12 h
of incubation. Thus, there is a notable diﬀerence in the
ﬂuorescence proﬁles of both dyes in the presence of aggregating
RCM α-LA. It appears that TPE-TPP ﬂuorescence is more
sensitive to the early species formed prior to the formation of
ﬁbrillar entities than those detected by ThT ﬂuorescence.
To examine whether this is a general phenomenon (i.e., that
TPE-TPP can monitor species formed early during protein
ﬁbrillation), we extended our studies to other amyloid ﬁbril-
forming proteins. Similar to RCM α-LA, TPE-TPP ﬂuorescence
intensity exhibited an initial decrease during the incubation
period and then rose at an earlier time point than ThT during
the ﬁbrillation process of RCM κ-casein and HEWL (Figure
2B,C). In each of the three cases examined, the dyes were
mixed with the proteins before aggregation commenced (i.e., in
situ assay; Figure 2A−C). To rule out the possibility of the
early increase in TPE-TPP ﬂuorescence being due to a change
in the rate of aggregation as a result of the interaction of AIE
molecules, we also conducted studies involving the addition of
the dyes to aliquots collected at diﬀerent time points during the
aggregation process (i.e., ex situ assay). The molecular
chaperone protein αB-crystallin, D76N β2-microglobulin
(β2m), a naturally occurring amyloidogenic variant of β2m
(the protein involved in dialysis-related amyloidosis), and the
synucleinopathies-associated protein α-synuclein, were used in
this work as they all readily form ﬁbrils under the conditions
tested.35−37 Consistent with the in situ assays, TPE-TPP
showed ﬂuorescence enhancement with these proteins at time
points earlier than ThT (Figure 2D−F). Both the in situ and ex
situ assay results clearly indicate that TPE-TPP is capable of
detecting early stage/preﬁbrillar aggregating species which are
not observed using ThT.
Spectral Shift of TPE-TPP Fluorescence with Diﬀerent
Protein Species. The normalized emission spectrum of TPE-
TPP exhibited a signiﬁcant blue and red shift when it was mixed
with puriﬁed preﬁbrillar and ﬁbrillar α-LA, respectively,
compared to that in the presence of the monomeric species
(Figure 3A). The emission spectrum of TPE-TPP exhibited an
emission maximum at 474 nm when mixed with RCM α-LA
monomers, which shifted to 460 nm with preﬁbrillar RCM α-
LA. In contrast, the emission maximum was red-shifted to 484
nm when mixed with puriﬁed RCM α-LA ﬁbrils. The early
stage species detected at around 6 h by TPE-TPP (Figure 2A)
was separated and puriﬁed from other RCM α-LA forms using
native agarose gel electrophoresis and an Ultrafree-DA
centrifugal unit, respectively. The Ultrafree-DA unit utilizes
centrifugal force and a microporous membrane to disperse the
agarose gel matrix, thereby allowing recovery of the protein.
The nonﬁbrillar spherical morphology of the preﬁbrillar RCM
α-LA was conﬁrmed by TEM (Figure 3B). A similar
hypsochromic shift of TPE-TPP ﬂuorescence emission
maximum to ∼465 nm was also observed when it was mixed
with preﬁbrillar D76N β2m, but no signiﬁcant change in the
emission maximum occurred when mixed with ﬁbrillar D76N
β2m compared to the monomeric form of the protein (Figure
S3). Thus, such spectral shifts in TPE-TPP ﬂuorescence
emission can be used to diﬀerentiate between various protein
forms.
Absence of Self-Quenching and Fibril Maturation-
Induced Fluorescence Quenching. Younan and Viles
reported that an excess of ThT can cause quenching of
ﬂuorescence upon binding to amyloid β-peptide ﬁbrils.38 To
test whether TPE-TPP has the same behavior, the dye-to-
protein ﬁbril ratio was increased, and ﬂuorescence spectra were
recorded. The concentration of the preformed protein ﬁbrils
was ﬁxed at 10 μM and the concentration of dye (ThT or TPE-
TPP) was altered from 1 to 40−50 μM. Consistent with the
above study, ThT ﬂuorescence decreased once the dye-to-
protein concentration ratio was greater than 1:1 for both
HEWL and α-synuclein ﬁbrils (Figure 4A and S4). In contrast,
the TPE-TPP ﬂuorescence intensity increased proportionally
with the increase in the dye-to-protein ﬁbril ratio, reaching a
plateau when the molar ratio reached 2:1 dye: ﬁbrillar protein.
No self-quenching of ﬂuorescence occurred even when the dye-
to-protein ﬁbril ratio was greater than 4:1 for both ﬁbrillar
species.
In addition to the problems associated with self-quenching,
we found that ThT only exhibited appreciable ﬂuorescence
with ﬁbrils of κ-casein, D76N β2m, and HEWL that were
Figure 3. Fluorescence emission spectrum of TPE-TPP upon binding
to diﬀerent forms of α-LA. (A) Normalized TPE-TPP ﬂuorescence
emission upon binding to fresh, nonaggregated (black curve),
preﬁbrillar (green curve) and ﬁbrillar (magenta curve) species of
RCM α-LA. (B) TEM image of RCM α-LA preﬁbrillar species; scale =
100 nm. The TPE-TPP ﬂuorescence emission spectrum was measured
with excitation at 350 nm.
Figure 4. Fluorescence change at diﬀerent dye: ﬁbril stoichiometry,
and upon maturation of ﬁbrils. (A) Change in ﬂuorescence intensity
with increasing dye-to-protein concentration ratio. Protein: 10 μM
mature α-synuclein ﬁbrils. The data of dye with mature HEWL ﬁbrils
are shown in Figure S4. TPE-TPP ﬂuorescence shown by solid black
circle and line, and ThT ﬂuorescence is represented by an open black
circle and dashed line (B) Fibril maturation-induced quenching of
ThT and TPE-TPP ﬂuorescence. Actual TPE-TPP and ThT
ﬂuorescence intensity upon binding to nonincubated 2-day (hollow
bar) and upon aging (solid black bar) protein ﬁbrils, as indicated in the
ﬁgure. The concentration of the proteins and dyes was each 10 μM.
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freshly prepared. In order to examine whether this is also a
limitation of TPE-TPP, the proteins were incubated under
conditions conducive to ﬁbril formation for 48 h. At the end of
the incubation, ThT and TPE-TPP ﬂuorescence spectra of an
aliquot from each protein was measured (before maturation),
and the remainder of the sample was then incubated at room
temperature for an additional 7−30 days and measured (after
maturation). We measured an ∼18-fold decrease in ThT
ﬂuorescence signal in the case of 30-day aged RCM κ-casein
ﬁbrils (Figure 4B). A ∼7- and 2.4-fold loss of ThT ﬂuorescence
signal occurred with 7-day and 30-day-old HEWL and D76N
β2m ﬁbrils, respectively (Figure 4B). On the contrary, no
notable reduction of TPE-TPP ﬂuorescence was observed
between the ﬁbrils formed at 48 h and aged ﬁbrils (7-day-old
HEWL and 30-day-old D76N β2 M ﬁbrils). However, a ∼2-
fold signal loss was observed in the case of 30-day aged RCM κ-
casein ﬁbrils. Hence, unlike ThT, TPE-TPP bound more
eﬃciently to aged HEWL, D76N β2m, and RCM κ-casein
ﬁbrillar species.
This self-quenching eﬀect makes it diﬃcult to measure the
rate of ﬁbril formation accurately using ThT ﬂuorescence. It is
also noteworthy to speculate that the extended lag phase in the
kinetic curves could be attributed to quenching of ThT
ﬂuorescence during the early phase of ﬁbrillation (i.e., when the
amyloid ﬁbril content is much lower than the dye
concentration). As a result, this may lead to inaccuracies in
the assessment of the lag phase of the reaction when using in
situ ThT assays. Similar to our observation, other studies have
also noted that ﬁbril morphology can signiﬁcantly aﬀect ThT
ﬂuorescence.33,39
Monitoring the Eﬀects of Amyloid Fibril Inhibitors.
Using a ﬂuorescence-based approach for rapid screening of
potential therapeutic agents that can act on various stages of the
amyloid ﬁbril-forming pathway is a challenging task because of
the limitations of routinely used amyloid probes. Since TPE-
TPP can follow the kinetics and reveal the early stage processes
during protein ﬁbrillation, the eﬀect of small molecules on
amyloid ﬁbril formation was investigated. We examined the
eﬀects of lysine and arginine, well-described potent inhibitors of
protein aggregation,40−42 on RCM α-LA ﬁbrillation using TPE-
TPP and ThT ﬂuorescence assays (Figure 5A,B). No signiﬁcant
increase in TPE-TPP ﬂuorescence was observed when RCM α-
LA was incubated in the presence of lysine or arginine,
suggesting complete suppression of the ﬁbrillation process
(Figure 5A). The inhibitory eﬀect of lysine and arginine was
conﬁrmed using a ThT-based ﬂuorescence assay (Figure 5B).
Quinacrine, a tricyclic acridine compound, has also been
extensively studied for its potential treatment of prion diseases
and has been reported to inhibit amyloid β peptide
ﬁbrillation.43−45 We investigated the eﬀect of quinacrine on
RCM α-LA amyloid ﬁbril formation via TPE-TPP ﬂuorescence
(Figure 5C). While quinacrine did not completely inhibit ﬁbril
formation by RCM α-LA, it slowed its rate of ﬁbril formation
and resulted in a change in ﬁbril morphology, as evident by
TEM (Figure S5A). When incubated in the presence of
quinacrine, RCM α-LA amyloid ﬁbrils (cf. Figure 1D) were
much shorter with more globular and spherical aggregates when
quinacrine was not present (Figure S5A). In addition, Ponceau
S, a diazo dye that is regularly used as a reversible stain for the
detection of proteins in Western blotting,46 modulates RCM α-
LA ﬁbril formation (Figure 5D). When monitored by TPE-TPP
ﬂuorescence, ﬁbril formation by RCM α-LA in the presence of
Ponceau S had an extended lag phase by about 1.5 h compared
to when Ponceau S was not present. By prolonging the lag
phase, the diazo dye acts on the early stage of the protein’s
aggregation, most likely by altering the ﬁbrillation pathway
resulting in the formation of unstable ﬁbrillar structures, as
observed by TEM (Figure S5B).
The formation of amyloid ﬁbrils can be prevented in a
number of ways: by stabilizing the native structure of the
precursor protein or peptide, by inhibiting or altering
oligomerization during the early stage of ﬁbrillation and by
modulating or suppressing ﬁbril elongation. Identifying distinct
inhibitors for each of these cases can be a diﬃcult process. The
TPE-TPP ﬂuorescence proﬁles of RCM α-LA in the presence
of arginine and lysine suggest that both positively charged
amino acids stabilized monomeric RCM α-LA, preventing it
from further aggregation. Ponceau S, a diazo compound,
modulated the preﬁbrillar RCM α-LA form leading to the
formation of unstable ﬁbrillar species, thereby altering the
normal RCM α-LA ﬁbrillation pathway as indicated by the
extended lag-phase. Quinacrine appears to attenuate the rate of
RCM α-LA amyloid formation, producing shorter ﬁbrillar
structures. Thus, by monitoring the TPE-TPP ﬂuorescence
associated with ﬁbril formation, we are able to draw conclusions
on the possible inhibitory mechanism of diﬀerent ﬁbril
inhibitors.
Fluorescence Polarization for Monitoring the Oligo-
meric Pathway during Protein Assembly. In addition to
measuring the change in ﬂuorescence intensity during amyloid
ﬁbril formation, we recorded the change in ﬂuorescence
polarization (FP) of TPE-TPP. FP reﬂects the mobility of the
emitting species such that when the ﬂuorescent molecule binds
to a small target it freely rotates and has small FP values.
However, when the ﬂuorescent molecule binds to a large
molecule, its rotation/mobility slows and its FP value increases.
The alteration in the FP value is therefore proportional to the
relative mass of the object to which it binds.1,47−49 The change
Figure 5. Screening and evaluation of potential inhibitors for amyloid
ﬁbril formation as monitored by TPE-TPP ﬂuorescence. (A) TPE-
TPP ﬂuorescence intensity of 125 μM RCM α-LA in the absence
(black circle) and presence of 10 mM lysine (blue circle) or 10 mM
arginine (red circle). (B) ThT ﬂuorescence intensity of 125 μM RCM
α-LA in the absence (open black diamond) and presence of 10 mM
lysine (open blue diamond) or 10 mM arginine (open red circle).
Normalized TPE-TPP ﬂuorescence intensity of (C) 125 μM RCM α-
LA in the absence (solid circle) and presence of 10 μM Quinacrine
(open circle), and (D) 125 μM RCM α-LA in the absence (solid
circle) and presence of 2.6 μM Ponceau S (open circle).
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in FP of TPE-TPP during the ﬁbrillation of RCM α-LA, RCM
κ-casein and insulin was therefore measured to examine
whether it could be used to monitor amyloid ﬁbril formation
by these proteins.
RCM α-LA (monomeric mass 14.7 kDa) follows classical
nucleation-dependent polymerization as apparent from its
sigmoidal kinetic ﬂuorescence curve.30 Starting from mono-
mers, soluble oligomers with increasing mass were formed after
2 h of incubation, as reﬂected by the steep increase of the FP.
Afterward, rigid insoluble ﬁbrils were formed with FP reaching
a maximum value and staying constant over the next 8 h
(Figure 6A). On the other hand, RCM κ-casein (monomeric
mass ∼19 kDa) forms amyloid ﬁbrils via a diﬀerent mechanism
with the absence of a signiﬁcant lag phase. In solution at 25 °C,
RCM κ-casein occurs as a spherical particle with a weight-
average molecular mass of ∼1180 kDa.50 Consistent with the
diﬀerence in molecular mass, the FP of RCM κ-casein prior to
incubation was higher than that of RCM α-LA (Figure 6B). At
37 °C and neutral pH, RCM κ-casein reassembles into ﬁbrillar
structures.50−52 Amyloid ﬁbril formation by RCM κ-casein
involves the dissociation of its spherical, oligomeric form into a
monomeric amyloidogenic precursor, which then undergoes
rapid aggregation to form a nucleus from which rigid, rod-like
amyloid ﬁbrils develop.51,52 Bovine insulin (monomeric mass
5.8 kDa) forms amyloid ﬁbrils at acidic pH (pH 2.0) and
elevated temperature (60 °C). Insulin exists as a dimer at acidic
pH, which rapidly dissociates to monomer at higher temper-
ature followed by a conformational change. The partially
unfolded monomers associate with each other to form
oligomeric intermediates including dimers, tetramers and
hexamers.53 Hexamers have been reported to be a critical
preﬁbrillar intermediate in the formation of mature amyloid
ﬁbrils.54 The progression from monomer to dimer, tetramer,
hexamer and then to insulin amyloid ﬁbril is observed by the
stepwise increase, each of around similar magnitude in the FP
of TPE-TPP (Figure 6C). Thus, TPE-TPP-based FP measure-
ments can map the oligomeric assemblies, while monitoring the
ﬁbrillar assembly, of a variety of amyloid ﬁbril-forming protein
in situ. Moreover, because FP is less dependent on the dye
concentration, its signal remained constant after reaching the
plateau, whereas a decrease in ﬂuorescence intensity is often
observed after the formation of insoluble ﬁbrils (cf Figure 2).
Mechanism of TPE-TPP Binding to Amyloid Fibrils.
TPE-TPP is nonﬂuorescent in buﬀer solution owing to the
aggregation-induced emission property of its TPE core as the
ﬂuorophore. Once bound to a macromolecule such as a protein,
the intramolecular motions of the peripheral phenyl rings of
TPE are restricted, and the dye becomes emissive.23 In contrast
to ThT, TPE-TPP does not have any electron-donating or
-accepting groups conjugated to its ﬂuorogenic unit (Figure
1A). Therefore, it is unlikely to undergo the twisted
intramolecular charge transfer mechanism ascribed to ThT
ﬂuorescence.55,56
Immediate TPE-TPP ﬂuorescence was observed following
incubation with all the freshly prepared (nonaggregated)
proteins used in this study (i.e., α-LA, HEWL, D76N β2m,
RCM κ-casein, αB-Crystallin, and α-synuclein). However, no
further enhancement of TPE-TPP ﬂuorescence occurred when
the proteins were induced to form the molten globule state or
amorphous aggregates. In contrast, TPE-TPP exhibited
signiﬁcant ﬂuorescence enhancement when incubated with
proteins as they underwent ﬁbril formation. TPE-TPP is like
ThT in binding preferentially to the cross β-sheet structure that
is characteristic of amyloid ﬁbrils. The exact mechanism of ThT
interaction with amyloid ﬁbrils is a matter of debate.
Potentially, TPE-TPP could interact with hydrophobic residues
and emit ﬂuorescence. Molten globule states and amorphous
aggregates both have signiﬁcant exposed hydrophobicity but
they do not have well-deﬁned β-sheet conformations in place
and are much more dynamic and less-structured entities than
the highly structured amyloid ﬁbrils and hence do not provide
signiﬁcant physical constraint to enhance TPE-TPP ﬂuores-
cence. Thus, TPE-TPP is a ﬂuorescent dye that selectively
monitors in vitro amyloid ﬁbril formation, but not molten
globule states or amorphous (disordered) protein aggregates.
Following incubation, TPE-TPP exhibited in situ and ex situ
ﬂuorescence enhancement much earlier than ThT during
protein ﬁbril formation, suggesting that TPE-TPP can interact
with preﬁbrillar aggregates but not interfere with aggregate
formation. Furthermore, a signiﬁcant blue shift in the
ﬂuorescence emission spectrum of TPE-TPP occurred in the
presence of preﬁbrillar, oligomeric species compared to native
forms of the same protein (Figures 3A and S3). The blue shift
observed in the ﬂuorescence emission spectrum when TPE-
TPP interacted with preﬁbrillar protein species also occurs for
TPE-TPP in the most viscous solvent, glycerol, when compared
with less viscous solvents or solvents with greater polarity, and
is accompanied by an increase in ﬂuorescence intensity at the
wavelength emission maximum (Figures S6 and S7). For
example, the emission maximum of TPE-TPP is ∼470 nm in
ethylene glycol but is shifted to ∼430 nm in 25% v/v glycerol
and is enhanced in intensity (Figure S6). Only a small change
in Stokes shift is observed when the glycerol percentage is
increased from 25% to 100% v/v but a large and linear increase
Figure 6. Protein ﬁbril formation monitored by FP. Time-dependent change in FP (ΔmP) of TPE-TPP (20 μM) during amyloid ﬁbril formation of
(A) 125 μM RCM α-LA, (B) 50 μM RCM κ-casein, and (C) 200 μM insulin.
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in ﬂuorescence intensity occurs (Figures S6 and S7). Such a
viscous and rigid local environment could restrict the
intramolecular motions of the excited species and may enable
the transition of the excited species from a higher energy level
to the ground state, resulting in a blue shift of the ﬂuorescence
spectrum. By extrapolation, potentially these observations
imply that the presence of soluble oligomeric assemblies
enhances the local viscosity in the surrounding environment of
the TPE-TPP dye. This is consistent with literature reports that
the formation of early stage soluble oligomeric assemblies
increases the viscosity of the local environment during protein
assembly.57−61
A red shift in TPE-TPP emission upon binding to RCM α-
LA mature ﬁbrils also occurred, which was not observed with
D76N β2m ﬁbrils (Figures 3A and S3), suggesting that TPE-
TPP can also detect morphological variations in amyloid ﬁbrils.
When the dye molecules bind to the mature ﬁbrils of ordered
structure, they may have to adjust their conformation, for
example via rearranging the dihedral angle between the phenyl
rings and the central double bond of TPE, to ﬁt into the
binding site. As a result, a red shift in the spectrum would be
observed.
TPE-TPP can thus recognize and bind to various protein
forms with diﬀerent speciﬁcity resulting in spectral changes.
Importantly, by monitoring such changes in the TPE-TPP
emission spectrum, it is feasible to diﬀerentiate between
nonaggregated, pre- and ﬁbrillar protein forms. Although
complementary assays based on TEM or atomic force
microscopy are always useful to characterize protein morphol-
ogy, the possibilities of using TPE-TPP ﬂuorescence provides a
rapid and convenient way to diﬀerentiate proteins adopting
diﬀerent morphologies.
■ CONCLUSIONS
In summary, our work demonstrates that TPE-TPP has many
advantages over ThT in its applicability to monitor amyloid
ﬁbril formation. TPE-TPP detects the emergence of preﬁbrillar
aggregates, is more robust in monitoring amyloid ﬁbril
formation at highly acidic pH and/or high temperatures, and
it can be used in the presence of exogenous potential inhibitors,
including in high-throughput screening. It also does not
undergo self-quenching when present in excess compared to
the concentration of the ﬁbrils, and it retains its ﬂuorescence
properties when used with aged amyloid ﬁbrils. Furthermore,
TPE-TPP ﬂuorescence can monitor the oligomeric pathway of
a protein during amyloid ﬁbril formation. Thus, we propose
that in many respects, TPE-TPP is a superior dye for
ﬂuorescence-based detection and characterization of amyloid
ﬁbril aggregation.
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EXPERIMENTAL SECTION 
Stock solution preparation and measurement of protein, ThT and TPE-TPP 
concentrations.  Reduction and carboxymethylation of RCM α-LA and RCM κ-casein were 
performed according to the methods outlined in previous publications1,2. Concentrations of 
RCM α-LA, RCM κ-casein, D76N β2m, αB-crystallin and α-synuclein in solutions were 
determined using a NanoDrop ND-1000 spectrophotometer (Thermo Fisher Scientific). The 
molar extinction coefficients and molecular masses of the proteins were as follows; α-LA – 
28,826 M-1 cm-1 and 14.7 kDa 2, κ-casein – 95,000 M-1 cm-1 and 19.7 kDa 1, D76N β2m – 
20,000 M-1 cm-1 and 12 kDa 3, αB-crystallin – 19,000 M-1 cm-1 and 20 kDa 4, α-synuclein – 
5,600 M-1 cm-1 and 14 kDa 5. Stock solutions of 2.5 mM ThT in 1 mL of 50 mM glycine-
NaOH, pH 8.5, were prepared. The exact dye concentration was determined experimentally 
from the absorbance in water using the reported value of 36,000 M-1 cm-1 for the molar 
extinction coefficient of ThT in water at 412 nm 6. The stock solution was prepared by 
dissolving 1 mg of TPE-TPP in 1 mL of DMSO to give a concentration of 1 mM. 
Transmission electron microscopy (TEM). Samples for TEM imaging were applied to 
Formvar with carbon coating on 400 mesh copper grids and negatively stained with uranyl 
acetate (2% (w/v); AJAX chemicals). A Hitachi 7100 TEM was used to view samples under a 
magnification of 100,000-200,000 at a 125-kV excitation voltage. Bright field images were 
formed using a small objective aperture and analyzed using the Gatan micrograph and 
captured with a side-mounted Orius camera. 
Fluorescence spectra of TPE-TPP. The excitation spectra of TPE-TPP in different solvents 
were acquired with 470 nm as the emission wavelength using Cary Eclipse fluorescence 
spectrophotometer. All samples were prepared in a final volume of 500 µL in a high precision 
quartz fluorescence cuvette (Hellma Analytics) having a path length of 0.1 cm and 
equilibrated at room temperature for 15 min before the measurements. The slit width was set 
to 5 nm and the scan speed was set to medium for all readings. The emission spectra of TPE-
TPP with different solvents, proteins and fibrils were recorded with an excitation wavelength 
of 350 nm using the same setup, cuvette and spectrophotometer as used for the excitation 
spectra.  
Purification of early-stage aggregates/ prefibrillar species. The early-stage/prefibrillar 
species of RCM α-LA and D76N β2m detected by TPE-TPP fluorescence were loaded into 
two adjacent lanes in two separate 0.6% (w/v) native agarose gels and were isolated 
according to a previously described protocol 7. A sharp, sterile surgical blade was used to 
separate the two lanes from the gel. One of the lanes was stained using the Coomassie 
Brilliant Blue R gel-staining solution, and the other was stored submerged in running buffer 
at 4 °C. Once the region containing the soluble protein aggregates was identified in the first 
band, the identical region was excised from the unstained gel fragment. The unstained gel 
fragment containing the soluble aggregates was placed into an Ultrafree®-DA unit 
(centrifugal filter unit from Millipore). The soluble aggregate complex was recovered by 
centrifuging the Ultrafree®-DA filtrate vial containing the complex at 5000g for 10 min at 4 
°C. 
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Table S1: Aggregation conditions and types of aggregates formed by α-LA 
Protein (100 
µM) 
Aggregation conditions Type of 
aggregate 
RCM α-LA 20 mM sodium phosphate pH 7.4, 100 mM KCl, 10 mM 
MgCl2, 37 °C, slow shaking 
8
 
Fibril 
α-LA 50 mM glycine-HCl pH 2.0, 37 °C, slow shaking 9  Molten globule 
α-LA (Apo) 50 mM sodium phosphate pH 7.2, 100 mM NaCl, 2.5 mM 
EDTA, 20 mM DTT, 37 °C, 300 rpm 
9
 
Amorphous 
α-LA (Holo) 50 mM imidazole buffer pH 7.2, 100 mM NaCl, 5 mM CaCl2, 
20 mM DTT, 37 °C, 300 rpm 
9
 
Amorphous 
 
Table S2: Aggregation conditions for HEWL, BSA, and the corresponding aggregate 
types 
Protein  Aggregation conditions Type of 
aggregate 
HEWL (35 µM) 50 mM glycine-HCl pH 2.0, 137 mM NaCl, 2.7 mM KCl, 
0.01% (w/v) NaN3, 55 °C,  medium shaking 
10
 
Fibril 
HEWL (70 µM) 50 mM glycine-HCl pH 2.0, 37 °C, 300 rpm 
11
  Amorphous 
BSA (1 mg/mL) 20 mM sodium phosphate pH 7.4, 95 °C for 20 min. Amorphous 
 
Table S3 Aggregation conditions for amyloid fibril formation by different proteins 
Protein  Aggregation conditions Type of 
aggregate 
50 µM RCM 
κ-casein 
20 mM sodium phosphate pH 7.4, 37 °C, 300 rpm 
12
 Fibril 
10 µM αB-
crystallin 
20 mM sodium phosphate pH 7.4, 37 °C, agitation using 
magnetic stirrer at 450 rpm  
 Fibril 
40 µM D76N 
β2m  
20 mM sodium phosphate pH 7.4, 37 °C, agitation using 
magnetic stirrer at 450 rpm  
Fibril 
40 µM α-
synuclein 
20 mM sodium phosphate pH 7.4, 37 °C, agitation using 
magnetic stirrer at 450 rpm  
Fibril 
200 µM 
insulin 
50 mM glycine-HCl pH 2.0, 60 °C 
13
 Fibril 
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Figure S1. Fluorescence response of TPE-TPP to different forms of HEWL. HEWL fibrils 
were prepared by incubating 35 µM HEWL at pH 2.0, 55 °C. The change in TPE-TPP 
fluorescence intensity was monitored using the excitation and emission filters of 380/20 and 
460/20 nm, respectively. Amorphous HEWL aggregates were prepared by incubating 70 µM 
HEWL at pH 12.2. The formation of amorphous aggregates was monitored by turbidity 
measurement at 350 nm (red line, right y-axis). Both in-situ (solid black triangle) and ex-situ 
(solid black circle and dashed line) measurement of TPE-TPP fluorescence (left y-axis 
marked in black) show no fluorescence enhancement during the formation of amorphous 
aggregates of HEWL. Table S2 summarizes the method and conditions of HEWL 
aggregations. 
S-6 
 
 
  
Figure S2. Heat denaturation of BSA. Actual ThT and TPE-TPP fluorescence intensity before 
(hollow bar) and after (solid bar) heat denaturation of 1 mg/mL BSA at pH 7.4 at 95 
o
C for 20 min. 
20 µM of dye was used for the aggregation assay. Table S2 summarizes the method and conditions 
of BSA denaturation. 
 
 
 
 
Figure S3. Fluorescence emission profile of TPE-TPP binding to different forms of D76N 2m. 
Normalized TPE-TPP fluorescence emission upon binding to fresh, non-aggregated (black curve), 
prefibrillar (green curve) and fibrillar (magenta curve) forms of D76N β2m. The concentration of 
protein and dye used was around 10 µM each. TPE-TPP fluorescence emission was measured with 
excitation at 350 nm. 
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Figure S4. Change in fluorescence intensity with increasing dye-to-protein concentration ratio for 
10 µM mature HEWL fibrils. 
 
 
 
 
Figure S5. TEM images of RCM α-LA fibril formed in the presence of (A) Quinacrine and (B) 
Ponceau S. The in situ concentration of ThT and TPE-TPP used in assays was 20 µM.  
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Figure S6. Excitation (left) and emission spectra (right) coloured in light and dark shades of the 
same colors of 400 nM TPE-TPP in (A) solvents of increasing polarity (from ethyl acetate to water) 
and (B) solvent mixtures of increasing viscosity, i.e. ethylene glycol with increasing glycerol v/v 
percentages. 
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Figure S7. Solvatochromism and viscosity dependence of TPE-TPP fluorescence. (A) Lippert-
Mataga
14,15
 solvatochromism plot (Stokes shift (), i.e. the difference between the excitation and 
emission wavelength maxima, left y-axis, labeled in black) and maximum fluorescence intensity 
(right y-axis, labeled in red) of TPE-TPP as a function of solvent polarity (f). (B) Stokes shift 
(() left y-axis, labeled in black) and TPE-TPP fluorescence intensity (right y-axis, labeled in red) 
as a function of solvent viscosity. Abbreviations in panel A: EA - ethyl acetate, O - octanol, D - 
dimethyl sulfoxide (DMSO), EG - ethylene glycol, M - methanol and W- water. For the viscosity 
experiments (B), TPE-TPP was mixed in solutions of ethylene glycol and increasing amounts (v/v) 
of glycerol. 
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CHAPTER 4 
The molecular chaperones clusterin and αB-crystallin prevent primary and 
secondary nucleation of a potently amyloidogenic variant of β2-microglobulin  
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Abstract 
Amyloid fibril formation by β2-microglobulin (β2m) and subsequent accumulation in 
periarticular tissues have been linked to hemodialysis-related amyloidosis. D76N β2m, a natural 
variant of human β2m responsible for aggressive systemic amyloidosis, readily forms amyloid 
fibrils in vitro under conditions of physiological pH and temperature. Significant quantities of the 
molecular chaperones clusterin, αB-crystallin (αB-C), haptoglobin (Hp) and α2-macroglobulin 
(α2M) are present in several tissues and have been shown to prevent the aggregation of wild type 
β2m under acidic conditions in vitro. In the present study, we examined the role of these four 
chaperones in modulating D76N β2m fibrillogenesis in vitro. Thioflavin T (ThT), 8-
Anilinonaphthalene-1-sulfonic acid (ANS) assays and the contrasting suppressive and 
proliferative effect of oppositely charged amino acids indicated that clusterin and αB-C interact 
with various D76N β2m species including monomeric, oligomeric, prefibrillar and fibrillar forms, 
presumably via hydrophobic and ionic interactions. Hp and α2M did not show any inhibitory 
effect on D76N β2m aggregation. Moreover, α2M and αB-C themselves formed ThT positive, 
amyloid fibril-like structures under the conditions used to induce amyloid fibril formation of 
D76N β2m. Additionally, whilst interacting with D76N β2m, clusterin and αB-C were 
incorporated into the aggregates formed, as indicated by transmission electron microscopy and 
confirmed by SDS-PAGE of depolymerised fibrils. SYPRO Orange and ThT fluorescence assays 
suggest that D76N β2m fibrils formed in the presence of clusterin and αB-C are chemically more 
stable and have a significantly reduced ability to act as seeds to potentiate D76N β2m fibril 
formation, compared to D76N β2m fibrils alone. Together, these results indicate that αB-C and 
clusterin prevent both primary and secondary nucleation events during the fibrillation of D76N 
β2m and therefore may affect amyloidogenesis in vivo by slowing amyloid proliferation in fibril-
containing tissues. 
Keywords: hemodialysis-related amyloidosis, D76N β2-microglobulin, αB-crystallin, clusterin, 
α2-macroglobulin, haptoglobin, molecular chaperone, amyloid fibril, fibril stability, fibril seeding 
Abbreviations: ANS: 8-Anilinonaphthalene-1-sulfonic acid, αB-C: Alpha B-crystallin, α2M: α2-
macroglobulin, β2m: β2-microglobulin, D76N β2m: D76N variant of β2-microglobulin, DRA: 
hemodialysis-related amyloidosis, GdmCl: Guanidinum hydrochloride, Hp: Haptoglobin 
(phenotype 2-1), SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis, sHsps: 
Small heat-shock proteins, TEM: Transmission electron microscopy, ThT: Thioflavin T, tlag: Lag 
time. 
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4.1 Introduction 
Protein aggregation, in particular, the formation of β-sheet rich structures called amyloid fibrils, 
have been linked to a wide range of diseases, many of which are age-related and neurological (1). 
β2m is the invariant (non-polymorphic) light chain class I component of the human major 
histocompatibility complex (MHC-I). In adults, approximately 200 mg of the protein is produced 
per day, and the excess is cleared through the kidneys. In patients with end-stage renal failure on 
long-term dialysis, the plasma concentration of β2m gradually rises from the standard 1-2 mg/L 
to approximately 50-70 mg/L, which can lead to the development of dialysis-related amyloidosis 
(DRA) (2, 3). The in vitro conversion of wild type β2m to amyloid fibrils is an unfavourable 
process under physiologically relevant conditions, i.e. pH and temperature (4-9). However, 
recently a natural amyloidogenic variant of human β2m, D76N β2m, was reported (10).  
Individuals bearing a mutation of β2m at position 76 (an asparagine for an aspartic acid) with 
ageing, develop an aggressive systemic amyloidosis and impair several organs. The deposits 
mainly comprises of D76N β2m amyloid, despite the presence of the wild-type species 
(phenotypes are always heterozygous) (11). Within a few hours, D76N β2m readily forms 
amyloid fibrils in vitro under conditions of physiological pH and temperature and has also been 
shown to induce wild-type fibrillogenesis resulting in copolymerisation (12). 
The accumulation of β2m in periarticular tissue following its conversion to amyloid fibrils leads 
to hemodialysis-related amyloidosis (DRA), a disabling condition resulting in painful 
inflammation of the bones and joints, leading to movement impairment and even spontaneous 
fractures (2, 13). Although the most detrimental consequences of DRA pathology come from 
mechanical impairment and joint tissue degeneration, the general features of amyloid disease are 
of relevance to DRA. Those features are much more likely to exhibit their effect in systemic 
amyloidosis associated with the occurrence of D76N β2m. There is a growing consensus that 
intermediates formed during fibril assembly (i.e. soluble oligomers and prefibrillar species) are 
the disease-causing agents rather than the mature fibrils (14-18). Furthermore, it has been 
proposed that such pathogenic species are predominantly generated as a result of the breakage 
(i.e. fragmentation) of mature fibrils rather than the association of monomeric, precursor proteins 
(19). Xue et al. (20) proposed that the adverse role of fibril fragmentation in disease is two-fold; 
fragmentation not only leads to the generation of smaller, more toxic entities but also provides an 
additional source of nuclei to ‘seed’ fibril formation and potentiate disease. Additionally, self-
catalysis of secondary nucleation on the fibril’s surface is considered to play a significant role in 
the formation of oligomers and fibril proliferation, which can also contribute to disease (21-23). 
Organisms, organs and cells respond to the adversities associated with protein aggregation by 
constitutive expression, secretion and upregulation of a group of proteins, collectively known as 
molecular chaperones. A wide variety of structurally different chaperones and other regulatory 
factors are synthesised and secreted by cells, forming cooperative pathways and networks. 
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Together, they provide machinery for protein quality control system the and maintenance of 
protein homoeostasis (proteostasis) (24, 25). 
Clusterin, haptoglobin (Hp), α2-macroglobulin (α2M) and small heat-shock proteins (sHsps) such 
as αB-crystallin (αB-C) act as molecular chaperones to suppress protein aggregation. Despite a 
lack of significant sequence similarity, these chaperones interact with client proteins via a similar 
‘holdase’ type mechanism to prevent aggregation (25, 26). sHsps are ubiquitous intracellular 
proteins whereas clusterin, Hp and α2M are generally present extracellularly (25, 27-29), as is 
β2m and the naturally occurring D76N variant. Under conditions of stress such as elevated 
temperature, oxidation and reduction, all of the mentioned molecular chaperones effectively 
inhibit the in vitro amorphous aggregation of a wide range of proteins (25, 30, 31). Moreover, all 
of these chaperones inhibit amyloid fibril formation of several peptides and proteins, including 
β2m. Previous work has shown that clusterin and αB-C inhibit β2m fibril formation under acidic 
conditions (32, 33), as well as neutral pH (34), whereas Hp and α2M inhibit β2m fibril formation 
induced by the presence of serum fatty acid (35) and sodium dodecyl sulphate (SDS) (36), 
respectively.  
Furthermore, αB-C and clusterin are found co-localised in amyloid deposits associated with 
Alzheimer’s disease and various other amyloidosis (26, 37). Clusterin is also a recognised 
biomarker for Alzheimer’s disease (38, 39). The process of undesired protein assembly and 
disassembly can compromise the protein quality control machinery, due to aberrant protein 
interactions, which can lead to the sequestration of molecular chaperones (37, 40). Additionally, 
Narayan et al. (41) observed that Aβ oligomers formed during Aβ (1-40) and Aβ (1-42) 
aggregation can damage neuronal cells within half an hour of exposure, demonstrating the innate 
toxic nature of protein aggregation processes. By contrast, the clinical progression of Alzheimer’s 
disease and many other amyloidosis including DRA is very slow, typically over decades.  
In this study, we investigated the in vitro effects of αB-C, clusterin, Hp and α2M on D76N β2m 
aggregation under conditions of physiological pH and temperature, to gain insight into aspects 
underlying the development of protein aggregation diseases, namely the effect of molecular 
chaperones with a paradigmatic amyloidogenic motif such as the immunoglobulin-like domain of 
β2m. We observed that αB-C and clusterin stabilise various forms of D76N β2m, including 
prefibrillar intermediates and fibrillar forms. In doing so, both these chaperones not only delayed 
the onset of D76N β2m fibrillation but also increased the chemical stability of D76N β2m fibrils 
and prevented secondary nucleation events.  
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4.2 Experimental Procedures 
4.2.1 Materials 
Recombinant D76N β2m and αB-C were expressed in BL21 (DE3) E. coli and purified as 
described previously (42, 43). Clusterin, α2M and Hp (phenotype 2-1) were purified from human 
serum as described previously (27, 44). Thioflavin T (ThT), lysine, arginine, 8-
anilinonaphthalene-1-sulfonic acid (ANS), SYPRO Orange and Guanidinium hydrochloride 
(GdmCl) were purchased from Sigma-Aldrich. All other chemicals were of analytical grade. 
4.2.2 Induction of amyloid fibril formation 
Proteins prepared at 0.4-40 µM in 20 mM sodium phosphate buffer, pH 7.4, were incubated in 
the absence or presence of varying concentrations of the molecular chaperones in a vial (Wheaton 
Glass Millville, Sigma-Aldrich) with constant stirring using 3 x 10 mm magnetic beads at 450 
rpm at 37 °C.  
4.2.3 ThT fluorescence assay 
Samples of aggregated protein prepared as described above were aliquoted in triplicate at different 
time intervals and stored at –20 °C. After thawing, 5 µM of the protein samples were mixed with 
5 µM ThT in 20 mM phosphate buffer, pH 7.4 and their fluorescence emission was recorded with 
a 480/20 nm filter following excitation with a 440/40 nm filter on a Biotek Synergy 2 microplate 
reader. Like other nucleation-dependent amyloid fibril-forming systems, D76N β2m 
fibrillogenesis, as monitored by ThT fluorescence, can be described by a sigmoidal function, 
comprising of lag, exponential and plateau phases. The lag time, tlag, was defined as the incubation 
time required to reach a ThT intensity that is ≤ 10% of the intensity of the plateau (45-47).  
4.2.4 8-Anilinonaphthalene-1-sulfonic acid (ANS) binding assay 
The degree of exposed hydrophobicity of αB-C, α2M, clusterin, and D76N β2m in the absence 
and presence of chaperones was calculated based on the fluorescence emission of ANS using a 
460/40 emission filter, following excitation with a 380/20 filter, on a Biotek Synergy 2 microplate 
reader. Samples for the ANS assay were prepared by adding freshly prepared ANS stock solution 
to the incubated sample, such that the final concentration of the protein and ANS were 5 µM and 
500 µM, respectively. The time-dependent percentage increase in ANS fluorescence intensity 
(ANS F.I) of D76N β2m in the absence and presence of the molecular chaperones was calculated 
based on equation 1: 
% 𝑖𝑛𝑐𝑟𝑒𝑎𝑠𝑒 = [(𝐴𝑁𝑆 𝐹. 𝐼 𝑎𝑡 9.5 ℎ –  𝐴𝑁𝑆 𝐹. 𝐼 𝑎𝑡 0ℎ)/ (𝐴𝑁𝑆 𝐹. 𝐼 𝑎𝑡 9.5ℎ)]  ∗ 100     (Eq. 1)    
where the ANS F.I at 9.5 h represents the ANS binding maximum at the end of the exponential 
phase, the ANS F.I at 0 h represents ANS binding of the native protein(s). 
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4.2.5 Transmission electron microscopy 
Samples following incubation under the above-mentioned aggregation condition were transferred 
to formvar- and carbon-coated copper grids 400 mesh and negatively stained with uranyl acetate 
(2% (w/v); Ajax Chemicals) in water. Samples were examined using a Hitachi 7100 TEM at a 
125 kV accelerating voltage under a magnification of 100-200k. Images were visualised with the 
Gatan Microscopy Suite Software and captured using a side-mounted Orius camera. 
4.2.6 Purification of amyloid fibrils 
D76N β2m amyloid fibrils formed in the absence and presence of αB-C and clusterin were 
centrifuged at 14,100 x g at room temperature for 1 h. After discarding the supernatant, the pellet 
was washed with 20 mM sodium phosphate buffer, pH 7.4, and centrifuged again at 14,100 x g 
for 1 h. The resultant pellet was resuspended and washed again in the same buffer. The final 
washed pellet was then used for further analysis. 
4.2.7 Depolymerisation of amyloid fibrils 
Purified D76N β2m amyloid fibrils pellets were resuspended in 7 M GdmCl, 20 mM sodium 
phosphate, pH 7.4, in such a way that the final concentration of the fibrils was 20 µM. Samples 
were subsequently incubated overnight at room temperature. The depolymerised fibrils of D76N 
β2m formed in the absence and presence of αB-C and clusterin were subjected to SDS-PAGE 
using NuPAGE® Novex® 4-12% Bis-Tris protein gels and 2-(N-morpholino) ethane sulfonic 
acid (MES) as a running buffer. Precision plus ProteinTM KaleidoscopeTM standards (Bio-rad) was 
used as a molecular weight marker. 
4.2.8 SYPRO Orange-based assay of the chemical stability of D76N β2m fibrils 
 The chemical stability of the D76N β2m fibrils was determined by measuring the fluorescence 
intensity following incubation with SYPRO Orange as the binding of SYPRO Orange provides a 
measure of exposed hydrophobicity. Purified D76N β2m amyloid fibrils formed in the absence 
or presence of 10 µM αB-C and 0.4 µM clusterin, were resuspended in 20 mM sodium phosphate, 
pH 7.4, which contained Gdm-HCl (ranging from 0 to 7 M increasing in 0.5 M increments), such 
that final concentration of D76N β2m was 20 µM. The samples (20 µL in volume) were allowed 
to stand at room temperature overnight before adding 2.5 µL of a 50 x concentrate of SYPRO 
Orange. The fluorescence emission at 610 nm following excitation at 485 nm, was measured using 
a SpectraMax M2e (Molecular Devices) at room temperature. 
4.2.9 Amyloid seeding/cross-seeding experiments 
20 µM of fresh, native state D76N β2m in 20 mM sodium phosphate, pH 7.4, was incubated at 
37°C with slow agitation either without (unseeded) or with (seeded) percentage (5% v/v and 50% 
v/v) of purified D76N β2m amyloid fibrils formed in the absence or presence of 10 µM αB-C and 
0.4 µM clusterin, respectively. The in situ aggregation kinetics were monitored via ThT 
fluorescence assay as described above. 
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4.3 Results 
4.3.1 Interaction of molecular chaperones during in vitro fibrillogenesis of D76N β2m under 
conditions of physiological pH and temperature  
D76N β2m aggregation at pH 7.4 at 37 °C, with agitation at 450 rpm, was monitored by a ThT 
assay in the absence or presence of the molecular chaperones αB-C, clusterin, Hp and α2M. 
Incubation of D76N β2m alone resulted in a sigmoidal increase in ThT fluorescence over time 
(Fig. 1A), indicative of the formation of amyloid fibrils, which was further confirmed by TEM 
(Fig. 1C). There was a sharp decline in ThT fluorescence observed after ~12 hours of incubation, 
which most likely was due to the precipitation of the aggregated species. The onset of 
polymerisation, after ~5 hours of incubation, was delayed by the presence of substoichiometric 
concentrations of αB-C and clusterin (Fig. 1A) but not by Hp or α2M (Fig. S1). Thus, 10 µM αB-
C and 0.4 µM clusterin concentrations extended the lag phase of D76N β2m aggregation by 
almost 3.0 and 3.5 fold, respectively (Fig. 2B). Furthermore, the inhibition of aggregation was 
concentration-dependent, with the onset of aggregation (i.e. the initial rate) delayed further by 
higher chaperone concentrations, for example as observed with clusterin (Fig. 1B). However, 
whilst these chaperones had an effect on the lag phase and the initial rate of fibril formation by 
D76N β2m, none of the chaperones tested were able to suppress D76N β2m aggregation 
completely. Indeed, incubation with clusterin or αB-C eventually led to an increase in ThT 
fluorescence equal to or greater than when D76N β2m was incubated alone. The high ThT 
fluorescence in the presence of chaperones, in particular αB-C, was associated with the formation 
of relatively disordered aggregates entangled with fibrillar structures (Fig. 1D, E). We 
hypothesised that these large fibril entanglements resulted from the co-fibrillation of αB-C with 
D76N β2m (see below). 
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Figure 1. The effect of the molecular chaperones αB-C and clusterin on D76N β2m aggregation. Dβ2m was 
incubated in 20 mM phosphate buffer, pH 7.4, at 37 °C with agitation (450 rpm). (A) ThT fluorescence shows the 
aggregation kinetics of 40 µM D76N β2m alone (solid circle) and in the presence of 10 µM αB-C (empty square) or 
0.4 µM clusterin (hollow triangle). (B) The dependence of the relative initial rate of D76N β2m aggregation (v/v0) on 
the ratio of the concentrations of the clusterin and D76N β2m (x). The following designations are used: v0 and v are the 
initial rate of D76N β2m fibrillation in the absence and the presence of clusterin, respectively; x is the [clusterin]/ 
[D76N β2m] ratio. The initial rates of aggregation were calculated based on a quadratic fitting of the aggregation curves 
as described in (48). (Inset) Concentration-dependent inhibition of D76N β2m aggregation by clusterin. β2m was 
incubated in 20 mM phosphate buffer, pH 7.4, at 37 °C with agitation (450 rpm). ThT fluorescence assay of the 
aggregation of 40 µM D76N β2m alone (black) and in the presence of 0.2 µM (red), 0.4 µM (cyan), 0.8 µM (green), 
2.0 µM (brown), 20 µM (blue) and 40 µM (pink), clusterin. TEM images of D76N β2m fibrils in the absence (C) and 
presence of either αB-C (D) or clusterin (E). Scale bars represent 200 nm as indicated. 
 
4.3.2 Effect of αB-C and clusterin on prefibrillar and immature fibrillar forms of D76N β2m 
The ability of αB-C and clusterin to act on D76N β2m during various stages of its aggregation 
pathway was investigated.  αB-C and clusterin were added to solutions of D76N β2m after 4.5 h 
and 9.0 h incubation, corresponding approximately to the generation of predominantly pre-
fibrillar (i.e. at the end of the lag phase of aggregation) and fibrillar (i.e. at the commencement of 
the plateau phase of aggregation) species, respectively. The addition of chaperone at 4.5 h (Fig. 
2A) led to a delay in the onset of aggregation, with αB-C and clusterin extending the lag phase 
associated with D76N β2m aggregation by almost 1.7 and 2.5 fold, respectively (Fig. 2B). A 
similar delay in aggregation was observed when the chaperone was added at 0 h prior to 
incubation (Figs 1A & 2B). It is worth also noting that while the onset of aggregation is delayed, 
the rise of the exponential growth phase was not altered significantly by the addition of  
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Figure 2. The effect of αB-C and clusterin on prefibrillar and immature fibrils of D76N β2m. ThT fluorescence 
aggregation profiles of 40 µM D76N β2m alone (solid circle) and in the presence of either 10 µM αB-C (hollow square) 
or 0.4 µM clusterin (empty triangle) introduced to the solution after (A) 4.5 hours and (C) 9 hours of incubation when 
D76N β2m is predominantly in a prefibrillar and an immature fibrillar state, respectively. (B) The effect of chaperones 
on the duration of the lag phase, tlag (h), of D76N β2m aggregation kinetics when introduced to the solution at 0 hours 
(data derived from Fig. 1A) and at 4.5 hours.  
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the chaperone at either 0 h or 4.5 h, suggesting that clusterin and αB-C do not inhibit the 
elongation of D76N β2m fibrils. Consistent with this, the addition of either chaperone at 9.0 h 
(Fig. 2C) led to an increase in ThT fluorescence relative to D76N β2m alone. We attribute this to 
either the co-aggregation of D76N β2m with the chaperone or the modulation of immature D76N 
β2m fibrils. Thus, we conclude that αB-C and clusterin appear to stabilise the monomeric and/ or 
the oligomeric, prefibrillar species of D76N β2m, thereby delaying their conversion to fibrils, 
having little capacity to prevent or slow the growth of fibrillar species formed during the later 
stages of D76N β2m aggregation. 
4.3.3 Characterisation of the chemical forces involved during D76N β2m aggregation 
To investigate the mechanism of the anti-aggregation activities of the chaperones, we studied the 
role of hydrophobic and electrostatic interactions during D76N β2m aggregation. As monitored 
by ANS fluorescence, we observed a gradual increase in surface hydrophobicity over the course 
of D76N β2m aggregation (mainly during the formation of D76N β2m pre- and pro-fibrillar 
species) (Fig. 3A). Furthermore, the rise in D76N β2m surface hydrophobicity in the presence of 
αB-C or clusterin significantly decreased during the initial phase of fibrillation (Fig. 3A). Thus, 
the molecular chaperones αB-C and clusterin stabilised the pre- and pro-fibrillar D76N β2m 
species by reducing their hydrophobicity by almost 14.0% and 17.5%, respectively (Fig. 3B).  
In addition, we used oppositely charged amino acids such as lysine and glutamic acid to examine 
the effect of ionic interactions during D76N β2m amyloid fibril formation. As monitored by ThT 
fluorescence (Fig. 3C), positively charged lysine co-incubated with D76N β2m completely 
suppressed dye fluorescence, suggesting the inhibition of D76N β2m fibrillation, which was 
confirmed by the absence of fibrillar structures based on TEM images (Figure S2A). By contrast, 
a rapid exponential rise in ThT fluorescence was observed in the sample containing negatively 
charged glutamic acid and D76N β2m (Fig. 3C), indicating spontaneous proliferation of the 
fibrillation process. The TEM image (Figure S2B), substantiated the D76N β2m amyloid fibril 
formation in the presence of the negatively charged amino acid. The contrasting effect of charges 
on D76N β2m exhibited the importance of ionic interactions during the process of its aggregation. 
Thus, electrostatic and hydrophobic interactions are critical in D76N β2m fibrillogenesis, as also 
reported by Mangione et al. (42).  
4.3.4 Susceptibility of molecular chaperones to form amyloid-like structures under the same 
conditions used for D76N β2m fibrillogenesis 
Meehan et al. (49, 50) showed that the αB-C readily forms amyloid fibrils at a higher temperature 
in the presence of a chemical denaturant, guanidine deuterochloride. Additionally, the higher ThT 
fluorescence generated by mixtures of D76N β2m with either αB-C or α2M relative to D76N β2m 
alone (Figs 1A & S1A) prompted us to verify the stability of the molecular chaperones under the 
conditions used for D76N β2m aggregation. Of the four  
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Figure 3. Determination of the effect of hydrophobic and electrostatic interactions on D76N β2m aggregation. 
A: ANS fluorescence assay monitoring the increase in surface hydrophobicity during D76N β2m fibrillogenesis (solid 
circle) and its stabilisation by αB-C (hollow square) and clusterin (empty triangle). ANS fluorescence intensity in 20 
mM phosphate buffer, pH 7.4 at 37 °C was used as a blank and subtracted from above samples.B: The bar graph depicts 
the magnitude (%) of ANS binding to exposed hydrophobic regions during 40 µM D76N β2m amyloid fibril formation 
in the absence (solid bar) and the presence of either 10 µM αB-C (grated bar) or 0.4 µM clusterin (empty bar). The 
increase in surface hydrophobicity (%) was calculated based on equation 1 as described in the Experimental Procedures. 
C: ThT fluorescence assay showing the effect of oppositely charged amino acids on D76N β2m fibrillation. 
Aggregation kinetics followed by ThT of 40 µM D76N β2m in the absence (solid circle) and the presence of either 10 
mM lysine (empty circle) or 10 mM glutamic acid (empty asterisk) in 20 mM sodium phosphate buffer, pH 7.4, at 37 
°C with agitation (450 rpm). 
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chaperones investigated in this study, 10 μM αB-C and α2M immediately started aggregating 
under physiological conditions (pH 7.4 and 37 °C) with agitation at 450 rpm, as indicated by ThT 
and ANS fluorescence assays, respectively (Fig. 4A, B). The formation of fibrillar structures by 
both chaperones were verified by TEM (Fig. 4C, D). Clusterin (400 nM) and Hp (10 μM) did not 
show any enhanced fluorescence upon binding to ThT, suggesting that these proteins have no 
detectable propensity to form fibrils under these conditions (Fig. 4A). The stability of clusterin 
was confirmed via an ANS binding assay, as no change in ANS fluorescence was monitored over 
the course of 54 hours of incubation (Fig. 4B).  
 
Figure 4. ThT and ANS fluorescence assays and TEM images of chaperone proteins under D76N β2m fibril 
forming conditions. A: ThT fluorescence assay of 10 µM α2M (empty circle), 10 µM αB-C (hollow square), 0.4 µM 
clusterin (empty triangle) and 10 µM Hp (solid diamond). B: ANS binding assay during fibrillogenesis of 10 µM α2M 
(empty circle), 10 µM αB-C (solid square) and 0.4 µM clusterin (empty triangle).TEM images of (C) α2M and (D) αB-
C fibrils formed by incubation at 37 °C with agitation (450 rpm). Scale bars represent 200 nm as indicated.  
 
4.3.5 The composition of D76N β2m fibrils formed in the presence of molecular chaperones 
To investigate the constituents of the fibrils formed by D76N β2m in the presence of αB-C or 
clusterin, the fibrils were purified and washed by centrifugation, disaggregated with 7M GdmCl, 
and analysed by SDS-PAGE (Fig. 5). The overloaded gel showed that depolymerised D76N β2m 
fibrils (lane 4) comprised of one major species corresponding to the monomer mass of D76N β2m 
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(~12 kDa). Lane 2 and lane 3 have an additional major species corresponding to the monomeric 
mass of clusterin (~35 kDa) and αB-C (~20 kDa), respectively. Thus, we speculate that the fibril 
entanglements observed by TEM were either the coalesced products of D76N β2m and chaperone 
or coaggregated proteins, particularly in the presence of αB-C. The weaker ~24 kDa band more 
prominent in lane 4 likely represents an oligomeric, dimeric form of D76N β2m which was not 
completely disaggregated by treatment with GdmCl and SDS. Similarly, the stained smear in lane 
2 stretching from the 35 kDa band (representing monomeric clusterin) to a band at approximately 
75 kDa, likely represents dimeric forms of clusterin along with its other glycosylated and 
polydispersed forms (51, 52). 
 
Figure 5. Composition of D76N β2m fibrils formed in the absence and presence of molecular chaperones. SDS-
PAGE of depolymerised, purified, two day-old, D76N β2m fibrils formed in the presence and absence of chaperones. 
Lane 1 – Protein molecular weight marker, lane 2 –D76N β2m with clusterin, lane 3 – D76N β2m with αB-C, lane 4 – 
D76N β2m alone. 
 
4.3.6 Molecular chaperones increase the chemical stability of D76N β2m fibrils  
As discussed in the Introduction, fibril fragmentation is thought to contribute to the proliferation 
of fibrils in various tissues by providing new termini for elongation in a process termed secondary 
nucleation (20). The potential of fibrils to contribute to pathogenesis can hence be viewed in terms 
of their stability. The chemical stability of D76N β2m fibrils formed in the absence and the 
presence of αB-C or clusterin (4:1, or 100:1 [D76N β2m]/ [chaperone], respectively) was assessed 
by treating the fibrils with increasing concentrations of denaturant. The disaggregation of the 
fibrils was measured as a function of exposed hydrophobicity based on their interaction with the 
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fluorescent dye SYPRO Orange. The SYPRO Orange fluorescence emission of D76N β2m fibrils 
formed with or without the presence of molecular chaperone increased in a non-linear manner 
over the concentration range of 0 to 7 M GdmCl (Fig. 6A), associated with an increase in exposed 
hydrophobicity upon fibril depolymerisation. Importantly, the rate and the final magnitude of 
increase in surface hydrophobicity was lower for fibrils formed in the presence of αB-C and 
clusterin compared to D76N β2m fibrils formed independently (Fig. 6A). It appears that either 
the molecular chaperones complexed with pro-fibrillar D76N β2m species or incorporated 
themselves onto the fibril surface and stabilised the D76N β2m against disaggregation (most 
likely in the case of clusterin). Additionally, molecular chaperones might have co-aggregated, 
forming an amalgamated fibrillar product thereby increasing their stability, especially in the 
presence of αB-C.  
4.3.7 Chaperone-stabilised D76N β2m fibrils have reduced seeding abilities 
The lag phase of D76N β2m fibril formation is associated with the formation of stable nuclei onto 
which monomers are sequentially added to form fibrils via a nucleation-dependent mechanism 
(42, 47). The lag phase can be accelerated with the aid of external factors including agitation or 
bypassed by the addition of preformed fibrils, which act as seeds to initiate fibril formation of the 
native protein (i.e. secondary nucleation). The seeding ability of D76N β2m fibrils formed in the 
absence and the presence of αB-C or clusterin (4:1, or 100:1 [D76N β2m]/ [chaperone], 
respectively) was investigated using an in situ ThT assay. Without agitation, D76N β2m does not 
readily aggregate, as shown by the negligible ThT fluorescence increase over the incubation 
period (Fig. 6B). Upon addition of 5% v/v and 50% v/v purified D76N β2m preformed fibrils to 
the fresh native protein, a hyperbolic increase in the ThT fluorescence indicative of the onset of 
fibril formation, bypassing the typical lag-phase associated with its fibrillation (Fig. 6B). Purified 
D76N β2m fibrils formed in the presence of chaperone, however, showed trivial ability to seed 
D76N β2m fibril formation, as indicated by the magnitude of ThT fluorescence (Fig. 6C, inset). 
The initial rate of D76N β2m secondary nucleation was ~200 and ~380 times slower in the 
presence of clusterin-stabilised fibrils and αB-C stabilised fibrils respectively, to that of the 
unstabilised D76N β2m fibrils (Fig. 6C). It is hence concluded that the interaction of clusterin 
and αB-C with aggregating D76N β2m, in part, prevents the secondary nucleation processes of 
D76N β2m fibrillation. 
  
2. The molecular chaperones clusterin and αB-crystallin prevent primary and secondary nucleation of a potently 
amyloidogenic variant of β2-microglobulin  
 
82 
 
 
Figure 6. Chemical stability, seeding and cross-seeding of D76N β2m fibrils formed in the presence of molecular 
chaperones. A: SYPRO Orange fluorescence assay monitoring the disaggregation of D76N β2m fibrils formed in the 
absence (solid circle) and the presence of αB-C (hollow square) or clusterin (empty triangle) as a function of GdmCl 
concentration (0 to 7 M). B: Seeding (Secondary nucleation) of D76N β2m fibril formation. ThT fluorescence assay 
demonstrating the aggregation kinetics of 20 µM D76N β2m in 20 mM sodium phosphate buffer, pH 7.4 at 37 °C with 
constant slow shaking, incubated without (red solid triangle, represented by right Y-axis marked in red; negative 
control), and with 5% v/v (empty circle) and 50% v/v (solid circle) preformed D76N β2m fibrils. ThT binding of 5% 
v/v (dashed spline curve) and 50% v/v (solid spline line) preformed D76N β2m fibrils alone and seeded are represented 
by left Y-axis marked in black. C: Cross-seeding of D76N β2m fibril formation. The relative initial rate of D76N β2m 
secondary nucleation when seeded with 50% v/v preformed D76N β2m fibrils formed in the absence (empty circle) 
and the presence of αB-C (hollow empty square) and clusterin (red empty triangle). (Inset) ThT fluorescence assay of 
[GdmCl] (M) 
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the aggregation of 20 µM D76N β2m in 20 mM sodium phosphate buffer, pH 7.4 at 37 °C with constant slow shaking, 
incubated with 50% v/v preformed D76N β2m fibrils formed in the absence (empty circle, represented by left Y-axis 
labelled in black; positive control) and the presence of αB-C (hollow empty square) and clusterin (red empty triangle) 
both represented by right Y-axis marked in red. Initial rates of aggregation were estimated from the slopes of the linear 
fittings (cyan line). 
4.4 Discussion  
As discussed above, molecular chaperones such as clusterin, αB-C, and other sHsps co-localise 
with both extra- and intra-cellular fibrillar deposits associated with various age-related, protein 
aggregation diseases. Several studies have suggested that the incorporation of chaperone proteins 
into fibril deposits is a protective action that minimises the deleterious effects of amyloid fibrils 
on cells by stabilising mature fibrils and inhibiting their fragmentation (53-56). Fibril 
fragmentation may contribute to pathogenesis by leading to the generation of smaller, more toxic 
amyloid species and/or promote the proliferation of fibrils in cellular tissues by secondary 
nucleation mechanisms (22).  
The substantial concentration increase of β2m in plasma due to renal failure, after long-term 
treatment with dialysis, leads to the deposition of amyloid fibrils in the collagen-rich tissues of 
bone joints (57). On the other hand, the accumulation of intra- and extra-cellular amyloid deposits 
of D76N β2m that is observed in aged individuals bearing the mutation occurs in  many tissues 
(spleen, liver, heart, salivary glands, nerves, vessel walls), featuring a pattern of  systemic 
amyloidosis (10). Due to their localisation within the interstitial space, extracellular chaperones 
have been proposed to play a significant role in modulating β2m fibril formation (58-60). In the 
present study, fibril formation by the amyloidogenic D76N β2m variant was delayed by the 
intracellular molecular chaperone αB-C, and only one of three extracellular chaperones (i.e. 
clusterin but not α2M and Hp). This finding presented contrasting results to previous studies 
performed with wild-type β2m in the presence of these two chaperones and a detergent or fatty 
acid (35, 36). The delaying effect of αB-C and clusterin is probably due to their ability to modulate 
electrostatic and hydrophobic interactions that are deemed critical for D76N β2m fibrillation. The 
precise reason for the inability of α2M and Hp to prevent rapidly aggregating D76N β2m under 
our conditions is unclear. α2M and Hp may exhibit a lower efficacy when acting against more 
rapidly aggregating species such as D76N β2m, which has been previously observed in α-
crystallin and other sHsps (61, 62). Indeed, Mangione et al. (42) reported that α-crystallin was 
significantly less efficient at inhibiting fibril formation by D76N β2m than the wild type protein. 
In the case of α2M, the aggregation of this protein under the conditions used in this study may 
have reduced its ability to act as a chaperone. Alternatively, α2M and Hp may function more 
efficiently as molecular chaperones in the presence of lipophilic substances such as fatty acids.  
The transition of soluble, functional proteins into amyloid fibrils entails a complicated process 
involving the formation of the highly dynamic early stage and prefibrillar intermediates, which 
are most likely the toxic agents in disease. Furthermore, the cytotoxic species can be generated 
due to fibril fragmentation and the auto-catalysis during secondary nucleation on the fibril’s 
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surface may also potentiate amyloid disease. Herein, we have shown that molecular chaperones 
modulate fibril formation of D76N β2m in a variety of ways, including the kinetics of the 
aggregation pathway and the stability of the end product, which in turn dictates the capacity for 
fibril proliferation and possibly slows their deposition as amyloid plaques in pathogenic tissue.  
 
 
Figure 7. Schematic representation of the effect of molecular chaperones on various stages of D76N β2m 
fibrillogenesis. The left-hand side shows the general process of D76N β2m amyloid fibril formation and their eventual 
deposition as amyloid plaques. During aggregation, the native, functional D76N β2m forms a partially folded 
amyloidogenic intermediate which rearranges to form prefibrillar species, leading to the formation of amyloid fibrils. 
The proliferation of D76N β2m fibril formation may take place via secondary nucleation mechanisms on fibril surface 
and/or fibril fragmentation. The right-hand side of the scheme indicates the role played by αB-C and clusterin during 
each stage of D76N β2m amyloid formation, including their protective role in fibril proliferation. Based on our findings, 
both chaperones delay the fibrillar conversion of native, functional D76N β2m by stabilising the monomeric and 
oligomeric, prefibrillar species. We have also shown that these chaperones increase the D76N β2m fibril chemical 
stability, and shield the reactive surfaces of fibrils, thereby minimising secondary nucleation processes and further 
decelerating the proliferation of amyloid fibril plaques. 
 
Figure 7 schematically demonstrates the sequence of events where various molecular chaperones 
can function during protein aggregation and the gradual build-up of protein aggregates associated 
with DRA. αB-C and clusterin stabilise monomeric/ or oligomeric, prefibrillar species of D76N 
β2m, thereby prolonging the lag phase of aggregation and delaying its conversion to fibrils. 
Furthermore, when fibrils are formed in the presence of clusterin and αB-C, the chaperones are 
incorporated into the final structure, which has increased chemical stability and therefore a 
decreased tendency to fragment and promote fibril proliferation. Additionally, αB-C and α2M 
formed amyloid fibrils under the same D76N β2m aggregation conditions. It seems likely that 
under severe conditions of stress, molecular chaperones can be overwhelmed during the protein 
aggregation process and are incorporated into the aggregation pathways. In doing so, molecular 
chaperones increase fibril stability and also mask the sites of secondary nucleation. Thus, the 
alteration of the nucleation site can be achieved by molecular chaperones upon interacting with 
various pre- and pro-fibrillar forms, binding to the fibril surface or by undergoing a similar 
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fibrillation process leading to the co-deposition of fibrils along with the target protein. The 
multifaceted ability of αB-C to prevent protein fibrillation by interacting with species at the 
various stages along the amyloid fibril-forming pathway has also been previously discussed (34). 
A similar process may occur in vivo as many chaperones co-localise with extracellular plaques 
and intracellular aggregates. Based on these findings, we conclude that the interaction of 
molecular chaperones with the aberrant protein forms of the paradigmatic amyloidogenic D76N 
β2m, which are critical for the growth and proliferation of amyloid fibrils in tissues, potentially 
slows the build-up of protein aggregates associated with amyloidosis. 
Acknowledgement: This work was supported by grants from the Australian National Health and 
Medical Research Council to JC. We thank the Centre for Advanced Microscopy, the ANU node 
of the Australian Microscopy & Microanalysis Research Facility (AMMRF) for Transmission 
electron microscopy. 
Author contributions: M.K. and J.C. designed the research; M.K. performed the research; M.K., 
D.T., V.B., G.E., M.W., H.E. and J.C. analysed the data; M.K., D.T. and J.C. wrote the manuscript 
with feedback from the other authors.   
Competing financial interests: The authors declare no competing financial interests. 
Additional information: The article contains supporting information online at xxxx 
 
 
  
2. The molecular chaperones clusterin and αB-crystallin prevent primary and secondary nucleation of a potently 
amyloidogenic variant of β2-microglobulin  
 
86 
 
4.5 Supplementary Information 
 
 
 
Figure S1. Effect of the molecular chaperones α2M and Hp on D76N β2m aggregation. β2m was incubated in 20 
mM phosphate buffer, pH 7.4 at 37 °C with agitation (450 rpm). (A) ThT fluorescence assay showing aggregation 
kinetics of 40 µM D76N β2m alone (solid circle) and in the presence of 20 µM Hp (hollow diamond) or 20 µM α2M 
(empty circle). TEM images of D76N β2m fibrils in the presence of either Hp (B) or α2M (C). Scale bars = 200 nm as 
indicated. 
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Figure S2. TEM images substantiating contrasting inhibitory and proliferative effect of the oppositely charged 
amino acids on D76N β2m fibrillation. TEM images of D76N β2m incubated for 48 hours in 20 mM phosphate 
buffer, pH 7.4 at 37 °C with agitation (450 rpm) in the presence of either lysine (D) or glutamic acid (E). Scale bar = 
200 nm. 
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Abstract 
The presynaptic, homologous, acidic proteins α-synuclein and β-synuclein form homo- and 
hetero-oligomers that are implicated in Parkinson’s disease and related synucleinopathies. 
Monomeric α-synuclein can adopt conformations that promote the formation of toxic oligomers, 
which can further assemble into insoluble amyloid fibrils, eventually depositing as Lewy bodies. 
In contrast, the role of β-synuclein has been contentious; it has been proposed that it is a potent 
inhibitor of αS-induced-neurotoxicity both in vitro and in vivo (1-4), and has been directly 
implicated in neurodegeneration in vivo (5-8). However, no apparent molecular mechanism for 
either the neuroprotective or neurodegenerative role of β-synuclein has been described.  
Here we report on work in which we have isolated oligomers of α- and β-synuclein, and found 
that β-synuclein (which has an isoelectric point of ~ 4.4) forms negatively charged monomers and 
positively charged oligomers under conditions of physiological pH, temperature and 
macromolecular crowding. The β-synuclein oligomers polymerised to form non-amyloid fibril-
like, self-assembled structures, a process that was enhanced by the presence of αS and under 
conditions of macromolecular crowding. In addition, β-synuclein oligomerisation and 
polymerisation led to the aggregation of α-synuclein. Interestingly, the destabilising interaction 
of α-synuclein with β-synuclein was significantly reduced under conditions of macromolecular 
crowding. The results obtained from this work indicate that β-synuclein stimulate α-synuclein to 
aggregate, thereby acting as a neurodegeneration-inducing factor. We also propose that, the 
previously described pathogenic effect of β-synuclein may be due to its ability to form positively 
charged oligomers that can interact with phospholipid-containing cell membranes, resulting in 
pore formation and cell lysis. Thus, the role of β-synuclein as a putative modulator of 
neuropathology needs to be reconsidered, and strategies to prevent the proclivity of β-synuclein 
to form positively charged oligomers and non-amyloid fibrillar structures may provide a novel 
effective drug target in synucleinopathies.  
Keywords: α-synuclein, bi-directional native agarose gel electrophoresis, β-synuclein, crowding 
agents, oligomers, protein aggregation, synucleinopathies, small-angle scattering. 
Abbreviations: Å: Angstrom, αS: Alpha-synuclein, AGE: Agarose gel electrophoresis, AFM: 
Atomic force microscopy, βS: Beta-synuclein, CD: Circular dichroism, CSD: Charge state 
distribution, DLB: Dementia with Lewy bodies, D2O: Deuterium oxide (heavy water), D: 
Deuterated, ESI-MS: Electrospray ionisation mass spectrometry, Fc70: Ficoll 70, Fc400: Ficoll 
400, H: Non-deuterated , h: Hours, LB: Luria-Bertani broth, nm: Nanometre, p(r): Pair-distance 
distribution function, PEG1000: Polyethylene glycol 1000, d: Porod exponent, Rg: Radius of 
gyration, RT: Room temperature, SAS: Small-angle scattering, SANS: Small-angle neutron 
scattering, SDS-PAGE: Sodium dodecyl sulfate polyacrylamide gel electrophoresis, SAXS: 
Small-angle x-rays scattering, ThT: Thioflavin T, TPE-TPP: Tetraphenylethene tethered with 
triphenylphosphonium, TEM: Transmission electron microscopy. 
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5.1 Introduction 
The synuclein family of cytoplasmic, predominantly unstructured proteins (112–140 amino acid 
residues) comprises of α-, β-, γ-synuclein and synoretnin, all of which are thought to play a 
significant role in synaptic vesicle homoeostasis and neuronal plasticity (9, 10). Among them, α-
synuclein (αS) and β-synuclein (βS) share ~62%  sequence similarity at the amino acid level 
across the full length of the proteins, and are ~90% identical in the N-terminus (residues 1–60). 
However, they are considerably divergent in the C-terminus, having only ~33% similarity 
(residues 96–140 for αS, residues 85–134 for βS), despite both containing a high proportion of 
acidic residues (11-15). Moreover, αS and βS co-localise within the presynaptic nerve terminals 
in the central nervous system (16). In spite of this, traditionally, only the ability of αS to aggregate 
and deposit into Lewy bodies has been considered as a pathological feature of disorders such as 
Parkinson’s disease (PD), dementia with Lewy bodies (DLB), and multiple system atrophy 
(MSA) (17). The association of αS with neurodegenerative diseases is most likely due to its 
inherent propensity to form well-ordered, β-sheet containing amyloid fibrils and cytotoxic non-
fibrillar oligomers. The fibrillation of αS involves reorganisation of a natively unstructured 
monomer to partially folded -sheet rich forms, leading to self-assembly and the subsequent 
formation of dimers, trimers, tetramers, and eventually higher order soluble oligomers and 
protofibrils (18). It is believed that the soluble oligomers are the primary cytotoxic species as they 
have the potential to interact with and disrupt cell membranes (19). Although the normal 
physiological role of the synucleins is yet to be elucidated, βS has been shown to modulate αS 
oligomerisation and amyloid fibril formation in vitro (1) and in vivo (3). 
Interestingly, axonal lesions in the hippocampus, considered a pathological hallmark of PD and 
DLB, have been reported to be immunoreactive for βS (8). Recently, βS has been shown to act as 
a neurodegeneration-inducing factor as βS aggregates are toxic to cultured primary neurons and 
nigral dopaminergic neurons (5). Abnormal accumulation of βS has also been found in the brain 
of patients with Hallervorden-Spatz syndrome and MSA (6, 7).  A clinical study demonstrated 
that the P123H mutation of βS strongly predisposes the individual to DLB pathology (20).  
Moreover, transgenic mice harbouring the P123H βS mutation did not differ in the DLB 
pathological phenotype when crossbred with αS knock out transgenic mice, which suggests that 
endogenous αS may not be required for DLB pathology (20, 21). Both P123H βS and V70M βS 
are prone to aggregation in vitro and when overexpressed in neuroblastoma cells, result in 
lysosomal pathology associated with protein aggregation (22, 23). Additionally, the 
neurodegenerative effect of the P123H mutation in βS was enhanced in transgenic mice when 
they were crossed with αS transgenic mice (20). Moreover, overexpression of βS in double 
transgenic mice reduced αS protein expression but not its mRNA expression level (24). Thus, it 
appears that βS and its missense mutants (P123H and V70M) exhibit pathogenicity on their own 
and also exacerbate neurotoxicity in vivo by enhancing αS aggregation. The pathogenic nature of 
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βS is perplexing since βS is believed to be non-amyloidogenic, as it lacks the non-A amyloid 
component (NAC) domain involved in amyloid fibril formation of αS (25). However, it is 
speculated that βS may form toxic soluble oligomers and non-amyloid aggregates, as does αS, 
which may account for its pathogenicity. 
Recent studies have provided direct evidence for the occurrence of homo and hetero-oligomers 
of αS and βS in vivo (15, 26-33), with the former observed both within and outside of neurons 
(34, 35). The level of αS oligomers found in the plasma and cerebrospinal fluid have been reported 
as a biomarker for the diagnosis of PD and other related diseases (36-38). Thus, it is likely that 
the intra- and extra-cellular levels of αS monomers and oligomers are in equilibrium with each 
other via a secretion mechanism (17). Several factors can influence αS oligomer formation, 
including oxidative stress, reactive aldehydes, interaction with fatty acids, mutations, and 
macromolecular crowding (39-41). The structural element of these dynamic intermediate 
oligomers that cause cellular dysfunction is not yet clear, and it has proven to be a challenging 
task to isolate and characterise them in vitro. To overcome this, chemicals or cross-linkers such 
as ethanol (42), dopamine (43), peroxynitrite or myeloperoxidase (44), lipid droplets (45) and 
epigallocatechin gallate (EGCG) (46) have been used to trap the oligomeric species of αS. Some 
of these oligomers promoted further αS polymerisation, whilst others behaved as a stable species, 
emphasising the conformational complexities of the oligomerisation process (46, 47). 
Furthermore, the overexpression of αS in transgenic mice resulted in the generation of oligomers 
with selective toxicity towards dopaminergic neuronal cells (48, 49). In addition, Wang et al. (50) 
reported the presence of a dynamic tetramer from heterologously expressed αS in Escherichia 
coli.  A year later, Trexler and Rhoades (51) isolated αS oligomers via a mild purification method 
from bacterially expressed αS. Given the dynamic structural flexibility of αS and its ability to 
form multimeric assemblies (52), it is becoming increasingly clear that the manner by which αS 
is expressed and purified may dictate the state(s) in which it is found. 
The internal environment of living cells contains high concentrations of macromolecules (80-400 
mg/mL) (53). While the concentration of any given macro solute constitutes only a minute 
proportion of the total volume of a cell, together they occupy up to 40% of cell volume, which 
creates a crowded medium with significantly restricted amounts of free water (54, 55). This 
reduces the volume accessible to other proteins and macromolecules. Experiments conducted in 
vivo as well as under conditions aimed at mimicking the crowded conditions in cells have shown 
that macromolecular crowding can alter the conformation, flexibility and oligomeric state of 
proteins, leading to numerous biological consequences including the development of aggregation-
related diseases (56, 57). In vivo, synucleins function in a crowded intracellular environment and 
interact with lipid membranes and other biological molecules, adopting a more ordered 
conformation (58, 59). In vitro, inert crowding agents such as polyethylene glycol (PEG), ficoll 
and dextran alter the native state of αS and affect its aggregation propensity (60, 61). Thus, the 
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structural flexibility, propensity to oligomerise, aggregate, and the interaction with other proteins 
(such as βS) of αS are all susceptible to the effects of macromolecular crowding such as occurs 
in cells.  
Whilst there are several in vitro reports related to the interaction of monomeric αS and βS, and 
the latter’s role in modulating αS amyloid fibril formation, little is known about the ability of βS 
to form oligomers, aggregates and the exacerbating effect(s) of these on αS. Therefore, in order 
to better understand the roles of synucleins in normal and diseased states, we have examined the 
low molecular weight oligomers formed by αS and βS, as well as the interaction between the two 
under conditions of macromolecular crowding. We show that βS oligomers have a unique 
electrical charge transition during oligomerisation, in which the acidic monomer is converted to 
a positively charged (basic) oligomer under physiological-like conditions (pH, temperature and 
macromolecular crowding). This conversion results in an increased tendency of βS to form a non-
amyloid, fibril-like structure in the presence of αS which is further enhanced under the conditions 
of macromolecular crowding. 
5.2 Materials and Methods 
5.2.1 Materials 
Tryptone, yeast extract and agar were purchased from Bacto Laboratories, New South Wales, 
Australia. Analytical grade D2O was purchased from AJAX chemicals, Sydney, Australia. TPE-
TPP was synthesised based on the method described in (62). All other reagents used in this study 
were purchased from Sigma Life Sciences and Sigma-Aldrich unless otherwise specified.  
5.2.2 Expression of non-deuterated (H) αS and βS 
Recombinant αS and βS were expressed under the control of the T7 promoter in E. coli BL21 
(DE3) using the plasmids pET-24a(+) and pRK172, respectively. Transformed cells were selected 
for on agar plates supplemented with kanamycin (50 μg/mL) and ampicillin (100 μg/mL), 
respectively from which starter cultures were prepared using single individual colonies. The 
starter cultures (10 mL) were grown overnight in LB medium at 37 0C, 200 rpm, in the presence 
of kanamycin (50 μg/mL) and ampicillin (100 μg/mL) and subsequently used to inoculate 1 L of 
LB medium also containing kanamycin (50 μg/mL) and ampicillin (100 μg/mL), respectively. 
Cells were grown (37 0C, 200 rpm) until an OD600 of 0.8 was reached. αS and βS over-expression 
was then induced using IPTG (final concentration 1 mM), after which cells were grown at 25 0C, 
200 rpm, overnight. Cells were then harvested by centrifugation (4 0C, 5,000 rpm, 20 min) using 
a VX 22G centrifuge (R9A rotor, Hitachi, Japan). 
5.2.3 Expression of deuterated (D) αS and βS 
BL21*(DE3) E.coli was transformed with pET-28a plasmids containing the αS and βS gene 
sequences.  The cells from single colonies were then adapted to heavy water-based minimal “Mod 
C1” media with kanamycin (50 μg/mL), in a step-wise fashion, i.e., by increasing the 
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concentration of D2O from 0 to 100%, and stored as glycerol stocks at -80 0C until required. 
Starter cultures (100 mL) in 100% D2O (for αS) or 85% D2O (for βS) minimal medium was used 
to inoculate RTF-5 fermentor bioreactors (Real Time Engineering) containing 900 mL of the same 
medium. Cells were cultured at 37 0C with automatically regulated pH and dissolved oxygen until 
the OD600 reached a value of 1.3-1.5, and then were induced with 1 mM IPTG to express the 
desired proteins at 25 0C (63).  After 12-16 hours of expression, the biomasses were harvested and 
stored at -80 0C. 
5.2.4 Purification of synucleins 
The αS and βS containing E. coli cell pellets were resuspended in 20 mM Tris, pH 8.3 containing 
a protease inhibitor. Cell pellets were sonicated 3 times for 3 min with the pulser (OMNI Sonic 
Ruptor), with the power set at 50%, followed by chemical lysis using lysozyme (100 µg/mL). 
Cell lysates were then heat treated for 10 min at 80 0C under constant shaking at 60 rpm in a water 
bath (Grant OLS200) and centrifuged (VX 22G, rotor R15A) at 26,200 x g for 30 min, 4 0C. 
Supernatants obtained were then acid precipitated at pH 3.5, followed by centrifugation at 26,200 
x g for 30 min, 4 0C. The pH of the supernatants was immediately brought up to pH 8.3 by adding 
0.1 N sodium hydroxide solution. The solution was then treated with 0.1% octyl β-D-
glucopyranoside (BOG) and 1 mM EDTA at 4 0C for 20-30 min. The supernatants obtained after 
centrifugation were further treated with 10 mg/mL streptomycin sulphate at 4 0C for 20 min, and 
then centrifuged. Ammonium sulphate precipitation (57% saturation) was used to fractionate the 
synucleins. The pellets were resuspended in a small volume of 20 mM Tris, pH 8.3 and dialysed 
against the same buffer overnight at 4 0C. Purified synucleins were obtained by performing ion-
exchange chromatography on the AKTA Pure (GE Healthcare) using a Q-sepharose (Q XL 16/10) 
column. Following dialysis against water overnight, the proteins were concentrated, aliquoted, 
flash-frozen using liquid nitrogen and stored at -80 0C for further use. 
MALDI-TOF mass spectrometry was carried out by the Australian Proteome Analysis Facility 
Ltd (APAF) proteome-mapping service at Macquarie University, and was used to determine the 
deuteration level of the synucleins.  By comparing the mass differences between H- and D-protein 
fragments relative to the estimated numbers of non-exchangeable H/D atoms (bound to carbon or 
sulphur), the levels of substitution were determined to be 81% and 61% for αS and βS, 
respectively.  The scattering length densities and D2O contrasts were calculated by entering the 
obtained deuteration values into the MULCH algorithm available at http://smb-
research.smb.usyd.edu.au/NCVWeb/input.jsp. 
5.2.5 Bi-directional Native Agarose Gel Electrophoresis (Native AGE) 
Electrophoresis of fresh and two day-old synuclein samples was performed using native agarose 
gels and a horizontal gel apparatus. The procedure was adapted from a previously published 
protocol (64). Gels (1.8% agarose, low electroendosmosis agarose from Roche) were cast on 12 
cm x 8 cm glass plates using surface tension. 10 µL of the 40 µM fresh and two day-old synuclein 
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solutions samples were mixed with 10 µL of 2x loading dye (126 mM Tris-HCl pH 6.8, 1.500% 
ficoll 400, 0.002% bromophenol blue and 0.002% methylene blue) and loaded into a set agarose 
gel placed onto a horizontal electrophoresis unit containing running/resolving buffers (90 mM 
Tris base pH 8.5, 90 mM boric acid). The samples were run for three hours at 60 V. The gels were 
stained with a gel-staining solution (0.12% Coomassie Brilliant Blue R, 40% methanol, 10% 
acetic acid for 10 min, and destained using distilled water until the protein bands were clearly 
visible.   
5.2.6 SDS-PAGE of αS and βS and their mixture 
20 μM αS, 5 μM βS and their mixture (i.e. a 4αS: 1βS molar ratio) in 20 mM phosphate buffer, 
pH 7.4 were mixed with 5x NuPAGE® Lithium Dodecyl Sulfate loading dye and immediately 
treated for 5 min at 90 ⁰C before loading onto NuPAGE® Novex® 4-12% Bis-Tris protein gels, 
1.0 mm x10 well, alongside Precision Plus Protein Standards (Kaleidoscope TM, Biorad). The 
constituent proteins were separated using NuPAGE® MES running buffer in the Bolt® Mini Gel 
Tank at 150 V for 35 min. 
5.2.7 Native Electrospray Ionisation (ESI) Mass Spectrometry 
ESI mass spectra of αS and βS and their mixture (1:1 molar ratio) in 10 mM ammonium acetate 
buffer, pH 7.0, were collected on Waters LCT Premier XE instrument and processed using 
MassLynx software. All the samples were incubated for 10 min at room temperature. 
5.2.8 Atomic force microscopy (AFM) 
10 μL sample from the 20 μM two day-old βS solution was added to freshly cleaved muscovite 
mica (G51-50, grade V-1, PST – ProSciTech)  mounted on a AFM metal specimen disc (GA530-
12, PST – ProSciTech) and kept for 2 minutes to allow for adsorption of the sample onto the mica 
sheet before rinsing it with deionised water to remove any unadsorbed sample. The discs were 
then dried overnight, and AFM measurements were acquired on a Nanoscope VIII AFM (Bruker 
Corporation, Santana Barbara, CA) operating under non-contact mode. 
5.2.9 Transmission electron microscopy (TEM) 
Samples (5 μL each from the 20 μM freshly prepared and two day-old βS) for TEM imaging were 
applied to Formvar with carbon coating on 400 mesh copper grids (GSCu400C, PST – 
ProSciTech) and negatively stained with uranyl acetate (2% (w/v); AJAX chemicals) in water. A 
Hitachi 7100 TEM was used to view samples under a magnification of 100-200K at a 125-kV 
excitation voltage. Images were analysed using the Gatan micrograph and captured with a side-
mounted Orius camera. 
5.2.10 In-situ amyloid-dye binding assays 
The dye-binding assays were performed using the protocol described in Chapter 3.   
5.2.11 Optical density measurement 
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The change in light scattering at 350 nm over time was used to monitor the stability of 250 μM 
αS in 20 mM phosphate buffer, pH 7.4. The in-situ assays was conducted in Greiner bio-one, half 
area, clear bottom, medium binding, 96 well plate, sealed with a transparent film, incubated at 37 
°C for ~167 h and read using a Biotek Synergy 2 microplate reader. 
5.2.12 Far-UV circular dichroism (CD) spectroscopy 
The far-UV CD spectra of 5 μM, αS and βS, and their 4:1, 1:4 molar ratios mixtures (7 μM in 
total) were collected over a wavelength range of 180-260 nm, with 0.5 s time-per-point, a 
bandwidth of 1 nm with 0.5 nm step-increment. Each spectrum was obtained on the Chirascan 
(Applied Photophysics) using a 0.01 cm path length, QS High Precision cell (Hellma Analytics). 
All the samples were prepared in 10 mM phosphate buffer, pH 7.4 and the average of three 
accumulations (blank subtracted) was considered as the final result. All high voltage tension 
records above 600 V were discarded. Protein concentration and molar ellipticity per residue were 
estimated based on the method described in (65).  
5.2.13 Fractional volume occupancy (ψ)  
The Ψ of 100 mg/mL of PEG1000, Fc70 and Fc400 were calculated as described in (66). 
5.2.14 Small-angle X-ray scattering (SAXS) experiment and analysis 
Hydrogen- and deuterium-labelled synucleins solutions were prepared at 8 mg/mL in 50 mM 
phosphate buffers, pH 7.4, made with standard milli-Q or heavy water (D2O) and placed in 2 mm 
i.d. quartz microcapillaries. All the protein samples were centrifuged at 13,500 rpm for 10 min 
before SAXS analysis. SAXS measurements were performed using a NanoSTAR II SAXS 
instrument (Bruker AXS, Karlsruhe) with Cu Kα radiation (λ =1.54 Å) at room temperature. A 
scattering vector, q (Equation 1), in the range of 0.012−0.390 Å−1 was used for the measurements 
(67). 
𝑞 = (4𝜋 𝑠𝑖𝑛𝜃)/𝜆   (1)      
Where θ is the angle of scattering and λ is the X-ray wavelength. The instrument and buffer 
backgrounds were subtracted from the sample signal to obtain the corrected intensity. The buffer 
subtraction on SAXS samples was performed using the PRIMUS program (68), P(r) was 
calculated on PRIMUS QT both available from ATSAS suite of applications 
(http://www.emblHamburg.de/ExternalInfo/Research/Sax/index.html) and fittings to the Guinier 
region (q.Rg < 1.3) was performed using ScÅtter software (http://www.bioisis.net).  
5.2.15 Small-angle neutron scattering (SANS) experiment and analysis 
For SANS experiments, 8 mg/mL of deuterated αS and βS and their mixtures in the absence and 
presence of Fc400 (100 g/L) were prepared in 50 mM phosphate buffer, pH 7.4 containing 
different percentages (v/v) of D2O (see Table S1). As in SAXS sample preparation, all the SANS 
samples were also centrifuged immediately before analysis to remove any insoluble mass. SANS 
measurements were obtained using the SANS instrument Quokka at OPAL, Australian Nuclear 
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Science and Technology Organisation (ANSTO), Sydney, with neutrons wavelength, λ = 5 Å. 
Three sample to detector distances of 2, 12, and 20 m were used to cover the q range of 
(0.0045−0.5000) Å−1 for the measurements and analysis (69). The scattering intensity I(q) was 
recorded against q using a two-dimensional detector placed perpendicular to the incident neutron 
beam. The instrument and buffer backgrounds were subtracted from the sample scattering.  D2O 
match points of synucleins used in SANS were estimated based on their atomic composition as 
described above and narrowed down during contrast-series SANS experiments. The match points 
measured for αS and βS were 100% and 90% D2O respectively; those of non-deuterated proteins 
were ~42%, and Fc400 at ~30%. SANS data from the synuclein complexes in the absence and 
presence of Fc400 were collected in 40% D2O. No significant contribution of Fc400 to the 
scattering pattern of synuclein complexes at 40% D2O concentration was observed. Fits to the 
Guinier region (qRg < 1.3) for Rg measurements were performed using SasView software 
(http://www.sasview.org). The Porod-Debye fourth power law envisages a behaviour within a 
limited range of scattering angles similar to that of linear relationship predicted by Guinier 
analysis (qRg < 1.3) for the calculation of Rg, and can be used for objective evaluation of proteins 
and the flexibility of their complexes (70). For reliable Porod exponent (describes the 
compactness of the particle) interpretation, Porod-Debye plots just outside of the Guinier region 
were used in the ScÅtter software. The molecular mass of deuterated synucleins was estimated 
based on the trapezoid rule as described in (71). 
5.3 Results 
5.3.1 Native Electrospray Ionisation Mass Spectrometry (ESI-MS) 
Following purification of the bacterially-expressed recombinant human proteins, ESI-MS spectra 
indicated the presence of homo-dimeric forms of αS and βS. Bacterially produced recombinant 
human αS and βS have molecular masses of 14,460 Da and 14,288 Da, respectively. Accordingly, 
peaks corresponding to the monomeric mass of αS (14,460.74 Da) and βS (14,288.33 Da) were 
observed in samples in which the synucleins were not mixed (Fig. 1a,b).  Additionally, much less 
intense peaks corresponding to dimeric αS (28,921.15 Da) and βS (28,579.28 Da) were observed 
in these samples (Fig. 1a,b), indicated by green arrows. The predicted molecular mass of the αS 
and βS homo-dimers are 28,920 Da and 28,576 Da, respectively. ESI-MS performed immediately 
after mixing αS and βS in an equimolar ratio, revealed no peak corresponding to that of a hetero-
oligomer of the two. Moreover, the βS dimer failed to ionise in the presence of αS (Fig. 1c). 
Furthermore, the occurrence of a bimodal charge state distribution (CSD) in all three samples 
(Fig. 1) revealed the presence of both unfolded and folded domains in αS and βS. The 
manifestation of broad CSD with +14 and +13 as the most intense average charge state in αS and 
βS, respectively reflected disordered regions of the proteins, while a narrow CSD of +8 suggested 
some degree of a compact or folded component in both proteins (72).   
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Figure 1. ESI-mass spectra of αS, βS and at their 1: 1 molar ratio mixture demonstrating oligomerisation of the 
synucleins. As indicated in the figure, the top spectrum (a) displays monomeric (A: monomeric mass) and dimeric (D: 
dimeric mass) peaks of 5 μM αS. (b) The middle spectrum is of 5 μM βS and shows peaks corresponding to monomeric 
(B: monomeric mass) and dimeric (D: dimeric mass) forms of βS. (c) The bottom spectrum is of an equimolar mixture 
(1:1) of αS and βS (both at 5 μM), displaying monomeric peaks of αS (peaks labelled A in the spectrum) and the peak 
corresponding to dimeric αS (peak labelled D in the spectrum). A βS monomeric peak in the mixture could not be 
labelled due to a comparatively lower intensity than αS and overlap of the spectra. We have shown that βS aggregation 
was enhanced in the presence of αS (See result section of this article). Synucleins and their mixture were prepared in 
10 mM ammonium acetate, pH 7.0 and ESI-MS was performed immediately after mixing. 
 
5.3.2 Bi-directional Native AGE and SDS-PAGE 
Agarose gels under non-denaturing conditions can be used to separate and analyse proteins and 
their complexes of masses up to 600,000 Da in their native states (73). Horizontal agarose gel 
electrophoresis (AGE) of proteins and their homo/hetero-association is an important tool for 
determining their net charge. The presence of four negatively charged bands of freshly prepared 
αS in an agarose gel confirms the varied oligomeric states in which αS can exist in solution (Fig. 
2a, indicated by magenta ellipsoid). As indicated in figure 2a, at time 0, βS had one intense band 
that corresponded to a negatively charged monomer. An additional band (circled in teak) 
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Figure 2. Bi-directional native AGE and SDS-PAGE demonstrating ageing, oligomerisation and aggregation of 
αS, βS and their mixture. As labelled in figure 2a, native AGE of 40 μM αS, 40 μM βS and their equimolar mixture 
in the absence and presence of 100 mg/mL Fc400 incubated in 20 mM phosphate buffer, pH 7.4, 25° C for up to 2 days. 
αS and its oligomers are highlighted with magenta ellipsoids and the positively charged βS oligomer with black and 
teak ellipsoids. As indicated in figure 2b, SDS-PAGE of 40 μM αS, 40 μM αS + 10 μM βS, and 10 μM βS incubated 
in 50 mM ammonium acetate buffer, pH 7.0, 25° C for up to 14 days.  
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corresponding to a positively charged oligomer was observed after two days of incubation of βS 
and its 1:1 molar ratio mixture with αS at pH 7.4, 25°C. Whilst in freshly prepared βS and its 1:1 
molar ratio mixture with αS in the presence of ficoll 400 (Fc400), a very weak positively charged 
band was evident (circled in black), possibly corresponding to a βS oligomer, which developed 
upon incubation (circled in teak). A similar enhancing effect of the positively charged band 
(circled in teak) in the mixture of αS and βS compared to βS alone was observed in the absence 
of the crowding agent. The change in the intensity of the positively charged band of βS in the 
presence of αS and Fc400, compared to that of βS by itself, suggests that crowding might augment 
the oligomerisation of βS (Fig. 2a). SDS-PAGE of the aged synuclein samples ruled out the 
possibility of the positively charged band of βS, both in the absence and presence of αS, being a 
by-product of degradation (Fig. 2b). Some bands corresponding to the degradation of αS were 
observed only after 14 days of incubation at pH 7.4, 25°C (Fig. 2b). However, no degraded βS 
band was observed in the equimolar mixture of αS and βS; in fact, higher molecular weight 
species (Fig. 2b, indicated by black ellipsoids) were observed for both samples after six days of 
incubation, implying oligomerisation and aggregation. 
5.3.3 Determining the aggregation propensity of αS and βS 
The appearance of a small proportion of higher molecular mass species in SDS-PAGE and a 
positively charged oligomer in native AGE following two days of incubation suggested 
polymerisation of βS. To confirm this, AFM and TEM images were acquired of βS, incubated at 
pH 7.4, 25°C for two days (Fig. 3a,b). Surface topology images of the βS self-assembled structure, 
obtained using AFM, suggested the assembly of fibril-like species into a net-like structure. The 
fibril-like aggregates formed by βS under these conditions were Thioflavin T (ThT) negative 
suggesting it is non-amyloidogenic in nature (not shown). A TEM image (Fig. 3b) of the βS self-
assembled structure suggested similar features as observed by AFM. No fibrillar or other 
structures were observed by TEM for the freshly prepared βS sample (not shown). 
High molecular mass αS oligomers can exhibit different biophysical and biochemical properties, 
either through promoting or inhibiting αS fibrillation-associated toxicity (46, 47). The formation 
of low molecular mass oligomers is also considered a critical step in αS amyloid formation. 
Hence, to examine αS and the aggregation propensity of its oligomers, we undertook in situ ThT 
and bis(triphenylphosphonium) tetraphenylethene (TPE-TPP) fluorescence assays. We also 
monitored light scattering at 350 nm of αS over seven days. The ThT amyloid-dye binding assay 
indicated that at physiologically relevant conditions i.e. pH 7.4 and 37 °C, the αS oligomers, 
present in the initial sample alongside monomers as shown by electrophoresis and ESI-MS did 
not polymerise to form ThT positive fibrillar species (Fig. 3c). No increase in TPE-TPP 
fluorescence during the incubation period suggested that αS and its low molecular weight 
oligomers did not polymerise to form high molecular weight oligomers (Fig. 3c, inset). 
Furthermore, as no change in light scattering at 350 nm was observed over the ~168 h of  
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Figure 3. Examining the aggregation propensity of αS and βS. (a) Atomic force microscopic (AFM) image of 2-
day old 20 μM βS. Scale = 100 nm. (b) Transmission electron microscopic (TEM) image of 2-day old 20 μM βS. Scale 
= 100 nm. 250 μM of αS was incubated in 20 mM phosphate buffer, pH 7.4 at 37 °C with fast agitation in a microplate 
(c) Left Y-axis (labelled in black): In situ ThT based fluorescence assay of αS (black circle) and 50 μM ThT (empty 
black circle). Right Y-axis (labelled in red): Light scattering of 20 mM phosphate buffer, pH 7.4 (empty orange triangle) 
and αS (solid red triangle) at 350 nm. Inset: TPE-TPP fluorescence of assay of αS (solid black circle) and 100 μM TPE-
TPP (black empty rhomboid). 
incubation, this also indicated that αS did not aggregate over this period. The in vitro transition 
of wild-type αS to amyloid fibrils is a kinetically unfavourable process under physiologically 
relevant pH and temperature conditions, and usually require driving forces such as agitation and 
supersaturation (74-76). Furthermore, various αS oligomeric species are known to exist in 
5. Interaction of oppositely charged α- and β-synuclein oligomers in a crowded environment: a case of β-synuclein-
assisted α-synucleinopathy 
104 
 
equilibrium with the monomeric form and in a low molar ratio of monomers to oligomeric species, 
conversion to fibrils is very slow (77). Our failure to observe fibril formation by αS under the 
conditions and duration of our study can be attributed to any of the factors mentioned above.  
5.3.4 Far-UV CD of αS and βS and their mixtures in the absence and presence of crowding 
agents 
Both αS and βS appeared to be disordered in nature (mainly random coils) as indicated by the 
presence of a major peak at a negative ellipticity of ~ 196 – 198 nm. However, the presence of 
some degree of secondary structure (i.e. polyproline-II helices) in βS was indicated by weak 
positive ellipticities from ~214 – 229 nm (78-80) (Fig. 4a). A small contribution of α-helix in αS 
is possible due to weak negative peaks as indicated in figure 4a by magenta ellipsoids, in the 
vicinities of ~208 – 210 nm and ~ 222 nm.  
Interestingly, we noticed an overall reduction in molar ellipticities in samples containing mixtures 
of αS and βS compared to those of the individual synucleins (Fig. 4a). Specifically, a major loss 
of negative ellipticity in the random coil region, as indicated by the decrease in the negative 
ellipticity at around 196 – 198 nm in the samples containing both αS and βS was observed. Loss 
of ellipticity at 196 – 198 nm with no additional gain of ellipticity at any other wavelength in the 
far-UV region in the mixture of the oppositely charged βS and αS oligomers indicated the 
spontaneous deleterious nature of the two. However, no major qualitative structural changes were 
observed in the aged αS, βS and their mixtures (Supplementary Fig. 1a,b), except for the gradual 
loss in the signal attributable to oligomerisation and aggregation. 
Varied secondary structural changes were observed when the synucleins were incubated in the 
presence of inert crowding agents aimed at mimicking the crowded cellular environment (Fig. 
4b,c). Fractional volume occupancy (ψ) of 100 mg/mL of PEG1000, Fc70 and Fc400 were 
calculated to be ~ 0.1%, 23.0% and 32.0% v/v, respectively, based on method previously 
described (66). All three crowding agents appeared to increase the random coil content in βS, as 
evident by the gradual increase in the βS negative ellipticity at around 196 - 199 nm (Fig. 4b). 
PEG1000 enhanced the random coil content of βS and maintained the polyproline-II helices as 
indicated by the presence of weak positive ellipticities from ~214 – 229 nm. In contrast, low and 
high molecular weight ficoll resulted in the loss of a positive CD signal of βS suggesting 
disruption of the polyproline-II helices. With regards to the effect of these macromolecular 
crowding agents on the secondary structure of αS (Fig. 4c), ficoll 70 (Fc70) increased the random 
coil content in αS as indicated by the increase in negative ellipticity at ~196 - 199 nm, while 
Fc400 reduced this ellipticity. In the presence of PEG1000, αS had a strong positive ellipticity at  
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Figure 4. Far-UV circular dichroism demonstrating conformational changes of αS, βS and their mixtures in the 
absence and presence of crowding agents (Fc70, Fc400 and PEG1000). Proteins were incubated in 10 mM 
phosphate buffer, pH 7.4 in the absence or presence of 100 mg/mL Ficoll 70 (Fc70), Ficoll 400 (Fc400) or PEG1000. 
(a) Spectra of 40 µM αS (black circle), 40 µM βS (blue circle), 40 µM αS + 10 µM βS (lime circle) and 10 µM αS + 
40 µM βS (teal circle). (b) Spectra of 40 µM βS in the absence (blue circle) and presence of 100 mg/mL Fc70 (salmon 
circle), Fc400 (cyan circle) and PEG1000 (mustard circle). (c) Spectra of 40 µM αS in the absence (black circle) and 
presence of 100 mg/ mL Fc70 (salmon circle), Fc400 (cyan circle) and PEG1000 (mustard circle). In all cases, proteins 
were mixed with the crowding agent, and the CD spectra was acquired immediately after mixing. 
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~ 190 – 195 nm and weak negative ellipticity peak at 222 nm, probably suggesting a minor 
contribution of β-sheet. Furthermore, a weak negative ellipticity peak from 210 – 215 nm, 
probably of α-helix, was also observed in αS with this crowding agent. After two days, all the 
three crowding agents increased the random coil content of both synucleins (Supplementary Fig. 
1c,d).   
5.3.5 Small-angle scattering of αS and βS in the absence and presence of Fc400 
SAXS was used to check the quality of samples used for the SANS studies. The parameter 
considered was the change in the distribution of mass around the particle’s centre of inertia (i.e. 
the radius of gyration, Rg). The Rg values from the SAXS data based on the Guinier approximation 
of deuterated (D) and non-deuterated (H) αS were 53.4 Å and 52.6 Å, respectively, whereas that 
of D and H βS were 38.7 Å and 35.0 Å, respectively. The real space Rg values based on the p(r) 
function were on the higher than the Guinier Rg for all the samples (Supplementary Table 2, 
Supplementary Fig. 2). Some differences in the Rg values of proteins estimated through Guinier 
approximation and pair-distance distribution function, p(r), can be expected to be seen in flexible 
proteins (81).  
 
 
 
Figure 5. Small angle neutron scattering (SANS) of αS and βS in the absence and presence of Fc400. (a) SANS 
intensity plot indicating Guinier radius-of-gyration, Rg of αS in the absence (empty black circle) and presence of Fc400 
(empty magenta circle) in 40% D2O buffer. (b) Power law plot indicating the Porod exponent (d), of deuterated αS in 
the absence (empty black circle) and presence of Fc400 (empty magenta circle). (c) SANS intensity plot indicating 
Guinier radius-of-gyration, Rg of βS in the absence (empty blue circle) and the presence of Fc400 (empty cyan circle) 
in 40% D2O buffer. Fluctuation in the low q region, indicating attractive inter-particle interaction in βS, is highlighted 
5. Interaction of oppositely charged α- and β-synuclein oligomers in a crowded environment: a case of β-synuclein-
assisted α-synucleinopathy 
107 
 
by red rectangle. (d) Power law plot displaying Porod exponent (d), of deuterated βS in the absence (empty blue circle) 
and presence of Fc400 (empty cyan circle). Experimental conditions are summarised in Supplementary Table 1. 
As shown by the CD studies, Fc400 decreased the random coil content of αS but had the opposite 
effect on βS. The SANS data indicated a minor increase in the Rg value of αS from 54. 6 ± 2.9 Å 
to 56.3 ± 0.5 Å in the presence of Fc400 (Fig. 5a). The Porod exponent (d) estimated based on 
the ‘power-law relationship’ is proportional to the ratio of a molecule’s volume to its surface area 
and is highly dependent on the compactness and dimension of the particle (82). For one-
dimensional, complex, flexible macromolecules appearing as infinitely thin rods or Gaussian 
coils, the value of d range from ~ 1.0 to 1.6 (83-85). The d=1.1 obtained for αS confirmed its 
flexible nature. However, Fc400 reduced the protein flexibility as indicated by an increased 
(d=1.3) value (Fig. 5b, Supplementary Fig. 3a,b). For βS, a large change in the Rg value was 
observed from 41.8 ± 0.6 Å to 56.9 ± 2.0 Å in the presence of Fc400 (Fig. 5c) coinciding with an 
increase in flexibility, as revealed by a decrease in d from 0.9 to 0.7 (Figs. 5d, Supplementary 
Fig. 3c,d). 
5.3.6 Characterisation of αS, βS and their interaction in the absence and presence of Fc400 
using SANS  
The determination of Rg value (Fig. 6, left Y-axis) and Porod exponent (Fig. 6, right Y-axis) 
assisted in understanding the nature of the association between the two proteins in a crowded 
environment. No significant change in the Rg value of deuterated αS (i.e. 54. 6 ± 2.9 Å) was 
observed in the presence of non-deuterated βS (55. 5 ± 2.5 Å) (Fig. 6, Supplementary Fig. 4a), 
when the scattering signal from non-deuterated protein was matched out using 40% D2O. 
However, a minor reduction of the Porod exponent (d) from 1.1 to 1.0, may indicate a slight 
increase in the flexibility of the deuterated αS (Fig. 6, Supplementary Fig. 5). Moreover, Fc400 
appeared to stabilise the association of αS and βS, as indicated by the increase in d from 1.0 to 
1.2 and decrease of the Rg value to 52. 0 ± 1.4 Å (Fig. 6, Supplementary Figs. 4a and 5).      
A noticeable increase in the Rg value of deuterated βS from 41.8 ± 0.6 Å to 52.1 ± 5.7 Å (Fig. 6, 
Supplementary Fig. 4b) occurred in the presence of non-deuterated αS (matched out in 40% D2O). 
This change in the Rg value coincided with a decrease of the Porod exponent from 0.9 to 0.7 (Fig. 
6, Supplementary Fig. 6). Consistent with all our previous findings, this suggests that βS 
oligomerises in the presence of αS. The same mixture was stabilised by Fc400 as shown by a 
reduction in the Rg value of βS to 47.5 ± 1.3 Å and no change in d (Fig. 6, Supplementary Figs. 
4b and 6).  
A very high Rg value (~184.9 ± 1.6 Å) was observed for the non-deuterated βS in the presence of 
deuterated αS (matched out in 100% D2O), indicative of βS aggregation (Fig. 6, Supplementary 
Fig. 4a). A comparatively lower Rg value (~85.5 ± 0.4 Å) was obtained for non-deuterated αS in 
the presence of deuterated βS (matched out in 90% D2O) (Fig. 6, Supplementary Fig. 4b) indicated 
that the aggregate contained larger amount of βS than αS.   
5. Interaction of oppositely charged α- and β-synuclein oligomers in a crowded environment: a case of β-synuclein-
assisted α-synucleinopathy 
108 
 
 
Figure 6. Comparison of size and conformation parameters from SANS data of deuterated and non-deuterated 
αS, βS and their mixtures in the absence and presence of Fc400. Bar graph showing the radius of gyration, Rg (left 
Y- axis, marked in black) of deuterated αS (DαS) in 0% D2O buffer, DαS + non-deuterated βS (HβS) in 40% D2O 
buffer, DαS + HβS + Fc400 in 40% D2O buffer, deuterated βS (DβS) in 0% D2O buffer, DβS + non-deuterated αS 
(HαS) in 40% D2O buffer, DβS + HαS + Fc400 in 40% D2O buffer, DαS + HβS in 100% D2O buffer and DβS + HαS 
in 90% D2O buffer. Scatter plot (teal stars) denoting the Porod exponent, d (right Y-axis, marked in teal) of the samples 
mentioned above. No Porod exponent was assigned to DαS + HβS in 100% D2O buffer and DβS + HαS in 90% D2O 
buffer i.e. the aggregated samples. The experimental conditions are summarised in Table S1. 
 
5.4 Discussion 
5.4.1 Biophysical and biochemical characterisation of αS and βS oligomers 
Deciphering the enigma associated with synuclein oligomerisation, particularly of αS, is a 
fundamental step towards understanding the cytotoxicity associated with aggregation of these 
proteins. Previous work has attempted to address this by studying αS oligomers induced by 
chemical or physical means. However, the functional properties of the oligomers had contrasting 
features, either causing cell lysis or preventing αS fibril formation (42, 43, 45, 46, 86-95). Hence, 
no clear picture has emerged from these studies. We obtained αS and βS oligomers by altering 
the denaturation-purification method typically used to purify these proteins (9) and avoiding a 
final size-exclusion chromatography step, which would normally remove oligomeric species. 
Native ESI-MS spectra of the purified proteins indicated the presence of oligomers in these 
samples (Fig. 1), while the molecular masses of αS (~ 80,400 Da) and βS (~ 31,200 Da) estimated 
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based on the volume-of-correlation (Vc) function from small-angle scattering (SAS)-based 
studies as described in (71), provided additional evidence for the presence of oligomers. 
As expected, the monomeric, dimeric, trimeric and tetrameric forms of αS were found to all be 
negatively charged at physiological pH (7.4), temperature (25 °C) and crowding conditions. The 
trimeric and tetrameric forms probably failed to ionise in the native ESI-MS conditions and hence 
could not be detected (Fig. 1). However, βS with an acidic isoelectric point of ~4.4, behaved 
differently; as a monomer, it had a net negative charge, but the oligomeric form of βS migrated 
towards the cathode, indicating of it possessing a net positive charge (Fig. 2). Interactions between 
charged groups (amino acids, in the case of proteins) are often simply termed “electrostatic” even 
though the charges are not static. The charged entities on proteins are weak acids and bases, which 
are in dynamic equilibrium with their neutral forms through the exchange of protons with water 
(96). The net charge of a protein (Z) is a fundamental physical property, usually expressed as the 
sum over all the charged groups that are tightly associated with a protein (97). However, these 
values can be inaccurate due to the cooperativity associated with proton equilibria in proteins as 
well as the effect of local dielectric environments on the pK values, which are often neglected. 
Moreover, other charged species (mainly buffer ions) non-covalently interact with native and 
transient protein species formed during oligomerisation/aggregation (9). Thus, techniques to 
determine the “actual charge” of a protein undergoing oligomerisation/aggregation are limited. 
With the aid of bi-directional native AGE, we were able to identify a positively charged oligomer 
of βS. The presence of a positively charged species may facilitate the interaction with negatively 
charged lipid membranes resulting in pore formation and cell disruption, thereby providing an 
explanation for the cytotoxic nature of protein oligomers. Indeed, oligomeric βS forms ion-
conductive channels in membranes (5).  
5.4.2 Oligomerisation and self-assembly of βS 
When incubated under conditions of physiological pH (7.4), temperature (25 °C) and conditions 
of macromolecular crowding, βS monomers gradually transformed from negatively charged 
monomers to positively charged oligomers. The formation of insoluble non-amyloid fibrils by βS 
may result from the interaction of these oppositely charged species (Figs. 3 and 5c). βS has been 
induced to form fibrillar aggregates in the presence of SDS, Zn2+, Pb2+, Cu2+ (metal ions), rotenone 
(pesticides), under vigorous agitation conditions in vitro (5, 98) and amorphous aggregates in the 
presence of pesticides (dieldrin and paraquat) and organic solvents (hexafluoro-2-propanol and 
trifluoroethanol) (98). However, in our study, we showed that βS can self-assemble to form 
fibrillar species under physiologically relevant conditions, even in the absence of external 
chemical and physical factors.  
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5.4.3 Disruptive association of αS and βS 
When the proteins were analysed by CD, both αS and βS were found to give spectra typical of an 
unstructured (random coil) protein, as indicated by the characteristic negative ellipticity at ~ 196 
- 198 nm. However, our findings suggest that αS is more disordered than βS since the magnitude 
of the negative ellipticity was much greater for αS. This is in contrast to earlier finding that βS 
comprises of more random coil content than αS (1). It is possible that the low intensity of the 
signal for βS at ~ 196 – 198 nm is due to the oligomerisation of the protein. Formation of insoluble 
aggregates reduces the effective soluble concentration of βS, thereby decreasing its absorption 
(65, 94, 99). However, more studies need to be performed to fully elucidate the above findings. 
Furthermore, much lower intensity negative ellipticity bands at around 208 – 210 nm and ~222 
nm in αS and positive ellipticities from ~ 214 – 229 nm in βS, suggested some degree of a folded 
component in this sample as well (Fig. 4a). The bimodal CSD observed in the ESI-MS spectra 
(Fig. 1) also implied the presence of both unstructured and some folded elements in the two 
synucleins. Monomeric αS has been found to adopt an unfolded, extended conformation which 
exists in equilibrium with its oligomeric and/ or different conformational states, highlighting 
inherent structural flexibility in this protein (52, 77, 100, 101). 
A significant decrease in the negative ellipticity in the vicinity of ~ 196 – 198 nm in αS, and 
positive ellipticities of βS from ~ 214 – 229 nm in the 4:1 mixture (αS: βS) was observed. 
Likewise, a large decrease in the intensity in the vicinity of ~ 196 – 198 nm in both αS and βS, 
and positive ellipticities of βS from ~ 214 – 229 nm in the 1:4 mixture (αS: βS) was also apparent. 
The instantaneous loss of these CD signal for the combinations of 0 h αS and βS suggested a rapid 
deleterious association between the two (Fig. 4a).  
5.4.4 Effects of crowding agents on the synucleins 
Highly concentrated solutions of “crowding agents”, such as PEGs, Ficolls, dextran, or inert 
proteins are commonly used models for examining the effect of macromolecular crowding on the 
structure of biological macromolecules of interest (102). For a long time, excluded volume effects 
were regarded as the primary mechanism of action of crowded environments on the structure, 
folding and oligomerisation of proteins whereas perturbed diffusion, changes in viscosity, soft 
interactions, direct physical contacts and the effect of crowders on solvent properties, are often 
neglected (103). Here, we have observed some diverse effects of the crowding agents tested, 
namely PEG1000, Fc70 and Fc400 on fresh (i.e. non-aggregated) βS and αS solutions using CD 
spectroscopy (Fig. 4b,c). Interestingly, after two days, these crowding agents influenced both the 
proteins in an identical manner by increasing the random coil content (Supplementary Fig. 1c,d). 
The variations in αS and βS cannot be explained solely by considering simple excluded volume 
effects. In the crowded environments, the βS monomer, its oppositely charged oligomer, and the 
crowding agent compete for the same available space and exclude each other’s surroundings, 
which results in decreasing the entropy of the system. The excluded volume around the βS 
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oligomer is smaller than that of the monomer, as is generally the case with all protein oligomers 
(104). Hence, in order to maintain the overall entropy as high as possible to reduce the total 
excluded volume effect, the system attenuates the formation of oligomers due to the attractive 
interaction between the monomers and the oligomers (Fig. 2). The presence of the crowding 
agents also acts to increase the unfolded component of βS, as evident in figure 4b, thereby 
providing more exposed residues for two molecules to self-associate, resulting in augmentation 
of βS oligomerisation and aggregation (105, 106). For αS, the effects of crowding agents varied 
depending on their fractional volume occupancy (ψ) i.e. the respective volume occupied by them. 
For example, Fc400 with a higher ψ of around 32% led to a decrease in the random coil content 
of αS as shown by the decline in the negative ellipticity at around 196 – 199 nm by far-UV CD 
(105), probably resulting in compaction or reduced flexibility. In contrast, Fc70, with a slightly 
lower ψ of ~ 23%, may have an increased repulsive force exerting between the negatively charged 
αS oligomers, thereby disrupting the conformations and increasing the overall size as indicated 
by the increase in random coil content, as demonstrated by the ellipticities at ~ 196 – 199 nm (Fig. 
4c). PEG1000 with the lowest ψ of ~ 0.1% possibly may be involved in soft interactions with αS, 
thereby inducing some folded secondary structure component (Fig. 4c). The increase in the 
random coil content of αS and βS after two days of co-incubation with the crowding agents may 
be due to the increase in the size of the synucleins due to aggregation (Supplementary Fig. 1c,d) 
(106, 107). Indeed, the C-terminus of αS is believed to transiently interact with the N-terminus, 
forming multiple compact monomeric structures (108, 109). At elevated temperatures αS acquire 
an extended conformation, releasing the N-terminus and promoting aggregation (109, 110). 
However, to fully elucidate the effect of Fc70 and PEG1000 on the synucleins, more studies are 
required in the future. 
5.4.5 The design, analysis, and justification of SAXS and SANS based studies 
Small-angle scattering of X-rays (SAXS) and neutrons (SANS) is a proven method for the low-
resolution structural characterisation including shapes, flexibility, and assemblies of biological 
macromolecules such as proteins in dilute and crowded environments (111). Neutron-based 
scattering offers a particular advantage over x-rays as it readily employs contrast variation through 
the use of selective deuteration and solvent matching (81, 112-114). Isotopes of the same element 
can have different scattering properties as the scattering length density is due to the atomic nuclei. 
In particular, scattering from the major isotope of hydrogen, 1H, and 2H (deuterium) has a phase 
difference of about 180°. This allows to selectively suppress scattering of the selected component 
which is useful in characterising complex mixtures, such as in multi-protein solutions and 
crowding conditions (115, 116). The scattering intensity of the chosen components was 
eliminated by using the appropriate amount of D2O in the buffer to match the molecule’s 
scattering length density, effectively making them invisible, while providing sufficient neutron 
contrast with the molecules of interest. We estimated the D2O match point of our deuterated αS 
and βS as 100% and 90% D2O, respectively; while non-deuterated proteins and Fc400 scattering 
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signal can be matched out in ~42% and ~30% D2O, respectively. For practical purposes, we used 
40% D2O to match out both non-deuterated synucleins and Fc400, after confirming that a 
concentrated solution of Fc400 in 40% D2O gave scattering equal to that of background (not 
shown). Careful adjustment of the different components in a mixture containing deuterated, non-
deuterated macromolecules and D2O (heavy water), provided vital information about the 
disruptive association of αS and βS in crowding conditions. On the other hand, SAXS instruments 
with their high X-ray flux beam enable faster data collection and rapid sample characterisation, 
can be used to study single-component solutions or as a tool for an immediate quality check of 
deuterated and non-deuterated protein samples before SANS experiments (116-118).  
In our study, no significant differences in the Guinier Rg values of our deuterated and non-
deuterated αS were observed, however for deuterated βS, the Guinier Rg values calculated both 
from the SAXS and SANS profile were higher compared to the non-deuterated, most likely an 
indication of inter-particle interactions (Fig. 5, Supplementary Fig. 2). In fact, the results from the 
ESI-MS, and native bi-directional agarose gel supported the presence of the oppositely charged 
βS monomer (negatively charged) and oligomer (positively charged). We have also shown that 
βS undergoes oligomerisation to further form a self-assembled structure (Fig. 3). Hence, the 
higher Rg values can be attributed to the higher proportion of oligomers due to the faster rate of 
oligomerisation in the deuterated βS solution. Fluctuation in the deuterated βS SANS intensity 
I(q) in the low q region, as highlighted by the red rectangle in the figure 5c, due to varied particle 
distribution compared to that of an ideal protein solution, in this case, αS (Fig. 5a) also suggested 
an attractive interaction (119). In general, the calculation of the Rg from the pair-distance 
distribution function p(r) provides a better representation of the molecule’s size than the one 
calculated from Guinier approximation, which is limited to a small q region. The p(r) function is 
a real-space representation of the scattering data which takes into account all of the collected data, 
providing information about the particle size and shape. However, for predominantly unstructured 
and flexible proteins like αS and βS (Fig. 4a), the Rg values are commonly higher than for globular 
ones, due to conformational averaging, leading to the loss of inter-domain correlation peaks (81, 
120). Therefore, we used Guinier Rg rather than real space Rg to quantify the interaction of αS and 
βS in this study. 
Furthermore, we utilised the neutron contrast between deuterated, non-deuterated proteins and 
unlabelled polysaccharides, in this case, Fc400, to assess the interaction of αS and βS, and the 
effect of the crowder on the particle size and compactness of the synucleins (115). We noticed a 
large change of ~10.4 Å in the Rg of βS in the absence and the presence of matched-out αS (Fig. 
6), indicating rapid βS oligomerisation and aggregation and confirming the disruptive association 
of the synucleins observed via far-UV CD in figure 4a. The substantial change in the radius of 
gyration coincided with an increased flexibility of βS as evident by the decrease in the Porod 
exponent, Δd = 0.2 (Fig. 6). However, no significant difference (~0.9 Å) in the Rg of αS was 
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observed in the absence and presence of matched-out non-deuterated βS (Fig. 6), substantiating 
that the disruptive association is because of βS and not αS. A smaller change in αS flexibility (Δd 
= 0.1) was observed in this case (Fig. 6). Additionally, a very large Rg value was obtained for 
non-deuterated βS when the signal from deuterated αS was matched out confirming its 
aggregation. Moreover, a massive increase in the Rg value of αS was estimated in the presence of 
deuterated βS in 90% D2O consistent with the disruptive nature of βS (Fig. 6). The change in the 
Rg value of αS may suggest that αS was induced to form aggregates due to βS polymerisation, 
resulting in co-aggregation of the synucleins. The apparent change in morphology of the βS self-
assembled structure (protein clumps sitting on top of fibrils) in the presence of αS was also noticed 
via TEM imaging (Supplementary Fig. 7). Earlier, Koichi et al., (6) suggested the possibility of 
βS acting as a negative regulator of αS aggregation. Furthermore, a DLB-linked P123H variant 
of βS was also found to strongly exacerbate the neurodegenerative effect in transgenic mice when 
crossed with αS transgenic mice (20). The augmentation of βS oligomerisation and aggregation 
in the presence of αS may provide an explanation for the aforementioned process. Additionally, 
αS undergo aggregation during the process of βS self-assembly, thereby acting as a 
neurodegeneration-inducing factor (5). 
No real change in the radius of gyration, Rg, of αS was observed in the presence of Fc400 (Fig. 
5a), implying that the decrease in random coil content (Fig. 4c), did not correlate with the 
compaction of the molecule. On the other hand, the large increase in the Rg value of βS in the 
presence of Fc400 (Fig. 4b) was probably due to its oligomerisation, resulting from the attractive 
interaction and the excluded volume effect as discussed above. Fink et al., (98) have reported that 
macromolecular crowding agents or the addition of glycosaminoglycans can accelerate the metal-
induced fibrillation of βS (98). Our power law plot demonstrating the porod exponent estimated 
from the Porod-Debye law indicated a slight decrease in flexibility of αS (Δd = 0.2) in the presence 
of Fc400 (Fig. 5b, Supplementary Fig. 3a,b). The decrease in the flexibility of αS in the presence 
of Fc400 may result from the reduction of the random coil content as discerned by our far-UV 
CD studies. Perhaps, crowding limits the distribution of conformational ensembles of monomeric 
and oligomeric αS because of the reduced available volume (121). On the other hand, crowding 
appears to have enhanced the flexibility of βS (Fig. 5c, Supplementary Fig. 3c,d). In cases 
involving multi-domain proteins, their conformational flexibility can mainly be attributed to two 
classes of phenomena: intra-domain dynamics consisting of side-chain flexibility or the change 
in their transient secondary structure element, and global inter-domain dynamics, i.e. the 
movement of one subunit relative to others (122, 123). Our far-UV CD, Rg and d measurements, 
indicate localised intra-domain flexibility changes in αS, probably involving the C-terminus (52, 
124, 125). The change in βS monomer and oligomer dynamics was due to electrostatic attraction 
of the oppositely charged species. 
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Additionally, no significant change in the Rg value of αS was observed in the presence of matched-
out βS, confirming its stability (Fig. 6, Supplementary Fig. 4a). However, the 2.5 Å decrease in 
the Rg in crowding conditions suggests a minor compaction of the mixture, as also revealed with 
the increase in d (Fig. 6, Supplementary Fig. 4a). To rule out that observed differences in the Rg 
values were not due to some scattering from Fc400, we also measured the change in the Rg value 
of βS. A sharp increase of 10.5 Å in the Rg value of βS, along with its enhanced dynamics, in the 
presence of matched-out αS, confirmed βS oligomerisation (Fig. 6, Supplementary Fig. 4b). 
Interestingly, we noticed a 4.7 Å reduction in the Rg value of βS in the mixture comprising αS 
and Fc400, confirming the stabilising effect of Fc400 (Fig. 6, Supplementary Fig. 4b). Moreover, 
the increase in d in the mixtures of the synucleins in the presence of Fc400 from, 1.1 to 1.2 in αS 
(Figs. 6, Supplemenatry Fig. 5) and 0.7 to 0.9 in βS (Fig. 6, Supplementary Fig. 6), indicated a 
slight compaction of both αS and βS. It is highly likely that crowding may alleviate the disruptive 
association of the two by decreasing their flexibility. 
Astronomically high Rg values were obtained for βS when the signals from αS were completely 
matched-out in 100% D2O suggesting co-aggregation/ large-scale aggregation. Also, a massive 
increase in αS Rg value was estimated in the presence of βS in 90% D2O consistent with the 
disruptive nature of βS and indicating co-aggregation (Fig. 6). D2O is well known to stabilize 
protein structure and promote solubility by increasing “hydrophobic effect”, which by facilitating 
stronger association between hydrophobic groups act as a major driving force in protein folding 
(126). Most studies investigating isotopic solvent effects have been conducted on proteins with 
high degree of secondary and tertiary structure (127-129). However, in the case of intrinsically 
unstructured proteins such as synucleins, which do not contain large non-polar sequence regions, 
the same hydrophobic effect will likely lead to inter-molecular association and reduced solubility. 
Deuteration of non-exchangeable hydrogen positions in proteins would even further enhance their 
self-association by decreasing non-polar side chain interactions (130, 131). Therefore, D2O-based 
buffer solutions may have promoted the oligomerisation and aggregation in the mixture of 
deuterated and non-deuterated synucleins by stably exposing their hydrophobic residues to the 
solvent or by affecting the hydration forces from polar and electrically surface charged amino 
acids (132-134). 
5.5 Conclusion 
Based on the above discussed findings the significant outcomes of this work are presented in 
figure 7 and supplementary table 2. Purified βS forms negatively charged monomers and 
positively charged oligomers under conditions of physiological pH and temperature. Upon 
incubation, βS undergoes further oligomerisation and polymerisation leading to the formation of 
non-amyloid fibril-like species, a process enhanced in the presence of αS and under 
macromolecular crowding. The βS self-assembly stimulated αS to aggregate resulting in co-
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aggregate formation. Interestingly, the disruptive association of βS and αS was significantly 
stabilised under crowding conditions. 
 
 
 
Figure 7. Schematic representation of the βS self-assembly process and its interaction with αS in a crowding 
environment: βS exists as a negatively charged monomer and a positively charged oligomer at physiological pH, 
temperature and crowding conditions. The negatively charged βS monomer steadily undergoes oligomerisation to form 
a positively charged oligomer, which further polymerises to form insoluble, non-amyloid, fibril-like, self-assembled 
structures. During βS polymerisation, αS undergoes aggregation resulting in co-aggregation of synucleins. In addition, 
under crowding conditions and in the presence of αS, the process of βS self-assembly is enhanced. However, the 
destabilising association between βS and αS is extensively reduced under crowding conditions, such as those found in 
the cell. As indicated in the figure, the nascent polypeptide chain of βS is represented in dark green, partially folded 
monomeric βS in coral and brown, oligomeric βS in gold and αS and its oligomers in coral and mustard coloured 
structures. 
 
5.6 Biological Significance 
Soluble oligomeric forms of some proteins including αS and βS are believed to cause cell toxicity 
in neurodegenerative disorders such as the synucleinopathies (17, 135-137). Additionally, protein 
oligomers of different shapes and sizes have been implicated in neurological diseases through 
different functions (47, 138-141). One established mechanism of protein oligomer-induced-
cellular cytotoxicity is via cell membrane permeabilisation, pore-formation, leading to cell 
disruption (142). Nevertheless, the precise mechanism(s) of interaction, as well as the mode of 
cell lysis are still unclear. Our demonstration of a positively charged oligomeric species of βS that 
can form fibrillar species under physiologically relevant conditions might provide an explanation 
for the aforementioned process. The cell membrane bilayer is mostly made up of phospholipids 
which confer a negative surface charge and can attract positively charged soluble oligomers like 
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βS, thereby facilitating cell permeabilisation and disruption. Another plausible way in which 
positively charged soluble oligomers can mediate cellular dysfunction is through their own or 
other macromolecules’ conformational changes and aggregation, which our study demonstrated. 
Oppositely charged oligomers of βS not only promoted it’s self-assembly, but also caused αS and 
its oligomers to undergo aggregation. Ultimately, the complete understanding of the surface 
charge transformation during protein oligomerisation may uncover novel avenues for the 
development of therapeutic strategies for protein-misfolding disorders. 
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5.7 Supporting Information 
 
 
 
Supplementary Figure 1. Far-UV circular dichroism spectra of aged αS, βS and their mixtures in the absence 
and presence of crowding agents (Fc70, Fc400 and PEG1000). (A) Molar ellipticity of 3-d old, 40 µM αS (black 
circle), 40 µM βS (blue circle), 40 µM αS + 10 µM βS (lime circle) and 10 µM αS + 40 µM βS (teal circle). (B) Spectra 
of 6-d old, 40 µM αS (black circle), 40 µM βS (blue circle), 40 µM αS + 10 µM βS (lime circle) and 10 µM αS + 40 
µM βS (teal circle). (C) The molar ellipticity of 2-d old, 40 µM αS in the absence (solid circle) and the presence of 100 
mg/mL Fc70 (salmon circle), Fc400 (cyan circle) and PEG1000 (mustard circle). (D) The molar ellipticity of 2-d old, 
40 µM βS in the absence (blue circle) and presence of 100 mg/ mL Fc70 (salmon circle), Fc400 (cyan circle) and 
PEG1000 (mustard circle). 
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Supplementary Figure 2. Small angle x-ray scattering (SAXS) of deuterated and non-deuterated forms of αS and 
βS. Bar graph displaying radius of gyration, Rg; of non-deuterated βS (light blue solid bar calculated based on Guinier 
approximation, light blue patterned bar calculated based on pair-distance distribution function), deuterated βS (navy 
blue solid bar – Guinier, navy blue patterned bar – real space), deuterated αS (grey solid bar – Guinier, grey patterned 
bar – real space) and non-deuterated αS (black solid bar – Guinier, black patterned bar – real space). 
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Supplementary Figure 3. SANS scattering profiles of αS and βS in the absence and presence of Fc400. αS (A) 
Kratky-Debye plot and (B) Porod-Debye plot in the absence (empty black circle) and presence of Fc400 (empty 
magenta circle) in 40% D2O buffer. βS (C) Kratky-Debye plot and (D) Porod-Debye plot in the absence (empty blue 
circle) and presence of Fc400 (empty cyan circle) in 40% D2O buffer. The experimental conditions are summarised in 
Table S1. 
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Supplementary Figure 4. SANS intensity plots of deuterated and non-deuterated αS, βS and their mixtures in the 
absence and presence of Fc400. (A) Experimental SANS intensity plot of deuterated αS in 0% D2O buffer (black 
hollow circle), deuterated βS 0% D2O buffer (blue hollow circle), deuterated αS + non-deuterated βS in 40% D2O 
buffer (lime hollow circle), deuterated αS + non-deuterated βS + Fc400 in 40% D2O buffer (magenta hollow circle), 
deuterated αS + non-deuterated βS in 100% D2O buffer (mustard hollow circle). (B) Experimental SANS intensity plot 
of deuterated βS in 0% D2O buffer (blue hollow circle), deuterated αS 0% D2O buffer (black hollow circle), deuterated 
βS + non-deuterated αS in 40% D2O buffer (cyan hollow circle), deuterated βS + non-deuterated αS + Fc400 in 40% 
D2O buffer (red hollow circle), deuterated βS + non-deuterated αS in 90% D2O buffer (violet hollow circle). The 
experimental conditions are summarised in Table S1. 
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Supplementary Figure 5. Canonical SANS based profiles of deuterated and non-deuterated αS, βS and their 
mixtures in the absence and presence of Fc400. Detecting conformational flexibility of αS: (A) Power law plot, (B) 
Kratky-Debye plot and (C) Porod-Debye plot of deuterated αS in 0% D2O buffer (black hollow circle), deuterated βS 
0% D2O buffer (blue empty circle), deuterated αS + non-deuterated βS in 40% D2O buffer (lime hollow circle), 
deuterated αS + non-deuterated βS + Fc400 in 40% D2O buffer (magenta hollow circle), deuterated αS + non-deuterated 
βS in 100% D2O buffer (mustard hollow circle). The experimental conditions are summarised in Table S1. 
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Supplementary Figure 6. Canonical SANS based profiles of deuterated and non-deuterated βS, αS and their 
mixtures in the presence and absence of Fc400. Detecting conformational flexibility of βS: (A) Power law plot, (B) 
Kratky-Debye plot and (C) Porod-Debye plot of deuterated βS in 0% D2O buffer (blue hollow circle), deuterated αS 
0% D2O buffer (black empty circle), deuterated βS + non-deuterated αS in 40% D2O buffer (cyan hollow circle), 
deuterated βS + non-deuterated αS + Fc400 in 40% D2O buffer (red hollow circle), deuterated βS + non-deuterated αS 
in 90% D2O buffer (violet hollow circle). The experimental conditions are summarised in Table S1. 
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Supplementary Figure 7. βS self-assembled structures in the presence of αS. TEM image of 2-day incubated βS and 
αS mixture in 20 mM phosphate buffer, pH 7.4, room temperature at a 1:1 molar ratio. Scale = 50 nm. 
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Supplementary Table 1. List of small-angle neutron scattering (SANS) samples. 
S/No. 
Sample in 50 mM 
phosphate buffer, pH 7.4 
at room temperature 
Deuterated 
protein 
(8 mg/mL) 
Non-deuterated 
protein 
(8 mg/mL) 
Crowding 
agent 
(100 mg/mL) 
D2O 
(%) 
1 Deuterated αS  αS Nil Nil 0 
2 Deuterated αS and Fc400  αS Nil Ficoll 400 40 
3 
Deuterated αS and non-
deuterated βS  
αS βS Nil 40 
4 
Deuterated αS, non-
deuterated βS  
αS βS Nil 40 
5 
Deuterated αS, non-
deuterated βS and Fc400 
αS βS Ficoll 400 100 
6 Deuterated βS  βS Nil Nil 0 
7 Deuterated βS and Fc400  βS Nil Ficoll 400 40 
8 
Deuterated βS and non-
deuterated αS  
βS αS Nil 40 
9 
Deuterated βS, non-
deuterated αS and Fc400  
βS αS Ficoll 400 40 
10 
Deuterated βS and non-
deuterated αS  
βS αS Nil 100 
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Supplementary Table 2. Summary of SAXS- and SANS-based αS and βS values. 
S/No. Sample 
Guinier  
(radius of 
gyration), 
Rg (Å) 
Pair-
distribution 
function, Rg 
(real) (Å) 
Porod 
exponent 
(d) 
SAXS-based estimation 
1 
Deuterated αS in 100% D2O buffer, pH 
7.4 
53.4 62.1 - 
2 
Non-deuterated αS in 0% D2O buffer, 
pH 7.4 
52.6 67.9 - 
3 Deuterated βS in 0% D2O buffer, pH 7.4 38.7 46.0 - 
4 
Non-deuterated βS in 0% D2O buffer, 
pH 7.4 
35.0 43.9 - 
SANS-based estimation 
1 Deuterated αS in 0% D2O buffer, pH 7.4 54.6 ± 2.9 - 1.1 
2 
Deuterated αS and Fc400 in 40% D2O 
buffer, pH 7.4 
56.3 ± 0.5 - 1.3 
3 
Deuterated αS and non-deuterated βS in 
40% D2O buffer, pH 7.4 
55.5 ± 2.5 - 1.0 
4 
Deuterated αS, non-deuterated βS and 
Fc400 in 40% D2O buffer, pH 7.4 
52.0 ± 1.4 - 1.2 
5 
Deuterated αS and non-deuterated in 
100% D2O buffer, pH 7.4 (Aggregated) 
184.9 ± 1.6 - - 
6 Deuterated βS in 0% D2O buffer, pH 7.4 41.8 ± 0.6 - 0.9 
7 
Deuterated βS and Fc400 in 40% D2O 
buffer, pH 7.4 
56.9 ± 2.0 - 0.7 
8 
Deuterated βS and non-deuterated αS in 
40% D2O buffer, pH 7.4 
52.1 ± 5.7 - 0.7 
9 
Deuterated βS, non-deuterated αS and 
Fc400 in 40% D2O buffer, pH 7.4 
47.5 ± 1.3 - 0.9 
10 
Deuterated βS and non-deuterated αS in 
90% D2O buffer, pH 7.4 (Aggregated) 
85.5 ± 0.4 - - 
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CHAPTER 6 
Conclusions and Future Work 
6.1 Summary  
A nascent or unfolded polypeptide chain can attain various structures including that of the native 
functionally active form, oligomers, amyloid fibrils and many other less defined conformations 
via the on- and off-folding pathways. Specific features of the polypeptides that warrant such 
diverse folds are still unanswered. Additionally, loss-of-function or gain-of-function of the 
various protein conformations may either result in the accumulation and deposition of proteins in 
tissues, which can lead to more than 55 protein conformational disorders or provide beneficial 
functions in living organisms.  
One of the major issues affecting our understanding of protein conformational diseases is to 
precisely define the conformation, dynamics and biochemical properties of the heterogeneous 
population of the protein. The protein’s structural dynamics, proclivity to oligomerise and 
polymerise, and its ability to interact with other macromolecules are susceptible to the effects of 
macromolecular crowding as occurs in the cell. Typically, organisms respond to the complexities 
associated with protein conformations with the constitutive expression, secretion and 
upregulation of a group of proteins, collectively known as molecular chaperones. Molecular 
chaperones are involved with proteins from their synthesis to their clearance, by assisting them 
during de novo folding, oligomerisation, transport, stabilisation, refolding, proteolytic 
degradation and autophagy. Identifying and understanding the conformational, oligomeric 
heterogeneity, and the role of molecular chaperones during the process of protein assembly and 
disassembly are of vital importance to comprehend systemic and localised protein aggregation 
diseases as well as for functional amyloids. This could contribute to the development of more 
effective therapies for these diseases or lead to opportunities to exploit non-toxic protein 
conformations to our advantage.  
The overall objective of this thesis was to advance the understanding of the multifaceted nature 
of the process of protein assembly. Specifically, this aim was achieved by providing insights into 
the protein assembly and disassembly process of a novel amyloid fibril-forming protein. Secondly, 
a novel aggregation-induced emission luminogen was used to monitor the ordered protein 
assembly process and detect intermediate oligomeric assemblies. Thirdly, the role of molecular 
chaperones during various stages of protein polymerisation was studied. Finally, the interaction 
of two neighbouring macromolecules under crowding conditions was demonstrated. Before 
commenting on the importance and possible future directions of this research, the key findings of 
this thesis are summarised below.  
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In Chapter 2, it was shown that both the mouse and the human form of acyl-coenzyme thioesterase 
7 (Acot7), rapidly formed amyloid fibrils under physiological pH and temperature. Furthermore, 
mouse Acot7 underwent nucleation-independent, multi-stranded, passive polymerisation to form 
a superhelical amyloid fibril structure. The process of mAcot7 fibril formation was primarily 
affected by electrostatic or hydrogen bonding interactions. During the process of mAcot7 
fibrillation, an α-helical to β-sheet structural phase transition along with the appearance of various 
globular oligomeric entities were noticed. The generation of lower molecular mass species 
appeared to be critical for the structural rearrangement of mAcot7 and its further filamentous 
growth. Furthermore, the protein’s thioesterase activity was unaffected by the fibril assembly and 
disassembly process. 
Bis-(Triphenylphosphonium) tetraphenylethene (TPE-TPP), a novel aggregation-induced 
emission luminogen, was used for the rapid identification and monitoring of the early-stage 
aggregates during amyloid fibril formation (Chapter 3). The broad applicability of the fluorescent 
probe in monitoring the process of amyloid fibril formation under conditions of acidic pH and 
elevated temperature was determined. TPE-TPP was also a highly effective fluorescent detector 
of fibril formation while screening for potential amyloid inhibitors and to discern variations in 
fibril morphologies. 
In Chapter 4, it was shown that molecular chaperones such as αB-crystallin (αB-C) and clusterin 
stabilised different prefibrillar and fibrillar forms of D76N β2-microglobulin (D76N β2m), most 
likely via hydrophobic and ionic interactions. The interactions of αB-C and clusterin with 
aggregating D76N β2m delayed the fibrillation process, increased fibril stability and prevented 
self-propagation of fibrils. Additionally, molecular chaperones such as αB-C and α2-
macroglobulin (α2M) formed amyloid fibrils under the same physiological conditions of pH and 
temperature that were used for D76N β2m fibril formation. 
Finally in Chapter 5, α- and β-synuclein lower molecular mass oligomers were isolated and their 
interaction was studied under physiological pH, temperature and crowding conditions. The β-
synuclein (βS) monomer behaved as a negatively charged species while the oligomer appeared to 
be a positively charged complex. The oppositely charged βS species self-assembled to form non-
amyloid fibrillar structures, which was attenuated in the presence of a crowding agent (i.e. Ficoll 
400). α- and β-synuclein oligomers underwent a spontaneous destabilising interaction (i.e. they 
both aggregated in the presence of each other) which was moderated under crowding conditions. 
6.2 Future Directions 
Acyl co-enzyme thioesterase 7 (Acot7) is a brain cytosolic enzyme involved in the hydrolysis of 
arachidonoyl-CoA and plays a putative role during inflammation (1). The α-helical to the β-sheet 
conformational conversion in the soluble, native, functionally active form of the full-length 
protein resulted in the formation of various oligomeric species. The absence of a plateau phase in 
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mAcot7 full length (FL) ThT fluorescence profiles suggested that the process of fibril formation 
did not reach equilibrium until ~160 hours. Additionally, the thioesterase activity of the protein 
remained steady, indicating the constant formation of a native-like structure during the process of 
mAcot7 FL fibril assembly and disassembly. Isolation, biophysical and biochemical 
characterisation of different globular and fibrillar species of Acot7, and investigating its capacity 
to form amyloid fibrils in tissue(s) would greatly assist in understanding their biological 
significance (See Table 1).  
Furthermore, proteins may form a variety of oligomeric intermediates, with differing 
conformational and biological properties, on the pathway to form amyloid fibrils. Despite the 
diversity of prefibrillar or early-stage oligomeric assemblies and the significant role these 
cytotoxic species may play in amyloid-associated diseases, tools currently available to 
characterise these species and clarify the relationship between their precise molecular and 
pathogenic nature are inadequate (3, 4, 30). Rapid fluorescence based dye-binding amyloid assays 
using Thioflavin (ThT) and Congo red have been traditionally used to monitor the fibrillation of 
peptides and proteins. However, both these probes reveal limited information about the 
intermediate oligomeric species. Additionally, they may also promote β-sheet formation and offer 
a biased assessment in the presence of exogenous amyloid inhibitors, extreme pH, and 
temperature (5, 6). In this thesis, a novel fluorescent probe, TPE-TPP, detected early-stage 
aggregates, variations in fibril morphology and showed broader applicability in monitoring 
amyloid fibril formation. Our probe was more robust than ThT and provided data that were more 
reflective of the aggregation process under conditions such as acidic pH and elevated temperature, 
or in the presence of exogenous compounds. In future, we will endeavour to understand the 
structural and biological significance of the entities (e.g. prefibrillar species) detected by TPE-
TPP (See Table 1). 
In vivo, protein homoeostasis (proteostasis) is maintained with the assistance of a diverse group 
of intra- and extra-cellular molecular chaperones such as αB-crystallin, Hsp27, clusterin and α2-
macroglobulin (7-9). Full elucidation of the causes of protein conformational disorders cannot be 
accomplished without understanding the regulatory role of the molecular chaperones during the 
process of protein aggregation. Utilising αB-crystallin and clusterin, it was observed that 
molecular chaperones acted on various stages of D76N β2m polymerisation by stabilising its 
prefibrillar and fibrillar forms. Both chaperones were also found incorporated into the D76N β2m 
fibrils, which increased the latter’s chemical stability and prevented secondary nucleation events. 
It is conceivable that when faced with aggregation on a larger scale, the molecular chaperones 
can be overwhelmed, as suggested by the formation of αB-crystallin and α2M amyloid fibrils 
under the same conditions as D76N β2m. The propensity of molecular chaperones to form 
amyloid fibrils along with the target proteins under extreme conditions may lead to co-deposition 
of the fibrils in tissue. The elimination of nucleation centres on fibrils by the molecular chaperones 
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may be achieved simply by binding to the fibril’s surface or by the incorporation of the chaperone 
protein into the target protein fibril, further undergoing a similar fibrillation process leading to 
the co-deposition of fibrils. This molecular chaperone action of inhibiting fibril proliferation, may 
also reduce the toxic effects of various undesired protein species, and therefore may play a role 
in their regulatory mechanism in vivo. The observance of molecular chaperones co-localised with 
amyloid β plaques, Lewy bodies and other protein aggregates deposits, is consistent with this 
hypothesis. We aim to validate this with more experimental evidence in the future (See Table 1). 
Biological macromolecules including proteins and their complexes in cells have limited free space, 
as the intracellular environment is often crowded with tightly packed macromolecules (10). 
Molecular crowding significantly affects protein-protein interactions, protein oligomeric 
assemblies and their subsequent polymerisation to insoluble aggregates and in turn, proteostasis 
(11, 12). In vitro, researchers have used crowding agents such as Ficoll, Dextran and Polyethylene 
glycol to simulate crowding conditions. Using Ficoll 400, we endeavoured to better understand 
the interactions of presynaptic α- and β-synuclein in a crowded, cell-like environment. We 
observed that the β-synuclein (βS) oligomerisation and its self-assembly process are significantly 
enhanced under crowding conditions. In addition, we observed that the βS species were 
electrically oppositely charged; the monomer behaved like a negatively charged species whereas 
the oligomer acted as a positively charged compound. The observation of a positively charged βS 
oligomer may have direct relevance to understanding the toxic nature of oligomers, in particular 
their interaction with the negatively charged lipid bilayer, leading to the formation of pores and 
cell disruption. The self-assembly of βS to form non-amyloid fibrillar structures and its 
destabilising interaction with α-synuclein (αS) may be explained on the basis of electrostatic 
interactions, in which positively charged βS oligomers associate with negatively charged βS 
monomers and αS. However, more experimental work is needed to elucidate the mechanism and 
biological significance of the overall change in net charge in the βS oligomer, as well as other 
protein oligomers (See Table 1). In addition, investigating mutants of βS, particularly P123H and 
V70M which have been associated with the development of Parkinson’s disease and dementia 
with Lewy bodies (13), may aid in defining the complex behavioural and functional properties of 
βS, which is proposed to be the natural regulator of αS associated cytotoxicity (14, 15). 
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Table 1. Lists of objectives, methods and possible outcomes of future work 
Aims and Objectives Methods and Procedures Possible Outcomes 
CHAPTER 2– ACOT7 FIBRIL FORMATION 
Determine the molecular basis 
for the α-helical to β-sheet 
conformational transition and 
the precise structural role of the 
N-term and C-term hotdog 
domains in mAcot7 amyloid 
fibril formation 
Site-directed mutagenesis, mAcot7 
unfolding and refolding kinetic 
measurements using stopped-flow 
coupled to fluorescence 
spectrophotometer, circular 
dichroism, Bimolecular 
fluorescence complementation 
(BiFC) and Total internal reflection 
fluorescence microscopy (TIRF), 
(17-22, 31) 
Gain insight into the role of 
prolyl cis-trans isomerism 
and domain-swapping in the 
mechanism of mAcot7 
polymerisation 
Understand the structural 
instability of the fibril-prone N-
term and C-term domains of 
mAcot7  
Biophysical and biochemical 
characterisation using the 
techniques outlined above, intrinsic 
and extrinsic fluorescence 
measurements, native agarose gel 
electrophoresis (Native-AGE) (23) 
Gain insight into the 
increased amyloid-forming 
propensity of hotdog 
domains of mAcot7 
Purification and characterisation  
of globular, oligomeric 
intermediates and variously 
sized fibrillar forms of Acot 
proteins  
Size exclusion chromatography, 
ultra-centrifugation, native-AGE, 
mass-spectrometry techniques, cell-
based cytotoxicity assays 
Species-specific molecular 
weight and toxicity estimates 
Determine the capacity of the 
mouse and human forms of 
mAcot7 to form amyloid fibrils 
in the neuroblastoma cell lines 
NB41A3 and SH-SY5Y and 
evaluate their effect on 
proteostasis 
Fluorescence live cell imaging, 
proteomics, mass-spectrometry (24, 
25) 
Gain insight into the 
biological significance of 
Acot7 amyloid fibril 
formation  
CHAPTER 3– NOVEL AMYLOID BINDING DYE, TPE-TPP 
Isolate and test the toxicity of 
early-stage aggregates formed 
by various pathological and non-
pathological proteins detected by 
TPE-TPP 
Size exclusion chromatography, 
ultra-centrifugation, native-AGE, 
mass-spectrometry techniques, cell-
based cytotoxicity assays such as 
lactate dehydrogenase, MTT and 
neutral red   
Distinction between toxic 
and non-toxic intermediate 
protein aggregate forms  
Understand conjugation of TPE-
TPP and uranyl acetate  
Raman, Fourier transform infrared 
(FTIR), and UV-Vis spectroscopy, 
transmission electron microscopy 
(TEM) (26) 
Development of uranyl–
conjugated TPE-TPP as a 
positive stain for protein 
transmission electron 
microscope imaging  
Determine the binding site of 
TPE-TPP and its specificity to 
different protein forms  
Fluorescence quenching, Co-
crystallisation of TPE-TPP with the 
N-term and the C-term domains of 
mAcot7 FL (X-ray diffraction), 
equilibrium microdialysis-based 
techniques (27, 28)    
Gain insight into the 
mechanism of TPE-TPP 
detection of various protein 
forms at the atomic level 
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CHAPTER 4– INTERACTION OF MOLECULAR CHAPERONES WITH D76N Β2-
MICROGLOBULIN 
Characterisation of αB-crystallin 
and clusterin stabilised D76N 
β2m amyloid fibrils 
Ultrafast 2D-Infrared spectroscopy 
(2D-IR), morphological analysis by 
TEM, mechanical measurements 
using atomic force microscopy 
(AFM), real-time quantitative live-
cell analysis (29) 
Gain further insight into the 
protective role of molecular 
chaperones 
Determine the molecular basis 
and biological significance of 
amyloid fibril formation by 
molecular chaperones such as 
αB-crystallin and α2-
macroglobulin and understand 
their biological significance 
Biophysical and biochemical 
characterisation, toxicity estimation, 
determining the biomechanical 
properties using techniques 
described above, limited proteolysis  
May provide insight into the 
mechanism of their 
chaperone action, systemic 
and localised protein 
aggregation diseases, and 
functional amyloids 
CHAPTER 5– α-/β- SYNUCLEIN OLIGOMERISATION UNDER CROWDING CONDITIONS 
Understand the mechanism and 
biological significance of wild 
type and mutant (P123H and 
V70M) β-synuclein 
oligomerisation and self-
assembly 
90° light scattering assay to monitor 
oligomerisation using fluorescence 
spectrophotometer, evaluating 
chemical forces involved inβ-
synuclein self-assembly, 
morphological analysis using cryo-
TEM, cryo-electron tomography, 
AFM, Time-resolved X-ray 
scattering, Real-time quantitative 
live-cell analysis 
May assist in elucidating the 
underlying role of toxic 
oligomers in cell lysis 
Determine methods of 
stabilising the deleterious 
interaction between α- and β-
synuclein 
Evaluation of α- and β-synuclein 
interaction in the presence of 
phospholipids with the help of 
Small-angle scattering of neutrons 
(SANS), effect of small molecules 
on β-synuclein self-assembly, and α- 
and β-synuclein negative interaction 
To establish a novel drug 
target for the prevention of 
synucleinopathies 
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6.3 Concluding Remarks 
The multifaceted approach of this thesis helped in better understanding the complexities 
associated with the protein assembly and disassembly process responsible for more than 
55 human systemic and localised protein aggregation diseases. Acot7, a novel amyloid 
fibre forming, brain cytosolic protein underwent highly reversible nucleation-
independent, multi-stranded polymerisation to acquire a superhelical fibril structure 
(Chapter 2). Furthermore, a novel fluorescent probe, TPE-TPP, showed broader 
applicability in monitoring in vitro amyloid fibril formation along with the detection of 
early-stage aggregates. In addition, TPE-TPP exhibited a notable spectral shift upon 
binding to prefibrillar species, indicating a unique structural feature of these intermediates 
(Chapter 3). Molecular chaperones such as αB-C and clusterin prevented both primary 
and secondary nucleation of D76N β2m fibril formation by acting on various pre- and 
pro-fibrillar species. This may explain how these chaperones potentially regulate dialysis-
related amyloidosis by slowing the proliferation of D76N β2m amyloid fibril formation 
(Chapter 4). Under physiologically relevant i.e. pH, temperature and crowding conditions, 
βS exists as positively charged oligomers and underwent a deleterious interaction with 
αS resulting in co-aggregate formation (Chapter 5). Ultimately, complete understanding 
of the structural instability of Acot7 in regulating lipid metabolism, the unique structural 
features detected by TPE-TPP, the biological significance of chaperone- modulated pre-
and pro-fibrillar D76N β2m and the surface charge transformation of βS during 
oligomerisation may in turn, lead to novel therapeutic targets for preventing or controlling 
protein aggregation diseases.   
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